{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:11:13Z","timestamp":1788930673417,"version":"build-2803163510"},"reference-count":491,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci. China Life Sci."],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s11427-025-2991-7","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T12:26:39Z","timestamp":1770035199000},"page":"2543-2574","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Advances in Alzheimer\u2019s disease: mechanistic insights and therapeutic targets"],"prefix":"10.1007","volume":"69","author":[{"given":"Yu-Juan","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Jun","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaqiu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Hong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Tai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-Qiang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Zhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Jiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"key":"2991_CR1","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1093\/brain\/awr104","volume":"134","author":"R Abeti","year":"2011","unstructured":"Abeti, R., Abramov, A.Y., and Duchen, M.R. (2011). \u03b2-amyloid activates PARP causing astrocytic metabolic failure and neuronal death. Brain 134, 1658\u20131672.","journal-title":"Brain"},{"key":"2991_CR2","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1080\/19336896.2016.1223003","volume":"10","author":"S Abounit","year":"2016","unstructured":"Abounit, S., Wu, J.W., Duff, K., Victoria, G.S., and Zurzolo, C. (2016). Tunneling nanotubes: a possible highway in the spreading of tau and other prion-like proteins in neurodegenerative diseases. Prion 10, 344\u2013351.","journal-title":"Prion"},{"key":"2991_CR3","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1523\/JNEUROSCI.4042-03.2004","volume":"24","author":"AY Abramov","year":"2004","unstructured":"Abramov, A.Y., Canevari, L., and Duchen, M.R. (2004). \u03b2-amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase. J Neurosci 24, 565\u2013575.","journal-title":"J Neurosci"},{"key":"2991_CR4","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1093\/brain\/awz100","volume":"142","author":"M Albert","year":"2019","unstructured":"Albert, M., Mairet-Coello, G., Danis, C., Lieger, S., Caillierez, R., Carrier, S., Skrobala, E., Landrieu, I., Michel, A., Schmitt, M., et al. (2019). Prevention of tau seeding and propagation by immunotherapy with a central tau epitope antibody. Brain 142, 1736\u20131750.","journal-title":"Brain"},{"key":"2991_CR5","doi-asserted-by":"publisher","first-page":"3650","DOI":"10.1016\/j.jmb.2017.09.007","volume":"429","author":"YK Al-Hilaly","year":"2017","unstructured":"Al-Hilaly, Y.K., Pollack, S.J., Vadukul, D.M., Citossi, F., Rickard, J.E., Simpson, M., Storey, J.M.D., Harrington, C.R., Wischik, C.M., and Serpell, L.C. (2017). Alzheimer\u2019s disease-like paired helical filament assembly from truncated tau protein is independent of disulfide crosslinking. J Mol Biol 429, 3650\u20133665.","journal-title":"J Mol Biol"},{"key":"2991_CR6","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s40478-023-01563-4","volume":"11","author":"M Ali","year":"2023","unstructured":"Ali, M., Archer, D.B., Gorijala, P., Western, D., Timsina, J., Fern\u00e1ndez, M.V., Wang, T. C., Satizabal, C.L., Yang, Q., Beiser, A.S., et al. (2023). Large multi-ethnic genetic analyses of amyloid imaging identify new genes for Alzheimer disease. Acta Neuropathol Commun 11, 68.","journal-title":"Acta Neuropathol Commun"},{"key":"2991_CR7","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.1523\/JNEUROSCI.5098-09.2010","volume":"30","author":"I Allaman","year":"2010","unstructured":"Allaman, I., Gavillet, M., B\u00e9langer, M., Laroche, T., Viertl, D., Lashuel, H.A., and Magistretti, P.J. (2010). Amyloid-\u03b2 aggregates cause alterations of astrocytic metabolic phenotype: impact on neuronal viability. J Neurosci 30, 3326\u20133338.","journal-title":"J Neurosci"},{"key":"2991_CR8","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.3390\/molecules25051195","volume":"25","author":"ZL Almeida","year":"2020","unstructured":"Almeida, Z.L., and Brito, R.M.M. (2020). Structure and aggregation mechanisms in amyloids. Molecules 25, 1195.","journal-title":"Molecules"},{"key":"2991_CR9","volume-title":"The A\u03b2 targeting drug development","author":"Alzforum","year":"2024","unstructured":"Alzforum. (2024). The A\u03b2 targeting drug development. Available from URL: https:\/\/www.alzforum.org\/therapeutics\/search?fda_statuses=&target_types%5B%5D=170&therapy_types=&conditions%5B%5D=145&keywords-entry=&keywords=#results."},{"key":"2991_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1083\/jcb.200207030","volume":"161","author":"HK Anandatheerthavarada","year":"2003","unstructured":"Anandatheerthavarada, H.K., Biswas, G., Robin, M.A., and Avadhani, N.G. (2003). Mitochondrial targeting and a novel transmembrane arrest of Alzheimer\u2019s amyloid precursor protein impairs mitochondrial function in neuronal cells. J Cell Biol 161, 41\u201354.","journal-title":"J Cell Biol"},{"key":"2991_CR11","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s00401-016-1615-4","volume":"132","author":"OM Andersen","year":"2016","unstructured":"Andersen, O.M., Rudolph, I.M., and Willnow, T.E. (2016). Risk factor SORL1: from genetic association to functional validation in Alzheimer\u2019s disease. Acta Neuropathol 132, 653\u2013665.","journal-title":"Acta Neuropathol"},{"key":"2991_CR12","doi-asserted-by":"publisher","first-page":"3994","DOI":"10.3390\/cells11243994","volume":"11","author":"K Ando","year":"2022","unstructured":"Ando, K., Nagaraj, S., K\u00fc\u00e7\u00fckali, F., de Fisenne, M.A., Kosa, A.C., Doeraene, E., Lopez Gutierrez, L., Brion, J.P., and Leroy, K. (2022). PICALM and Alzheimer\u2019s disease: an update and perspectives. Cells 11, 3994.","journal-title":"Cells"},{"key":"2991_CR13","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.3390\/ijms24043754","volume":"24","author":"J Andrade-Guerrero","year":"2023","unstructured":"Andrade-Guerrero, J., Santiago-Balmaseda, A., Jeronimo-Aguilar, P., Vargas-Rodr\u00edguez, I., Cadena-Su\u00e1rez, A.R., S\u00e1nchez-Garibay, C., Pozo-Molina, G., M\u00e9ndez-Catal\u00e1, C.F., Cardenas-Aguayo, M.C., Diaz-Cintra, S., et al. (2023). Alzheimer\u2019s disease: an updated overview of its genetics. Int J Mol Sci 24, 3754.","journal-title":"Int J Mol Sci"},{"key":"2991_CR14","doi-asserted-by":"publisher","first-page":"104511","DOI":"10.1016\/j.ebiom.2023.104511","volume":"90","author":"SJ Andrews","year":"2023","unstructured":"Andrews, S.J., Renton, A.E., Fulton-Howard, B., Podlesny-Drabiniok, A., Marcora, E., and Goate, A.M. (2023). The complex genetic architecture of Alzheimer\u2019s disease: novel insights and future directions. eBioMedicine 90, 104511.","journal-title":"eBioMedicine"},{"key":"2991_CR15","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1038\/s41591-019-0611-3","volume":"25","author":"JF Arboleda-Velasquez","year":"2019","unstructured":"Arboleda-Velasquez, J.F., Lopera, F., O\u2019Hare, M., Delgado-Tirado, S., Marino, C., Chmielewska, N., Saez-Torres, K.L., Amarnani, D., Schultz, A.P., Sperling, R.A., et al. (2019). Resistance to autosomal dominant Alzheimer\u2019s disease in an APOE3 Christchurch homozygote: a case report. Nat Med 25, 1680\u20131683.","journal-title":"Nat Med"},{"key":"2991_CR16","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1007\/s00415-021-10826-w","volume":"269","author":"C Armon","year":"2022","unstructured":"Armon, C., Wolfson, S., Margalit, R., Avraham, L., Bugen, Y., Cohen, A., Meiri, A., and Shorer, R. (2022). Estimating the X chromosome-mediated risk for developing Alzheimer\u2019s disease. J Neurol 269, 2479\u20132485.","journal-title":"J Neurol"},{"key":"2991_CR17","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/nn.4132","volume":"18","author":"H Asai","year":"2015","unstructured":"Asai, H., Ikezu, S., Tsunoda, S., Medalla, M., Luebke, J., Haydar, T., Wolozin, B., Butovsky, O., K\u00fcgler, S., and Ikezu, T. (2015). Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nat Neurosci 18, 1584\u20131593.","journal-title":"Nat Neurosci"},{"key":"2991_CR18","doi-asserted-by":"publisher","first-page":"148368","DOI":"10.1016\/j.gene.2024.148368","volume":"912","author":"B Ataei","year":"2024","unstructured":"Ataei, B., Hokmabadi, M., Asadi, S., Asadifard, E., Aghaei Zarch, S.M., Najafi, S., and Bagheri-Mohammadi, S. (2024). A review of the advances, insights, and prospects of gene therapy for Alzheimer\u2019s disease: a novel target for therapeutic medicine. Gene 912, 148368.","journal-title":"Gene"},{"key":"2991_CR19","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s004010100423","volume":"103","author":"JC Augustinack","year":"2002","unstructured":"Augustinack, J.C., Schneider, A., Mandelkow, E.M., and Hyman, B.T. (2002). Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer\u2019s disease. Acta Neuropathol 103, 26\u201335.","journal-title":"Acta Neuropathol"},{"key":"2991_CR20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12964-021-00732-z","volume":"19","author":"AA Balmik","year":"2021","unstructured":"Balmik, A.A., and Chinnathambi, S. (2021). Methylation as a key regulator of Tau aggregation and neuronal health in Alzheimer\u2019s disease. Cell Commun Signal 19, 51.","journal-title":"Cell Commun Signal"},{"key":"2991_CR21","doi-asserted-by":"publisher","first-page":"102206","DOI":"10.1016\/j.cbpa.2022.102206","volume":"71","author":"I Barrio-Hernandez","year":"2022","unstructured":"Barrio-Hernandez, I., and Beltrao, P. (2022). Network analysis of genome-wide association studies for drug target prioritisation. Curr Opin Chem Biol 71, 102206.","journal-title":"Curr Opin Chem Biol"},{"key":"2991_CR22","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nm.4022","volume":"22","author":"K Baruch","year":"2016","unstructured":"Baruch, K., Deczkowska, A., Rosenzweig, N., Tsitsou-Kampeli, A., Sharif, A.M., Matcovitch-Natan, O., Kertser, A., David, E., Amit, I., and Schwartz, M. (2016). PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer\u2019s disease. Nat Med 22, 135\u2013137.","journal-title":"Nat Med"},{"key":"2991_CR23","doi-asserted-by":"publisher","first-page":"18118","DOI":"10.1038\/s41598-019-54741-7","volume":"9","author":"N Baruch-Eliyahu","year":"2019","unstructured":"Baruch-Eliyahu, N., Rud, V., Braiman, A., and Priel, E. (2019). Telomerase increasing compound protects hippocampal neurons from amyloid beta toxicity by enhancing the expression of neurotrophins and plasticity related genes. Sci Rep 9, 18118.","journal-title":"Sci Rep"},{"key":"2991_CR24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1750-1326-7-14","volume":"7","author":"JM Basak","year":"2012","unstructured":"Basak, J.M., Kim, J., Pyatkivskyy, Y., Wildsmith, K.R., Jiang, H., Parsadanian, M., Patterson, B.W., Bateman, R.J., and Holtzman, D.M. (2012). Measurement of apolipoprotein E and amyloid \u03b2 clearance rates in the mouse brain using bolus stable isotope labeling. Mol Neurodegener 7, 14.","journal-title":"Mol Neurodegener"},{"key":"2991_CR25","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1097\/NEN.0b013e31817275c7","volume":"67","author":"G Basurto-Islas","year":"2008","unstructured":"Basurto-Islas, G., Luna-Mu\u00f1oz, J., Guillozet-Bongaarts, A.L., Binder, L.I., Mena, R., and Garc\u00eda-Sierra, F. (2008). Accumulation of aspartic acid421- and glutamic acid391-cleaved tau in neurofibrillary tangles correlates with progression in Alzheimer disease. J Neuropathol Exp Neurol 67, 470\u2013483.","journal-title":"J Neuropathol Exp Neurol"},{"key":"2991_CR26","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1002\/alz.12318","volume":"17","author":"D Beckman","year":"2021","unstructured":"Beckman, D., Chakrabarty, P., Ott, S., Dao, A., Zhou, E., Janssen, W.G., Donis-Cox, K., Muller, S., Kordower, J.H., and Morrison, J.H. (2021). A novel tau-based rhesus monkey model of Alzheimer\u2019s pathogenesis. Alzheimers Dement 17, 933\u2013945.","journal-title":"Alzheimers Dement"},{"key":"2991_CR27","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1124\/jpet.108.137455","volume":"326","author":"AN Begum","year":"2008","unstructured":"Begum, A.N., Jones, M.R., Lim, G.P., Morihara, T., Kim, P., Heath, D.D., Rock, C.L., Pruitt, M.A., Yang, F., Hudspeth, B., et al. (2008). Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer\u2019s disease. J Pharmacol Exp Ther 326, 196\u2013208.","journal-title":"J Pharmacol Exp Ther"},{"key":"2991_CR28","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/glia.22432","volume":"61","author":"G Behrendt","year":"2013","unstructured":"Behrendt, G., Baer, K., Buffo, A., Curtis, M.A., Faull, R.L., Rees, M.I., G\u00f6tz, M., and Dimou, L. (2013). Dynamic changes in myelin aberrations and oligodendrocyte generation in chronic amyloidosis in mice and men. Glia 61, 273\u2013286.","journal-title":"Glia"},{"key":"2991_CR29","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","volume":"54","author":"C Bellenguez","year":"2022","unstructured":"Bellenguez, C., K\u00fc\u00e7\u00fckali, F., Jansen, I.E., Kleineidam, L., Moreno-Grau, S., Amin, N., Naj, A.C., Campos-Martin, R., Grenier-Boley, B., Andrade, V., et al. (2022). New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias. Nat Genet 54, 412\u2013436.","journal-title":"Nat Genet"},{"key":"2991_CR30","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1001\/jamaneurol.2024.2843","volume":"81","author":"ME Belloy","year":"2024","unstructured":"Belloy, M.E., Le Guen, Y., Stewart, I., Williams, K., Herz, J., Sherva, R., Zhang, R., Merritt, V., Panizzon, M.S., Hauger, R.L., et al. (2024). Role of the X chromosome in Alzheimer disease genetics. JAMA Neurol 81, 1032\u20131042.","journal-title":"JAMA Neurol"},{"key":"2991_CR31","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1126\/science.adp5186","volume":"385","author":"J Benn","year":"2024","unstructured":"Benn, J., Cheng, S., Keeling, S., Smith, A.E., Vaysburd, M.J., B\u00f6ken, D., Miller, L.V.C., Katsinelos, T., Franco, C., Dupr\u00e9, E., et al. (2024). Aggregate-selective removal of pathological tau by clustering-activated degraders. Science 385, 1009\u20131016.","journal-title":"Science"},{"key":"2991_CR32","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jare.2021.07.001","volume":"40","author":"S Bhardwaj","year":"2022","unstructured":"Bhardwaj, S., Kesari, K.K., Rachamalla, M., Mani, S., Ashraf, G.M., Jha, S.K., Kumar, P., Ambasta, R.K., Dureja, H., Devkota, H.P., et al. (2022). CRISPR\/Cas9 gene editing: new hope for Alzheimer\u2019s disease therapeutics. J Adv Res 40, 207\u2013221.","journal-title":"J Adv Res"},{"key":"2991_CR33","doi-asserted-by":"publisher","first-page":"11169","DOI":"10.1523\/JNEUROSCI.4704-12.2013","volume":"33","author":"R Bhattacharyya","year":"2013","unstructured":"Bhattacharyya, R., Barren, C., and Kovacs, D.M. (2013). Palmitoylation of amyloid precursor protein regulates amyloidogenic processing in lipid rafts. J Neurosci 33, 11169\u201311183.","journal-title":"J Neurosci"},{"key":"2991_CR34","doi-asserted-by":"publisher","first-page":"109134","DOI":"10.1016\/j.celrep.2021.109134","volume":"35","author":"R Bhattacharyya","year":"2021","unstructured":"Bhattacharyya, R., Black, S.E., Lotlikar, M.S., Fenn, R.H., Jorfi, M., Kovacs, D.M., and Tanzi, R.E. (2021). Axonal generation of amyloid-\u03b2 from palmitoylated APP in mitochondria-associated endoplasmic reticulum membranes. Cell Rep 35, 109134.","journal-title":"Cell Rep"},{"key":"2991_CR35","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/0896-6273(93)90279-Z","volume":"11","author":"J Biernat","year":"1993","unstructured":"Biernat, J., Gustke, N., Drewes, G., Mandelkow, E., and Mandelkow, E. (1993). Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: distinction between PHF-like immunoreactivity and microtubule binding. Neuron 11, 153\u2013163.","journal-title":"Neuron"},{"key":"2991_CR36","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13195-020-00664-9","volume":"12","author":"CP Boix","year":"2020","unstructured":"Boix, C.P., Lopez-Font, I., Cuchillo-Iba\u00f1ez, I., and S\u00e1ez-Valero, J. (2020). Amyloid precursor protein glycosylation is altered in the brain of patients with Alzheimer\u2019s disease. Alzheimers Res Ther 12, 96.","journal-title":"Alzheimers Res Ther"},{"key":"2991_CR37","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S1474-4422(11)70013-8","volume":"10","author":"DJ Bonda","year":"2011","unstructured":"Bonda, D.J., Lee, H., Camins, A., Pall\u00e0s, M., Casadesus, G., Smith, M.A., and Zhu, X. (2011). The sirtuin pathway in ageing and Alzheimer disease: mechanistic and therapeutic considerations. Lancet Neurol 10, 275\u2013279.","journal-title":"Lancet Neurol"},{"key":"2991_CR38","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1750-3639.1991.tb00661.x","volume":"1","author":"H Braak","year":"1991","unstructured":"Braak, H., and Braak, E. (1991). Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol 1, 213\u2013216.","journal-title":"Brain Pathol"},{"key":"2991_CR39","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.mad.2013.08.005","volume":"134","author":"MA Bradley-Whitman","year":"2013","unstructured":"Bradley-Whitman, M.A., and Lovell, M.A. (2013). Epigenetic changes in the progression of Alzheimer\u2019s disease. Mech Ageing Dev 134, 486\u2013495.","journal-title":"Mech Ageing Dev"},{"key":"2991_CR40","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.jalz.2017.03.010","volume":"13","author":"WD Brubaker","year":"2017","unstructured":"Brubaker, W.D., Crane, A., Johansson, J.U., Yen, K., Garfinkel, K., Mastroeni, D., Asok, P., Bradt, B., Sabbagh, M., Wallace, T.L., et al. (2017). Peripheral complement interactions with amyloid \u03b2 peptide: erythrocyte clearance mechanisms. Alzheimers Dement 13, 1397\u20131409.","journal-title":"Alzheimers Dement"},{"key":"2991_CR41","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1016\/S1473-3099(21)00258-9","volume":"21","author":"XL Bu","year":"2021","unstructured":"Bu, X.L., and Wang, Y.J. (2021). Should infectious diseases be targeted to prevent dementias? Lancet Infect Dis 21, 1477\u20131478.","journal-title":"Lancet Infect Dis"},{"key":"2991_CR42","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.conb.2021.10.003","volume":"72","author":"A Bubnys","year":"2022","unstructured":"Bubnys, A., and Tsai, L.H. (2022). Harnessing cerebral organoids for Alzheimer\u2019s disease research. Curr Opin Neurobiol 72, 120\u2013130.","journal-title":"Curr Opin Neurobiol"},{"key":"2991_CR43","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrneurol.2014.228","volume":"11","author":"F Burt\u00e9","year":"2015","unstructured":"Burt\u00e9, F., Carelli, V., Chinnery, P.F., and Yu-Wai-Man, P. (2015). Disturbed mitochondrial dynamics and neurodegenerative disorders. Nat Rev Neurol 11, 11\u201324.","journal-title":"Nat Rev Neurol"},{"key":"2991_CR44","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41586-018-0543-y","volume":"562","author":"TJ Bussian","year":"2018","unstructured":"Bussian, T.J., Aziz, A., Meyer, C.F., Swenson, B.L., van Deursen, J.M., and Baker, D.J. (2018). Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline. Nature 562, 578\u2013582.","journal-title":"Nature"},{"key":"2991_CR45","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.3390\/genes13081370","volume":"13","author":"M Butt","year":"2022","unstructured":"Butt, M., Zaman, M., Ahmad, A., Khan, R., Mallhi, T., Hasan, M., Khan, Y., Hafeez, S., Massoud, E., Rahman, M., et al. (2022). Appraisal for the potential of viral and nonviral vectors in gene therapy: a review. Genes 13, 1370.","journal-title":"Genes"},{"key":"2991_CR46","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","volume":"20","author":"DA Butterfield","year":"2019","unstructured":"Butterfield, D.A., and Halliwell, B. (2019). Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease. Nat Rev Neurosci 20, 148\u2013160.","journal-title":"Nat Rev Neurosci"},{"key":"2991_CR47","doi-asserted-by":"publisher","first-page":"e1022","DOI":"10.1038\/tp.2016.280","volume":"7","author":"M Cacciottolo","year":"2017","unstructured":"Cacciottolo, M., Wang, X., Driscoll, I., Woodward, N., Saffari, A., Reyes, J., Serre, M.L., Vizuete, W., Sioutas, C., Morgan, T.E., et al. (2017). Particulate air pollutants, APOE alleles and their contributions to cognitive impairment in older women and to amyloidogenesis in experimental models. Transl Psychiatry 7, e1022.","journal-title":"Transl Psychiatry"},{"key":"2991_CR48","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1038\/s41593-023-01356-x","volume":"26","author":"A Cain","year":"2023","unstructured":"Cain, A., Taga, M., McCabe, C., Green, G.S., Hekselman, I., White, C.C., Lee, D.I., Gaur, P., Rozenblatt-Rosen, O., Zhang, F., et al. (2023). Multicellular communities are perturbed in the aging human brain and Alzheimer\u2019s disease. Nat Neurosci 26, 1267\u20131280.","journal-title":"Nat Neurosci"},{"key":"2991_CR49","doi-asserted-by":"publisher","first-page":"661368","DOI":"10.3389\/fnmol.2021.661368","volume":"14","author":"FX Cantrelle","year":"2021","unstructured":"Cantrelle, F.X., Loyens, A., Trivelli, X., Reimann, O., Despres, C., Gandhi, N.S., Hackenberger, C.P.R., Landrieu, I., and Smet-Nocca, C. (2021). Phosphorylation and O-GlcNAcylation of the PHF-1 epitope of tau protein induce local conformational changes of the C-terminus and modulate tau self-assembly into fibrillar aggregates. Front Mol Neurosci 14, 661368.","journal-title":"Front Mol Neurosci"},{"key":"2991_CR50","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1523\/JNEUROSCI.14-05-03122.1994","volume":"14","author":"GL Caporaso","year":"1994","unstructured":"Caporaso, G.L., Takei, K., Gandy, S.E., Matteoli, M., Mundigl, O., Greengard, P., and De Camilli, P. (1994). Morphologic and biochemical analysis of the intracellular trafficking of the Alzheimer beta\/A4 amyloid precursor protein. J Neurosci 14, 3122\u20133138.","journal-title":"J Neurosci"},{"key":"2991_CR51","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1016\/S0002-9440(10)64296-4","volume":"162","author":"AD Cash","year":"2003","unstructured":"Cash, A.D., Aliev, G., Siedlak, S.L., Nunomura, A., Fujioka, H., Zhu, X., Raina, A.K., Vinters, H.V., Tabaton, M., Johnson, A.B., et al. (2003). Microtubule reduction in Alzheimer\u2019s disease and aging is independent of t filament formation. Am J Pathol 162, 1623\u20131627.","journal-title":"Am J Pathol"},{"key":"2991_CR52","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1002\/alz.12821","volume":"19","author":"EL Castranio","year":"2023","unstructured":"Castranio, E.L., Hasel, P., Haure-Mirande, J., Ramirez Jimenez, A.V., Hamilton, B.W., Kim, R.D., Glabe, C.G., Wang, M., Zhang, B., Gandy, S., et al. (2023). Microglial INPP5D limits plaque formation and glial reactivity in the PSAPP mouse model of Alzheimer\u2019s disease. Alzheimers Dement 19, 2239\u20132252.","journal-title":"Alzheimers Dement"},{"key":"2991_CR53","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.nbd.2012.05.021","volume":"48","author":"X Chai","year":"2012","unstructured":"Chai, X., Dage, J.L., and Citron, M. (2012). Constitutive secretion of tau protein by an unconventional mechanism. Neurobiol Dis 48, 356\u2013366.","journal-title":"Neurobiol Dis"},{"key":"2991_CR54","doi-asserted-by":"publisher","first-page":"5919","DOI":"10.1038\/s41467-023-41672-1","volume":"14","author":"P Chakraborty","year":"2023","unstructured":"Chakraborty, P., Rivi\u00e8re, G., Hebestreit, A., de Opakua, A.I., Vorberg, I.M., Andreas, L. B., and Zweckstetter, M. (2023). Acetylation discriminates disease-specific tau deposition. Nat Commun 14, 5919.","journal-title":"Nat Commun"},{"key":"2991_CR55","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/mp.2013.1","volume":"18","author":"J Chapuis","year":"2013","unstructured":"Chapuis, J., Hansmannel, F., Gistelinck, M., Mounier, A., Van Cauwenberghe, C., Kolen, K.V., Geller, F., Sottejeau, Y., Harold, D., Dourlen, P., et al. (2013). Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology. Mol Psychiatry 18, 1225\u20131234.","journal-title":"Mol Psychiatry"},{"key":"2991_CR56","doi-asserted-by":"publisher","first-page":"eaba0466","DOI":"10.1126\/sciadv.aba0466","volume":"6","author":"C Chen","year":"2020","unstructured":"Chen, C., Ahn, E.H., Kang, S.S., Liu, X., Alam, A., and Ye, K. (2020a). Gut dysbiosis contributes to amyloid pathology, associated with C\/EBP\u03b2\/AEP signaling activation in Alzheimer\u2019s disease mouse model. Sci Adv 6, eaba0466.","journal-title":"Sci Adv"},{"key":"2991_CR57","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.envint.2017.08.020","volume":"108","author":"H Chen","year":"2017","unstructured":"Chen, H., Kwong, J.C., Copes, R., Hystad, P., van Donkelaar, A., Tu, K., Brook, J.R., Goldberg, M.S., Martin, R.V., Murray, B.J., et al. (2017). Exposure to ambient air pollution and the incidence of dementia: a population-based cohort study. Environ Int 108, 271\u2013277.","journal-title":"Environ Int"},{"key":"2991_CR58","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.biopsych.2023.02.992","volume":"94","author":"SD Chen","year":"2023","unstructured":"Chen, S.D., Zhang, W., Feng, Y.W., Wu, B.S., Yang, L., Zhang, Y.R., Wang, H.F., Guo, Y., Deng, Y.T., Feng, J.F., et al. (2023). Genome-wide survival study identifies PARL as a novel locus for clinical progression and neurodegeneration in Alzheimer\u2019s disease. Biol Psychiatry 94, 732\u2013742.","journal-title":"Biol Psychiatry"},{"key":"2991_CR59","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13024-019-0354-0","volume":"15","author":"X Chen","year":"2020","unstructured":"Chen, X., Li, Y., Wang, C., Tang, Y., Mok, S.A., Tsai, R.M., Rojas, J.C., Karydas, A., Miller, B.L., Boxer, A.L., et al. (2020b). Promoting tau secretion and propagation by hyperactive p300\/CBP via autophagy-lysosomal pathway in tauopathy. Mol Neurodegener 15, 2.","journal-title":"Mol Neurodegener"},{"key":"2991_CR60","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1007\/s11427-024-2738-2","volume":"68","author":"X Chen","year":"2025","unstructured":"Chen, X., Xu, J., He, J., Guo, J., Xu, S., Yao, X., Liu, Y., Xu, X., Wei, H., and Li, M. (2025). Therapeutic hypothermia for acute ischemic stroke: from preclinical studies to clinical trials. Sci China Life Sci 68, 2867\u20132879.","journal-title":"Sci China Life Sci"},{"key":"2991_CR61","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41398-020-01113-9","volume":"10","author":"SH Chen","year":"2020","unstructured":"Chen, S.H., Tian, D.Y., Shen, Y.Y., Cheng, Y., Fan, D.Y., Sun, H.L., He, C.Y., Sun, P.Y., Bu, X.L., Zeng, F., Liu, J., Deng, J., Xu, Z. Q., et al. (2020c). Amyloid-beta uptake by blood monocytes is reduced with ageing and Alzheimer\u2019s disease. Transl Psychiatry 10, 423.","journal-title":"Transl Psychiatry"},{"key":"2991_CR62","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.cell.2023.11.029","volume":"187","author":"Y Chen","year":"2024","unstructured":"Chen, Y., Song, S., Parhizkar, S., Lord, J., Zhu, Y., Strickland, M.R., Wang, C., Park, J., Tabor, G.T., Jiang, H., et al. (2024). APOE3ch alters microglial response and suppresses A\u03b2-induced tau seeding and spread. Cell 187, 428\u2013445.e20.","journal-title":"Cell"},{"key":"2991_CR63","doi-asserted-by":"publisher","first-page":"8534","DOI":"10.1073\/pnas.0509955103","volume":"103","author":"YM Chen","year":"2006","unstructured":"Chen, Y.M., Wang, Q.J., Hu, H.S., Yu, P.C., Zhu, J., Drewes, G., Piwnica-Worms, H., and Luo, Z.G. (2006). Microtubule affinity-regulating kinase 2 functions downstream of the PAR-3\/PAR-6\/atypical PKC complex in regulating hippocampal neuronal polarity. Proc Natl Acad Sci USA 103, 8534\u20138539.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2991_CR64","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3233\/JAD-122173","volume":"36","author":"XS Cheng","year":"2013","unstructured":"Cheng, X.S., Zhao, K.P., Jiang, X., Du, L.L., Li, X.H., Ma, Z.W., Yao, J., Luo, Y., Duan, D.X., Wang, J.Z., et al. (2013). Nmnat2 attenuates tau phosphorylation through activation of PP2A. J Alzheimer Dis 36, 185\u2013195.","journal-title":"J Alzheimer Dis"},{"key":"2991_CR65","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s00401-023-02559-z","volume":"145","author":"Y Cheng","year":"2023","unstructured":"Cheng, Y., He, C.Y., Tian, D.Y., Chen, S.H., Ren, J.R., Sun, H.L., Xu, M.Y., Tan, C.R., Fan, D.Y., Jian, J.M., et al. (2023). Physiological \u03b2-amyloid clearance by the liver and its therapeutic potential for Alzheimer\u2019s disease. Acta Neuropathol 145, 717\u2013731.","journal-title":"Acta Neuropathol"},{"key":"2991_CR66","doi-asserted-by":"publisher","first-page":"54716","DOI":"10.1074\/jbc.M403364200","volume":"279","author":"JH Cho","year":"2004","unstructured":"Cho, J.H., and Johnson, G.V.W. (2004). Glycogen synthase kinase 3\u03b2 induces caspase-cleaved tau aggregation in situ. J Biol Chem 279, 54716\u201354723.","journal-title":"J Biol Chem"},{"key":"2991_CR67","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3233\/JAD-150497","volume":"49","author":"D Chu","year":"2016","unstructured":"Chu, D., Tan, J., Xie, S., Jin, N., Yin, X., Gong, C.X., Iqbal, K., Liu, F., and Wang, J. (2016). GSK-3\u03b2 is dephosphorylated by PP2A in a Leu309 methylation-independent manner. J Alzheimer Dis 49, 365\u2013375.","journal-title":"J Alzheimer Dis"},{"key":"2991_CR68","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/ncb1901","volume":"11","author":"F Clavaguera","year":"2009","unstructured":"Clavaguera, F., Bolmont, T., Crowther, R.A., Abramowski, D., Frank, S., Probst, A., Fraser, G., Stalder, A.K., Beibel, M., Staufenbiel, M., et al. (2009). Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol 11, 909\u2013913.","journal-title":"Nat Cell Biol"},{"key":"2991_CR69","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1038\/s41596-018-0028-3","volume":"13","author":"D Clift","year":"2018","unstructured":"Clift, D., So, C., McEwan, W.A., James, L.C., and Schuh, M. (2018). Acute and rapid degradation of endogenous proteins by Trim-Away. Nat Protoc 13, 2149\u20132175.","journal-title":"Nat Protoc"},{"key":"2991_CR70","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/nsmb.2555","volume":"20","author":"TJ Cohen","year":"2013","unstructured":"Cohen, T.J., Friedmann, D., Hwang, A.W., Marmorstein, R., and Lee, V.M.Y. (2013). The microtubule-associated tau protein has intrinsic acetyltransferase activity. Nat Struct Mol Biol 20, 756\u2013762.","journal-title":"Nat Struct Mol Biol"},{"key":"2991_CR71","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1093\/brain\/awu213","volume":"137","author":"L Collin","year":"2014","unstructured":"Collin, L., Bohrmann, B., G\u00f6pfert, U., Oroszlan-Szovik, K., Ozmen, L., and Gr\u00fcninger, F. (2014). Neuronal uptake of tau\/pS422 antibody and reduced progression of tau pathology in a mouse model of Alzheimer\u2019s disease. Brain 137, 2834\u20132846.","journal-title":"Brain"},{"key":"2991_CR72","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ebiom.2019.03.033","volume":"42","author":"EE Congdon","year":"2019","unstructured":"Congdon, E.E., Chukwu, J.E., Shamir, D.B., Deng, J., Ujla, D., Sait, H.B.R., Neubert, T. A., Kong, X.P., and Sigurdsson, E.M. (2019). Tau antibody chimerization alters its charge and binding, thereby reducing its cellular uptake and efficacy. EBioMedicine 42, 157\u2013173.","journal-title":"EBioMedicine"},{"key":"2991_CR73","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41582-023-00883-2","volume":"19","author":"EE Congdon","year":"2023","unstructured":"Congdon, E.E., Ji, C., Tetlow, A.M., Jiang, Y., and Sigurdsson, E.M. (2023). Tautargeting therapies for Alzheimer disease: current status and future directions. Nat Rev Neurol 19, 715\u2013736.","journal-title":"Nat Rev Neurol"},{"key":"2991_CR74","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","volume":"14","author":"EE Congdon","year":"2018","unstructured":"Congdon, E.E., and Sigurdsson, E.M. (2018). Tau-targeting therapies for Alzheimer disease. Nat Rev Neurol 14, 399\u2013415.","journal-title":"Nat Rev Neurol"},{"key":"2991_CR75","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1093\/hmg\/ddt402","volume":"23","author":"C Cook","year":"2014","unstructured":"Cook, C., Carlomagno, Y., Gendron, T.F., Dunmore, J., Scheffel, K., Stetler, C., Davis, M., Dickson, D., Jarpe, M., DeTure, M., et al. (2014). Acetylation of the KXGS motifs in tau is a critical determinant in modulation of tau aggregation and clearance. Hum Mol Genet 23, 104\u2013116.","journal-title":"Hum Mol Genet"},{"key":"2991_CR76","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.jocn.2010.04.020","volume":"17","author":"NM Corcoran","year":"2010","unstructured":"Corcoran, N.M., Martin, D., Hutter-Paier, B., Windisch, M., Nguyen, T., Nheu, L., Sundstrom, L.E., Costello, A.J., and Hovens, C.M. (2010). Sodium selenate specifically activates PP2A phosphatase, dephosphorylates tau and reverses memory deficits in an Alzheimer\u2019s disease model. J Clin Neurosci 17, 1025\u20131033.","journal-title":"J Clin Neurosci"},{"key":"2991_CR77","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder, E.H., Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., Small, G.W., Roses, A.D., Haines, J.L., and Pericak-Vance, M.A. (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science 261, 921\u2013923.","journal-title":"Science"},{"key":"2991_CR78","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s00401-018-1911-2","volume":"136","author":"JP Courade","year":"2018","unstructured":"Courade, J.P., Angers, R., Mairet-Coello, G., Pacico, N., Tyson, K., Lightwood, D., Munro, R., McMillan, D., Griffin, R., Baker, T., et al. (2018). Epitope determines efficacy of therapeutic anti-Tau antibodies in a functional assay with human Alzheimer Tau. Acta Neuropathol 136, 729\u2013745.","journal-title":"Acta Neuropathol"},{"key":"2991_CR79","doi-asserted-by":"publisher","first-page":"10092","DOI":"10.1038\/s41598-022-13683-3","volume":"12","author":"M De la Cueva","year":"2022","unstructured":"De la Cueva, M., Antequera, D., Ordo\u00f1ez-Gutierrez, L., Wandosell, F., Camins, A., Carro, E., and Bartolome, F. (2022). Amyloid-\u03b2 impairs mitochondrial dynamics and autophagy in Alzheimer\u2019s disease experimental models. Sci Rep 12, 10092.","journal-title":"Sci Rep"},{"key":"2991_CR80","doi-asserted-by":"publisher","first-page":"22058","DOI":"10.1038\/s41598-022-26657-2","volume":"12","author":"R De","year":"2022","unstructured":"De, R., and Azad, R.K. (2022). Molecular signatures in the progression of COVID-19 severity. Sci Rep 12, 22058.","journal-title":"Sci Rep"},{"key":"2991_CR81","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.neuron.2013.05.035","volume":"79","author":"U Das","year":"2013","unstructured":"Das, U., Scott, D.A., Ganguly, A., Koo, E.H., Tang, Y., and Roy, S. (2013). Activity-induced convergence of APP and BACE-1 in acidic microdomains via an endocytosis-dependent pathway. Neuron 79, 447\u2013460.","journal-title":"Neuron"},{"key":"2991_CR82","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1001\/jamaneurol.2021.2806","volume":"78","author":"EJ Davis","year":"2021","unstructured":"Davis, E.J., Solsberg, C.W., White, C.C., Mi\u00f1ones-Moyano, E., Sirota, M., Chibnik, L., Bennett, D.A., De Jager, P.L., Yokoyama, J.S., and Dubal, D.B. (2021). Sex-specific association of the X chromosome with cognitive change and tau pathology in aging and Alzheimer disease. JAMA Neurol 78, 1249\u20131254.","journal-title":"JAMA Neurol"},{"key":"2991_CR83","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1111\/acel.12359","volume":"14","author":"JM Deger","year":"2015","unstructured":"Deger, J.M., Gerson, J.E., and Kayed, R. (2015). The interrelationship of proteasome impairment and oligomeric intermediates in neurodegeneration. Aging Cell 14, 715\u2013724.","journal-title":"Aging Cell"},{"key":"2991_CR84","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1093\/brain\/awab028","volume":"144","author":"N Dehghani","year":"2021","unstructured":"Dehghani, N., Bras, J., and Guerreiro, R. (2021). How understudied populations have contributed to our understanding of Alzheimer\u2019s disease genetics. Brain 144, 1067\u20131081.","journal-title":"Brain"},{"key":"2991_CR85","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13148-017-0365-z","volume":"9","author":"R Delgado-Morales","year":"2017","unstructured":"Delgado-Morales, R., Ag\u00eds-Balboa, R.C., Esteller, M., and Berdasco, M. (2017). Epigenetic mechanisms during ageing and neurogenesis as novel therapeutic avenues in human brain disorders. Clin Epigenet 9, 67.","journal-title":"Clin Epigenet"},{"key":"2991_CR86","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1111\/ejn.12235","volume":"37","author":"Y Deng","year":"2013","unstructured":"Deng, Y., Wang, Z., Wang, R., Zhang, X., Zhang, S., Wu, Y., Staufenbiel, M., Cai, F., and Song, W. (2013). Amyloid-\u03b2 protein (A\u03b2) Glu11 is the major \u03b2-secretase site of \u03b2-site amyloid-\u03b2 precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to A\u03b2 Asp1 contributes to Alzheimer pathogenesis. Eur J Neurosci 37, 1962\u20131969.","journal-title":"Eur J Neurosci"},{"key":"2991_CR87","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1289\/EHP474","volume":"125","author":"KK Dennis","year":"2017","unstructured":"Dennis, K.K., Marder, E., Balshaw, D.M., Cui, Y., Lynes, M.A., Patti, G.J., Rappaport, S. M., Shaughnessy, D.T., Vrijheid, M., and Barr, D.B. (2017). Biomonitoring in the era of the exposome. Environ Health Perspect 125, 502\u2013510.","journal-title":"Environ Health Perspect"},{"key":"2991_CR88","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41586-023-06120-6","volume":"618","author":"C Depp","year":"2023","unstructured":"Depp, C., Sun, T., Sasmita, A.O., Spieth, L., Berghoff, S.A., Nazarenko, T., Overhoff, K., Steixner-Kumar, A.A., Subramanian, S., Arinrad, S., et al. (2023). Myelin dysfunction drives amyloid-\u03b2 deposition in models of Alzheimer\u2019s disease. Nature 618, 349\u2013357.","journal-title":"Nature"},{"key":"2991_CR89","doi-asserted-by":"publisher","first-page":"9080","DOI":"10.1073\/pnas.1708448114","volume":"114","author":"C Despres","year":"2017","unstructured":"Despres, C., Byrne, C., Qi, H., Cantrelle, F.X., Huvent, I., Chambraud, B., Baulieu, E.E., Jacquot, Y., Landrieu, I., Lippens, G., et al. (2017). Identification of the Tau phosphorylation pattern that drives its aggregation. Proc Natl Acad Sci USA 114, 9080\u20139085.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2991_CR90","doi-asserted-by":"publisher","first-page":"e068390","DOI":"10.1136\/bmj-2021-068390","volume":"377","author":"K Dhana","year":"2022","unstructured":"Dhana, K., Franco, O.H., Ritz, E.M., Ford, C.N., Desai, P., Krueger, K.R., Holland, T.M., Dhana, A., Liu, X., Aggarwal, N.T., et al. (2022). Healthy lifestyle and life expectancy with and without Alzheimer\u2019s dementia: population based cohort study. BMJ 377, e068390.","journal-title":"BMJ"},{"key":"2991_CR91","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1172\/JCI29715","volume":"117","author":"CA Dickey","year":"2007","unstructured":"Dickey, C.A., Kamal, A., Lundgren, K., Klosak, N., Bailey, R.M., Dunmore, J., Ash, P., Shoraka, S., Zlatkovic, J., Eckman, C.B., et al. (2007). The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins. J Clin Invest 117, 648\u2013658.","journal-title":"J Clin Invest"},{"key":"2991_CR92","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1007\/s12031-011-9589-0","volume":"45","author":"DW Dickson","year":"2011","unstructured":"Dickson, D.W., Kouri, N., Murray, M.E., and Josephs, K.A. (2011). Neuropathology of frontotemporal lobar degeneration-tau (FTLD-Tau). J Mol Neurosci 45, 384\u2013389.","journal-title":"J Mol Neurosci"},{"key":"2991_CR93","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.1007\/s00210-023-02873-z","volume":"397","author":"V Doshi","year":"2024","unstructured":"Doshi, V., Joshi, G., Sharma, S., and Choudhary, D. (2024). Gene therapy: an alternative to treat Alzheimer\u2019s disease. Naunyn Schmiedebergs Arch Pharmacol 397, 3675\u20133693.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2991_CR94","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41586-020-1978-5","volume":"578","author":"JA Doudna","year":"2020","unstructured":"Doudna, J.A. (2020). The promise and challenge of therapeutic genome editing. Nature 578, 229\u2013236.","journal-title":"Nature"},{"key":"2991_CR95","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1038\/mp.2016.59","volume":"22","author":"P Dourlen","year":"2017","unstructured":"Dourlen, P., Fernandez-Gomez, F.J., Dupont, C., Grenier-Boley, B., Bellenguez, C., Obriot, H., Caillierez, R., Sottejeau, Y., Chapuis, J., Bretteville, A., et al. (2017). Functional screening of Alzheimer risk loci identifies PTK2B as an in vivo modulator and early marker of Tau pathology. Mol Psychiatry 22, 874\u2013883.","journal-title":"Mol Psychiatry"},{"key":"2991_CR96","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s00394-025-03651-8","volume":"64","author":"A Drouka","year":"2025","unstructured":"Drouka, A., Ntetsika, K.D., Brikou, D., Mamalaki, E., Ntanasi, E., Chatzipanagiotou, S., Gu, Y., Scarmeas, N., and Yannakoulia, M. (2025). Associations of moderate alcohol intake with cerebrospinal fluid biomarkers of Alzheimer\u2019s disease: data from the ALBION study. Eur J Nutr 64, 142.","journal-title":"Eur J Nutr"},{"key":"2991_CR97","doi-asserted-by":"publisher","first-page":"3629","DOI":"10.1002\/alz.13805","volume":"20","author":"L Duchateau","year":"2024","unstructured":"Duchateau, L., Wawrzyniak, N., and Sleegers, K. (2024). The ABC\u2019s of Alzheimer risk gene ABCA7. Alzheimers Dement 20, 3629\u20133648.","journal-title":"Alzheimers Dement"},{"key":"2991_CR98","doi-asserted-by":"publisher","first-page":"e100760","DOI":"10.1371\/journal.pone.0100760","volume":"9","author":"S Dujardin","year":"2014","unstructured":"Dujardin, S., B\u00e9gard, S., Caillierez, R., Lachaud, C., Delattre, L., Carrier, S., Loyens, A., Galas, M.C., Bousset, L., Melki, R., et al. (2014). Ectosomes: a new mechanism for non-exosomal secretion of tau protein. PLoS One 9, e100760.","journal-title":"PLoS One"},{"key":"2991_CR99","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1001\/jamainternmed.2021.4607","volume":"181","author":"B Dunn","year":"2021","unstructured":"Dunn, B., Stein, P., and Cavazzoni, P. (2021). Approval of aducanumab for Alzheimer disease\u2014the FDA\u2019s perspective. JAMA Intern Med 181, 1276\u20131278.","journal-title":"JAMA Intern Med"},{"key":"2991_CR100","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1093\/ntr\/ntv075","volume":"18","author":"TC Durazzo","year":"2016","unstructured":"Durazzo, T.C., Mattsson, N., and Weiner, M.W. (2016). Interaction of cigarette smoking history with APOE genotype and age on amyloid level, glucose metabolism, and neurocognition in cognitively normal elders. Nicotine Tob Res 18, 204\u2013211.","journal-title":"Nicotine Tob Res"},{"key":"2991_CR101","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1212\/01.wnl.0000244749.20056.d4","volume":"68","author":"P Edison","year":"2007","unstructured":"Edison, P., Archer, H.A., Hinz, R., Hammers, A., Pavese, N., Tai, Y.F., Hotton, G., Cutler, D., Fox, N., Kennedy, A., et al. (2007). Amyloid, hypometabolism, and cognition in Alzheimer disease. Neurology 68, 501\u2013508.","journal-title":"Neurology"},{"key":"2991_CR102","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neuron.2018.06.030","volume":"99","author":"WA Eimer","year":"2018","unstructured":"Eimer, W.A., Vijaya Kumar, D.K., Navalpur Shanmugam, N.K., Rodriguez, A.S., Mitchell, T., Washicosky, K.J., Gy\u00f6rgy, B., Breakefield, X.O., Tanzi, R.E., and Moir, R.D. (2018). Alzheimer\u2019s disease-associated \u03b2-amyloid is rapidly seeded by herpesviridae to protect against brain infection. Neuron 99, 56\u201363.e3.","journal-title":"Neuron"},{"key":"2991_CR103","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1084\/jem.20021546","volume":"197","author":"JB El Khoury","year":"2003","unstructured":"El Khoury, J.B., Moore, K.J., Means, T.K., Leung, J., Terada, K., Toft, M., Freeman, M. W., and Luster, A.D. (2003). CD36 mediates the innate host response to \u03b2-amyloid. J Exp Med 197, 1657\u20131666.","journal-title":"J Exp Med"},{"key":"2991_CR104","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/0006-8993(93)91707-Y","volume":"601","author":"R Endoh","year":"1993","unstructured":"Endoh, R., Ogawara, M., Iwatsubo, T., Nakano, I., and Mori, H. (1993). Lack of the carboxyl terminal sequence of tau in ghost tangles of Alzheimer\u2019s disease. Brain Res 601, 164\u2013172.","journal-title":"Brain Res"},{"key":"2991_CR105","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1038\/s41380-024-02510-y","volume":"29","author":"N Enduru","year":"2024","unstructured":"Enduru, N., Fernandes, B.S., Bahrami, S., Dai, Y., Andreassen, O.A., and Zhao, Z. (2024). Genetic overlap between Alzheimer\u2019s disease and immune-mediated diseases: an atlas of shared genetic determinants and biological convergence. Mol Psychiatry 29, 2447\u20132458.","journal-title":"Mol Psychiatry"},{"key":"2991_CR106","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3389\/fnagi.2019.00174","volume":"11","author":"LD Estrada","year":"2019","unstructured":"Estrada, L.D., Ahumada, P., Cabrera, D., and Arab, J.P. (2019). Liver dysfunction as a novel player in Alzheimer\u2019s progression: looking outside the brain. Front Aging Neurosci 11, 174.","journal-title":"Front Aging Neurosci"},{"key":"2991_CR107","doi-asserted-by":"publisher","first-page":"eabq2915","DOI":"10.1126\/scitranslmed.abq2915","volume":"15","author":"TS Etel\u00e4inen","year":"2023","unstructured":"Etel\u00e4inen, T.S., Silva, M.C., Uhari-V\u00e4\u00e4n\u00e4nen, J.K., De Lorenzo, F., J\u00e4ntti, M.H., Cui, H., Chavero-Pieres, M., Kilpel\u00e4inen, T., Mechtler, C., Svarcbahs, R., et al. (2023). A prolyl oligopeptidase inhibitor reduces tau pathology in cellular models and in mice with tauopathy. Sci Transl Med 15, eabq2915.","journal-title":"Sci Transl Med"},{"key":"2991_CR108","doi-asserted-by":"publisher","first-page":"5592","DOI":"10.1038\/s41380-020-00926-w","volume":"26","author":"F Eysert","year":"2021","unstructured":"Eysert, F., Coulon, A., Boscher, E., Vreulx, A.C., Flaig, A., Mendes, T., Hughes, S., Grenier-Boley, B., Hanoulle, X., Demiautte, F., et al. (2021). Alzheimer\u2019s genetic risk factor FERMT2 (Kindlin-2) controls axonal growth and synaptic plasticity in an APP-dependent manner. Mol Psychiatry 26, 5592\u20135607.","journal-title":"Mol Psychiatry"},{"key":"2991_CR109","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1080\/15548627.2019.1596497","volume":"15","author":"EF Fang","year":"2019","unstructured":"Fang, E.F. (2019). Mitophagy and NAD+ inhibit Alzheimer disease. Autophagy 15, 1112\u20131114.","journal-title":"Autophagy"},{"key":"2991_CR110","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41593-018-0332-9","volume":"22","author":"EF Fang","year":"2019","unstructured":"Fang, E.F., Hou, Y., Palikaras, K., Adriaanse, B.A., Kerr, J.S., Yang, B., Lautrup, S., Hasan-Olive, M.M., Caponio, D., Dan, X., et al. (2019). Mitophagy inhibits amyloid-\u03b2 and tau pathology and reverses cognitive deficits in models of Alzheimer\u2019s disease. Nat Neurosci 22, 401\u2013412.","journal-title":"Nat Neurosci"},{"key":"2991_CR111","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1007\/s00424-023-02837-5","volume":"475","author":"LP Fang","year":"2023","unstructured":"Fang, L.P., and Bai, X. (2023). Oligodendrocyte precursor cells: the multitaskers in the brain. Pflugers Arch-Eur J Physiol 475, 1035\u20131044.","journal-title":"Pflugers Arch-Eur J Physiol"},{"key":"2991_CR112","doi-asserted-by":"publisher","first-page":"707","DOI":"10.3233\/JAD-190759","volume":"73","author":"L Fani","year":"2020","unstructured":"Fani, L., Hilal, S., Sedaghat, S., Broer, L., Licher, S., Arp, P.P., van Meurs, J.B.J., Ikram, M.K., and Ikram, M.A. (2020). Telomere length and the risk of Alzheimer\u2019s disease: the rotterdam study. J Alzheimer\u2019s Dis 73, 707\u2013714.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"2991_CR113","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1080\/15548627.2019.1633862","volume":"16","author":"Q Feng","year":"2020","unstructured":"Feng, Q., Luo, Y., Zhang, X.N., Yang, X.F., Hong, X.Y., Sun, D.S., Li, X.C., Hu, Y., Li, X. G., Zhang, J.F., et al. (2020). MAPT\/Tau accumulation represses autophagy flux by disrupting IST1-regulated ESCRT-III complex formation: a vicious cycle in Alzheimer neurodegeneration. Autophagy 16, 641\u2013658.","journal-title":"Autophagy"},{"key":"2991_CR114","doi-asserted-by":"publisher","first-page":"10014","DOI":"10.1073\/pnas.1507534112","volume":"112","author":"AJ Fletcher","year":"2015","unstructured":"Fletcher, A.J., Mallery, D.L., Watkinson, R.E., Dickson, C.F., and James, L.C. (2015). Sequential ubiquitination and deubiquitination enzymes synchronize the dual sensor and effector functions of TRIM21. Proc Natl Acad Sci USA 112, 10014\u201310019.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2991_CR115","doi-asserted-by":"publisher","first-page":"e20190086","DOI":"10.1084\/jem.20190086","volume":"218","author":"L Fontana","year":"2021","unstructured":"Fontana, L., Ghezzi, L., Cross, A.H., and Piccio, L. (2021). Effects of dietary restriction on neuroinflammation in neurodegenerative diseases. J Exp Med 218, e20190086.","journal-title":"J Exp Med"},{"key":"2991_CR116","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1126\/science.1172539","volume":"328","author":"L Fontana","year":"2010","unstructured":"Fontana, L., Partridge, L., and Longo, V.D. (2010). Extending healthy life span\u2014from yeast to humans. Science 328, 321\u2013326.","journal-title":"Science"},{"key":"2991_CR117","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41593-024-01801-5","volume":"28","author":"SL Fowler","year":"2025","unstructured":"Fowler, S.L., Behr, T.S., Turkes, E., O\u2019Brien, D.P., Cauhy, P.M., Rawlinson, I., Edmonds, M., Foiani, M.S., Schaler, A., Crowley, G., et al. (2025). Tau filaments are tethered within brain extracellular vesicles in Alzheimer\u2019s disease. Nat Neurosci 28, 40\u201348.","journal-title":"Nat Neurosci"},{"key":"2991_CR118","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1038\/s41467-019-09564-5","volume":"10","author":"N Franzmeier","year":"2019","unstructured":"Franzmeier, N., Rubinski, A., Neitzel, J., Ewers, M., Weiner, M.W., Aisen, P., Petersen, R., Jack, C.R., Jagust, W., Trojanowski, J.Q., et al. (2019). The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory. Nat Commun 10, 1766.","journal-title":"Nat Commun"},{"key":"2991_CR119","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1038\/s41467-023-43822-x","volume":"15","author":"B Frieg","year":"2024","unstructured":"Frieg, B., Han, M., Giller, K., Dienemann, C., Riedel, D., Becker, S., Andreas, L.B., Griesinger, C., and Schr\u00f6der, G.F. (2024). Cryo-EM structures of lipidic fibrils of amyloid-\u03b2 (1-40). Nat Commun 15, 1297.","journal-title":"Nat Commun"},{"key":"2991_CR120","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1001\/archneurol.2012.85","volume":"69","author":"DR Galasko","year":"2012","unstructured":"Galasko, D.R., Peskind, E., Clark, C.M., Quinn, J.F., Ringman, J.M., Jicha, G.A., Cotman, C., Cottrell, B., Montine, T.J., Thomas, R.G., et al. (2012). Antioxidants for Alzheimer disease. Arch Neurol 69, 836\u2013841.","journal-title":"Arch Neurol"},{"key":"2991_CR121","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3233\/JAD-2003-5201","volume":"5","author":"F Garc\u00eda-Sierra","year":"2003","unstructured":"Garc\u00eda-Sierra, F., Ghoshal, N., Quinn, B., Berry, R.W., and Binder, L.I. (2003). Conformational changes and truncation of tau protein during tangle evolution in Alzheimer\u2019s disease. J Alzheimer Dis 5, 65\u201377.","journal-title":"J Alzheimer Dis"},{"key":"2991_CR122","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1001\/archpsyc.63.2.168","volume":"63","author":"M Gatz","year":"2006","unstructured":"Gatz, M., Reynolds, C.A., Fratiglioni, L., Johansson, B., Mortimer, J.A., Berg, S., Fiske, A., and Pedersen, N.L. (2006). Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry 63, 168\u2013174.","journal-title":"Arch Gen Psychiatry"},{"key":"2991_CR123","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","volume":"18","author":"GBD 2016 Neurology Collaborators","year":"2019","unstructured":"GBD 2016 Neurology Collaborators (2019). Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18, 459\u2013480.","journal-title":"Lancet Neurol"},{"key":"2991_CR124","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S1474-4422(24)00038-3","volume":"23","author":"GBD 2021 Nervous System Disorders Collaborators","year":"2024","unstructured":"GBD 2021 Nervous System Disorders Collaborators (2024). Global, regional, and national burden of disorders affecting the nervous system, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol 23, 344\u2013381.","journal-title":"Lancet Neurol"},{"key":"2991_CR125","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"A Auton","year":"2015","unstructured":"1000 Genomes Project Consortium, Auton, A., Abecasis, G.R., Altshuler (Co-Chair), D.M., Durbin (Co-Chair), R.M., Abecasis, G.R., Bentley, D.R., Chakravarti, A., Clark, A.G., Donnelly, P., et al. (2015). A global reference for human genetic variation. Nature 526, 68\u201374.","journal-title":"Nature"},{"key":"2991_CR126","doi-asserted-by":"publisher","first-page":"6243","DOI":"10.1002\/alz.14121","volume":"20","author":"Y Ge","year":"2024","unstructured":"Ge, Y., Chen, S., Wu, B., Zhang, Y., Wang, J., He, X., Liu, W., Chen, Y., Ou, Y., Shen, X., et al. (2024a). Genome-wide meta-analysis identifies ancestry-specific loci for Alzheimer\u2019s disease. Alzheimers Dement 20, 6243\u20136256.","journal-title":"Alzheimers Dement"},{"key":"2991_CR127","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.biopsych.2022.11.002","volume":"93","author":"YJ Ge","year":"2023","unstructured":"Ge, Y.J., Ou, Y.N., Deng, Y.T., Wu, B.S., Yang, L., Zhang, Y.R., Chen, S.D., Huang, Y. Y., Dong, Q., Tan, L., et al. (2023). Prioritization of drug targets for neurodegenerative diseases by integrating genetic and proteomic data from brain and blood. Biol Psychiatry 93, 770\u2013779.","journal-title":"Biol Psychiatry"},{"key":"2991_CR128","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/s41562-023-01722-6","volume":"8","author":"YJ Ge","year":"2024","unstructured":"Ge, Y.J., Wu, B.S., Zhang, Y., Chen, S.D., Zhang, Y.R., Kang, J.J., Deng, Y.T., Ou, Y.N., He, X.Y., Zhao, Y.L., et al. (2024b). Genetic architectures of cerebral ventricles and their overlap with neuropsychiatric traits. Nat Hum Behav 8, 164\u2013180.","journal-title":"Nat Hum Behav"},{"key":"2991_CR129","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13195-017-0237-y","volume":"9","author":"N Geifman","year":"2017","unstructured":"Geifman, N., Brinton, R.D., Kennedy, R.E., Schneider, L.S., and Butte, A.J. (2017). Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer\u2019s disease. AlzheimersRes Ther 9, 10.","journal-title":"AlzheimersRes Ther"},{"key":"2991_CR130","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/nchembio.2287","volume":"13","author":"ND Georgakopoulos","year":"2017","unstructured":"Georgakopoulos, N.D., Wells, G., and Campanella, M. (2017). The pharmacological regulation of cellular mitophagy. Nat Chem Biol 13, 136\u2013146.","journal-title":"Nat Chem Biol"},{"key":"2991_CR131","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","volume":"120","author":"GG Glenner","year":"1984","unstructured":"Glenner, G.G., and Wong, C.W. (1984). Alzheimer\u2019s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120, 885\u2013890.","journal-title":"Biochem Biophys Res Commun"},{"key":"2991_CR132","doi-asserted-by":"publisher","first-page":"101421","DOI":"10.1016\/j.arr.2021.101421","volume":"71","author":"HS G N S","year":"2021","unstructured":"G N S, H.S., Marise, V.L.P., Satish, K.S., Yergolkar, A.V., Krishnamurthy, M., Ganesan Rajalekshmi, S., Radhika, K., and Burri, R.R. (2021). Untangling huge literature to disinter genetic underpinnings of Alzheimer\u2019s disease: a systematic review and meta-analysis. Ageing Res Rev 71, 101421.","journal-title":"Ageing Res Rev"},{"key":"2991_CR133","doi-asserted-by":"publisher","first-page":"103691","DOI":"10.1016\/j.ebiom.2021.103691","volume":"74","author":"W Grabowska-Pyrzewicz","year":"2021","unstructured":"Grabowska-Pyrzewicz, W., Want, A., Leszek, J., and Wojda, U. (2021). Antisense oligonucleotides for Alzheimer\u2019s disease therapy: from the mRNA to miRNA paradigm. EBioMedicine 74, 103691.","journal-title":"EBioMedicine"},{"key":"2991_CR134","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.neuron.2019.06.010","volume":"103","author":"A Griciuc","year":"2019","unstructured":"Griciuc, A., Patel, S., Federico, A.N., Choi, S.H., Innes, B.J., Oram, M.K., Cereghetti, G., McGinty, D., Anselmo, A., Sadreyev, R.I., et al. (2019). TREM2 acts downstream of CD33 in modulating microglial pathology in Alzheimer\u2019s disease. Neuron 103, 820\u2013835.e7.","journal-title":"Neuron"},{"key":"2991_CR135","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.neuron.2013.04.014","volume":"78","author":"A Griciuc","year":"2013","unstructured":"Griciuc, A., Serrano-Pozo, A., Parrado, A.R., Lesinski, A.N., Asselin, C.N., Mullin, K., Hooli, B., Choi, S.H., Hyman, B.T., and Tanzi, R.E. (2013). Alzheimer\u2019s disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron 78, 631\u2013643.","journal-title":"Neuron"},{"key":"2991_CR136","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cmet.2020.05.002","volume":"32","author":"L Grosse","year":"2020","unstructured":"Grosse, L., Wagner, N., Emelyanov, A., Molina, C., Lacas-Gervais, S., Wagner, K.D., and Bulavin, D.V. (2020). Defined p16High senescent cell types are indispensable for mouse healthspan. Cell Metab 32, 87\u201399.e6.","journal-title":"Cell Metab"},{"key":"2991_CR137","doi-asserted-by":"publisher","first-page":"13812","DOI":"10.1074\/jbc.RA120.012587","volume":"295","author":"J Gu","year":"2020","unstructured":"Gu, J., Xu, W., Jin, N., Li, L., Zhou, Y., Chu, D., Gong, C.X., Iqbal, K., and Liu, F. (2020). Truncation of Tau selectively facilitates its pathological activities. J Biol Chem 295, 13812\u201313828.","journal-title":"J Biol Chem"},{"key":"2991_CR138","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature07925","volume":"459","author":"JS Guan","year":"2009","unstructured":"Guan, J.S., Haggarty, S.J., Giacometti, E., Dannenberg, J.H., Joseph, N., Gao, J., Nieland, T.J.F., Zhou, Y., Wang, X., Mazitschek, R., et al. (2009). HDAC2 negatively regulates memory formation and synaptic plasticity. Nature 459, 55\u201360.","journal-title":"Nature"},{"key":"2991_CR139","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.cell.2013.10.037","volume":"155","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro, R., Br\u00e1s, J., and Hardy, J. (2013). SnapShot: genetics of Alzheimer\u2019s disease. Cell 155, 968\u2013968.e1.","journal-title":"Cell"},{"key":"2991_CR140","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.tins.2021.06.007","volume":"44","author":"A Guerrero","year":"2021","unstructured":"Guerrero, A., De Strooper, B., and Arancibia-C\u00e1rcamo, I.L. (2021). Cellular senescence at the crossroads of inflammation and Alzheimer\u2019s disease. Trends Neuroscis 44, 714\u2013727.","journal-title":"Trends Neuroscis"},{"key":"2991_CR141","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1007\/s11427-023-2510-0","volume":"67","author":"H Guo","year":"2024","unstructured":"Guo, H., Sun, Q., Huang, X., Wang, X., Zhang, F., Qu, W., Liu, J., Cheng, X., Zhu, Q., Yi, W., et al. (2024). Fucosyltransferase 8 regulates adult neurogenesis and cognition of mice by modulating the Itga6-PI3K\/Akt signaling pathway. Sci China Life Sci 67, 1427\u20131440.","journal-title":"Sci China Life Sci"},{"key":"2991_CR142","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1016\/S0021-9258(18)53650-4","volume":"268","author":"C Haass","year":"1993","unstructured":"Haass, C., Hung, A.Y., Schlossmacher, M.G., Teplow, D.B., and Selkoe, D.J. (1993). beta-Amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms. J Biol Chem 268, 3021\u20133024.","journal-title":"J Biol Chem"},{"key":"2991_CR143","doi-asserted-by":"publisher","first-page":"3783","DOI":"10.1523\/JNEUROSCI.11-12-03783.1991","volume":"11","author":"C Haass","year":"1991","unstructured":"Haass, C., Hung, A.Y., and Selkoe, D.J. (1991). Processing of beta-amyloid precursor protein in microglia and astrocytes favors an internal localization over constitutive secretion. J Neurosci 11, 3783\u20133793.","journal-title":"J Neurosci"},{"key":"2991_CR144","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/357500a0","volume":"357","author":"C Haass","year":"1992","unstructured":"Haass, C., Koo, E.H., Mellon, A., Hung, A.Y., and Selkoe, D.J. (1992). Targeting of cell-surface \u03b2-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments. Nature 357, 500\u2013503.","journal-title":"Nature"},{"key":"2991_CR145","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.nbd.2006.12.019","volume":"26","author":"VKM Halagappa","year":"2007","unstructured":"Halagappa, V.K.M., Guo, Z., Pearson, M., Matsuoka, Y., Cutler, R.G., LaFerla, F.M., and Mattson, M.P. (2007). Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer\u2019s disease. Neurobiol Dis 26, 212\u2013220.","journal-title":"Neurobiol Dis"},{"key":"2991_CR146","doi-asserted-by":"publisher","first-page":"8382","DOI":"10.1038\/s41467-024-52442-y","volume":"15","author":"YC Hsiao","year":"2024","unstructured":"Hsiao, Y.C., Wallweber, H.A., Alberstein, R.G., Lin, Z., Du, C., Etxeberria, A., Aung, T., Shang, Y., Seshasayee, D., Seeger, F., et al. (2024). Rapid affinity optimization of an anti-TREM2 clinical lead antibody by cross-lineage immune repertoire mining. Nat Commun 15, 8382.","journal-title":"Nat Commun"},{"key":"2991_CR147","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3389\/fimmu.2020.00456","volume":"11","author":"H Hampel","year":"2020","unstructured":"Hampel, H., Caraci, F., Cuello, A.C., Caruso, G., Nistic\u00f2, R., Corbo, M., Baldacci, F., Toschi, N., Garaci, F., Chiesa, P.A., et al. (2020). A path toward precision medicine for neuroinflammatory mechanisms in Alzheimer\u2019s disease. Front Immunol 11, 456.","journal-title":"Front Immunol"},{"key":"2991_CR148","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","volume":"26","author":"H Hampel","year":"2021","unstructured":"Hampel, H., Hardy, J., Blennow, K., Chen, C., Perry, G., Kim, S.H., Villemagne, V.L., Aisen, P., Vendruscolo, M., Iwatsubo, T., et al. (2021). The amyloid-\u03b2 pathway in Alzheimer\u2019s disease. Mol Psychiatry 26, 5481\u20135503.","journal-title":"Mol Psychiatry"},{"key":"2991_CR149","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1212\/WNL.0000000000006745","volume":"92","author":"Y Hara","year":"2019","unstructured":"Hara, Y., McKeehan, N., and Fillit, H.M. (2019). Translating the biology of aging into novel therapeutics for Alzheimer disease. Neurology 92, 84\u201393.","journal-title":"Neurology"},{"key":"2991_CR150","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy, J.A., and Higgins, G.A. (1992). Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science 256, 184\u2013185.","journal-title":"Science"},{"key":"2991_CR151","doi-asserted-by":"publisher","first-page":"310","DOI":"10.4103\/1673-5374.290898","volume":"16","author":"H Hassan","year":"2021","unstructured":"Hassan, H., and Chen, R. (2021). Hypoxia in Alzheimer\u2019s disease: effects of hypoxia inducible factors. Neural Regen Res 16, 310.","journal-title":"Neural Regen Res"},{"key":"2991_CR152","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s00401-017-1674-1","volume":"133","author":"RJ Hatch","year":"2017","unstructured":"Hatch, R.J., Wei, Y., Xia, D., and G\u00f6tz, J. (2017). Hyperphosphorylated tau causes reduced hippocampal CA1 excitability by relocating the axon initial segment. Acta Neuropathol 133, 717\u2013730.","journal-title":"Acta Neuropathol"},{"key":"2991_CR153","doi-asserted-by":"publisher","first-page":"19733","DOI":"10.1073\/pnas.1210659109","volume":"109","author":"F Hauler","year":"2012","unstructured":"Hauler, F., Mallery, D.L., McEwan, W.A., Bidgood, S.R., and James, L.C. (2012). AAA ATPase p97\/VCP is essential for TRIM21-mediated virus neutralization. Proc Natl Acad Sci USA 109, 19733\u201319738.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2991_CR154","doi-asserted-by":"publisher","first-page":"e924","DOI":"10.1038\/cddis.2013.437","volume":"4","author":"N He","year":"2013","unstructured":"He, N., Jin, W.L., Lok, K.H., Wang, Y., Yin, M., and Wang, Z.J. (2013). Amyloid-\u03b21\u201342 oligomer accelerates senescence in adult hippocampal neural stem\/progenitor cells via formylpeptide receptor 2. Cell Death Dis 4, e924.","journal-title":"Cell Death Dis"},{"key":"2991_CR155","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3233\/JAD-220125","volume":"88","author":"L Helboe","year":"2022","unstructured":"Helboe, L., Rosenqvist, N., Volbracht, C., Pedersen, L.\u00d8., Pedersen, J.T., Christensen, S., Egebjerg, J., Christoffersen, C.T., Bang-Andersen, B., Beach, T.G., et al. (2022). Highly specific and sensitive target binding by the humanized pS396-Tau antibody hC10.2 across a wide spectrum of Alzheimer\u2019s disease and primary tauopathy postmortem brains. J Alzheimer Dis 88, 207\u2013228.","journal-title":"J Alzheimer Dis"},{"key":"2991_CR156","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka, M.T., Carson, M.J., Khoury, J.E., Landreth, G.E., Brosseron, F., Feinstein, D.L., Jacobs, A.H., Wyss-Coray, T., Vitorica, J., Ransohoff, R.M., et al. (2015). Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol 14, 388\u2013405.","journal-title":"Lancet Neurol"},{"key":"2991_CR157","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1515\/cclm-2017-0870","volume":"56","author":"M Herrmann","year":"2018","unstructured":"Herrmann, M., Pusceddu, I., M\u00e4rz, W., and Herrmann, W. (2018). Telomere biology and age-related diseases. Clin Chem Lab Med 56, 1210\u20131222.","journal-title":"Clin Chem Lab Med"},{"key":"2991_CR158","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s40262-017-0608-3","volume":"57","author":"JA Hey","year":"2018","unstructured":"Hey, J.A., Yu, J.Y., Versavel, M., Abushakra, S., Kocis, P., Power, A., Kaplan, P.L., Amedio, J., and Tolar, M. (2018). Clinical pharmacokinetics and safety of ALZ-801, a novel prodrug of tramiprosate in development for the treatment of Alzheimer\u2019s disease. Clinical Pharmacokinet 57, 315\u2013333.","journal-title":"Clinical Pharmacokinet"},{"key":"2991_CR159","doi-asserted-by":"publisher","first-page":"13966","DOI":"10.1074\/jbc.M110.186338","volume":"286","author":"DT Hickman","year":"2011","unstructured":"Hickman, D.T., L\u00f3pez-Deber, M.P., Ndao, D.M., Silva, A.B., Nand, D., Pihlgren, M., Giriens, V., Madani, R., St-Pierre, A., Karastaneva, H., et al. (2011). Sequence-independent control of peptide conformation in liposomal vaccines for targeting protein misfolding diseases. J Biol Chem 286, 13966\u201313976.","journal-title":"J Biol Chem"},{"key":"2991_CR160","doi-asserted-by":"publisher","first-page":"8354","DOI":"10.1523\/JNEUROSCI.0616-08.2008","volume":"28","author":"SE Hickman","year":"2008","unstructured":"Hickman, S.E., Allison, E.K., and El Khoury, J. (2008). Microglial dysfunction and defective \u03b2-amyloid clearance pathways in aging Alzheimer\u2019s disease mice. J Neurosci 28, 8354\u20138360.","journal-title":"J Neurosci"},{"key":"2991_CR161","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1038\/s41588-022-01208-7","volume":"54","author":"H Holstege","year":"2022","unstructured":"Holstege, H., Hulsman, M., Charbonnier, C., Grenier-Boley, B., Quenez, O., Grozeva, D., van Rooij, J.G.J., Sims, R., Ahmad, S., Amin, N., et al. (2022). Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer\u2019s disease. Nat Genet 54, 1786\u20131794.","journal-title":"Nat Genet"},{"key":"2991_CR162","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1126\/science.aav2546","volume":"363","author":"JK Holth","year":"2019","unstructured":"Holth, J.K., Fritschi, S.K., Wang, C., Pedersen, N.P., Cirrito, J.R., Mahan, T.E., Finn, M. B., Manis, M., Geerling, J.C., Fuller, P.M., et al. (2019). The sleep-wake cycle regulates brain interstitial fluid tau in mice and CSF tau in humans. Science 363, 880\u2013884.","journal-title":"Science"},{"key":"2991_CR163","doi-asserted-by":"publisher","first-page":"7895","DOI":"10.1523\/JNEUROSCI.1988-04.2004","volume":"24","author":"PM Horowitz","year":"2004","unstructured":"Horowitz, P.M., Patterson, K.R., Guillozet-Bongaarts, A.L., Reynolds, M.R., Carroll, C. A., Weintraub, S.T., Bennett, D.A., Cryns, V.L., Berry, R.W., and Binder, L.I. (2004). Early N-terminal changes and caspase-6 cleavage of Tau in Alzheimer\u2019s disease. J Neurosci 24, 7895\u20137902.","journal-title":"J Neurosci"},{"key":"2991_CR164","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","volume":"15","author":"Y Hou","year":"2019","unstructured":"Hou, Y., Dan, X., Babbar, M., Wei, Y., Hasselbalch, S.G., Croteau, D.L., and Bohr, V.A. (2019). Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol 15, 565\u2013581.","journal-title":"Nat Rev Neurol"},{"key":"2991_CR165","first-page":"115","volume-title":"Proc Natl Acad Sci USA","author":"Y Hou","year":"2018","unstructured":"Hou, Y., Lautrup, S., Cordonnier, S., Wang, Y., Croteau, D.L., Zavala, E., Zhang, Y., Moritoh, K., O\u2019Connell, J.F., Baptiste, B.A., et al. (2018). NAD+ supplementation normalizes key Alzheimer\u2019s features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency. Proc Natl Acad Sci USA 115."},{"key":"2991_CR166","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41392-022-01006-x","volume":"7","author":"S Huang","year":"2022","unstructured":"Huang, S., Zhang, Z., Cao, J., Yu, Y., and Pei, G. (2022). Chimeric cerebral organoids reveal the essentials of neuronal and astrocytic APOE4 for Alzheimer\u2019s tau pathology. Sig Transduct Target Ther 7, 176.","journal-title":"Sig Transduct Target Ther"},{"key":"2991_CR167","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41590-021-00913-5","volume":"22","author":"Y Huang","year":"2021","unstructured":"Huang, Y., Happonen, K.E., Burrola, P.G., O\u2019Connor, C., Hah, N., Huang, L., Nimmerjahn, A., and Lemke, G. (2021). Microglia use TAM receptors to detect and engulf amyloid \u03b2 plaques. Nat Immunol 22, 586\u2013594.","journal-title":"Nat Immunol"},{"key":"2991_CR168","doi-asserted-by":"publisher","first-page":"979","DOI":"10.3233\/JAD-190604","volume":"71","author":"CJ Huseby","year":"2019","unstructured":"Huseby, C.J., Hoffman, C.N., Cooper, G.L., Cocuron, J.C., Alonso, A.P., Thomas, S.N., Yang, A.J., and Kuret, J. (2019). Quantification of tau protein lysine methylation in aging and Alzheimer\u2019s disease. J Alzheimer\u2019s Dis 71, 979\u2013991.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"2991_CR169","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1161\/CIRCRESAHA.118.313260","volume":"124","author":"C Iadecola","year":"2019","unstructured":"Iadecola, C., and Gottesman, R.F. (2019). Neurovascular and cognitive dysfunction in hypertension. Circ Res 124, 1025\u20131044.","journal-title":"Circ Res"},{"key":"2991_CR170","doi-asserted-by":"publisher","first-page":"24","DOI":"10.15212\/AMM-2021-0001","volume":"1","author":"H Inuzuka","year":"2022","unstructured":"Inuzuka, H., Liu, J., Wei, W., and Rezaeian, A.H. (2022). PROTAC technology for the treatment of Alzheimer\u2019s disease: advances and perspectives. Acta Materia Medica 1, 24\u201341.","journal-title":"Acta Materia Medica"},{"key":"2991_CR171","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1093\/brain\/aws013","volume":"135","author":"DJ Irwin","year":"2012","unstructured":"Irwin, D.J., Cohen, T.J., Grossman, M., Arnold, S.E., Xie, S.X., Lee, V.M.Y., and Trojanowski, J.Q. (2012). Acetylated tau, a novel pathological signature in Alzheimer\u2019s disease and other tauopathies. Brain 135, 807\u2013818.","journal-title":"Brain"},{"key":"2991_CR172","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1016\/j.jalz.2018.08.004","volume":"14","author":"RS Isaacson","year":"2018","unstructured":"Isaacson, R.S., Ganzer, C.A., Hristov, H., Hackett, K., Caesar, E., Cohen, R., Kachko, R., Mel\u00e9ndez-Cabrero, J., Rahman, A., Scheyer, O., et al. (2018). The clinical practice of risk reduction for Alzheimer\u2019s disease: a precision medicine approach. Alzheimers Dement 14, 1663\u20131673.","journal-title":"Alzheimers Dement"},{"key":"2991_CR173","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/s41591-024-03400-0","volume":"31","author":"T Islam","year":"2025","unstructured":"Islam, T., Hill, E., Abrahamson, E.E., Servaes, S., Smirnov, D.S., Zeng, X., Sehrawat, A., Chen, Y., Kac, P.R., Kvartsberg, H., et al. (2025). Phospho-tau serine-262 and serine-356 as biomarkers of pre-tangle soluble tau assemblies in Alzheimer\u2019s disease. Nat Med 31, 574\u2013588.","journal-title":"Nat Med"},{"key":"2991_CR174","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.cell.2010.06.036","volume":"142","author":"LM Ittner","year":"2010","unstructured":"Ittner, L.M., Ke, Y.D., Delerue, F., Bi, M., Gladbach, A., van Eersel, J., W\u00f6lfing, H., Chieng, B.C., Christie, M.D.J., Napier, I.A., et al. (2010). Dendritic function of tau mediates amyloid-\u03b2 toxicity in Alzheimer\u2019s disease mouse models. Cell 142, 387\u2013397.","journal-title":"Cell"},{"key":"2991_CR175","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.1093\/brain\/awab478","volume":"145","author":"RJ Jackson","year":"2022","unstructured":"Jackson, R.J., Meltzer, J.C., Nguyen, H., Commins, C., Bennett, R.E., Hudry, E., and Hyman, B.T. (2022). APOE4 derived from astrocytes leads to blood-brain barrier impairment. Brain 145, 3582\u20133593.","journal-title":"Brain"},{"key":"2991_CR176","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41591-020-0755-1","volume":"26","author":"S Janelidze","year":"2020","unstructured":"Janelidze, S., Mattsson, N., Palmqvist, S., Smith, R., Beach, T.G., Serrano, G.E., Chai, X., Proctor, N.K., Eichenlaub, U., Zetterberg, H., et al. (2020). Plasma P-tau181 in Alzheimer\u2019s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer\u2019s dementia. Nat Med 26, 379\u2013386.","journal-title":"Nat Med"},{"key":"2991_CR177","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1038\/s41562-022-01408-5","volume":"6","author":"SK Jang","year":"2022","unstructured":"Jang, S.K., Evans, L., Fialkowski, A., Arnett, D.K., Ashley-Koch, A.E., Barnes, K.C., Becker, D.M., Bis, J.C., Blangero, J., Bleecker, E.R., et al. (2022). Rare genetic variants explain missing heritability in smoking. Nat Hum Behav 6, 1577\u20131586.","journal-title":"Nat Hum Behav"},{"key":"2991_CR178","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41588-018-0311-9","volume":"51","author":"IE Jansen","year":"2019","unstructured":"Jansen, I.E., Savage, J.E., Watanabe, K., Bryois, J., Williams, D.M., Steinberg, S., Sealock, J., Karlsson, I.K., H\u00e4gg, S., Athanasiu, L., et al. (2019). Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer\u2019s disease risk. Nat Genet 51, 404\u2013413.","journal-title":"Nat Genet"},{"key":"2991_CR179","doi-asserted-by":"publisher","first-page":"e174290","DOI":"10.1172\/jci.insight.174290","volume":"8","author":"K Jia","year":"2023","unstructured":"Jia, K., Tian, J., Wang, T., Guo, L., Xuan, Z., Swerdlow, R.H., and Du, H. (2023). Mitochondria-sequestered A\u03b2 renders synaptic mitochondria vulnerable in the elderly with a risk of Alzheimer disease. JCI Insight 8, e174290.","journal-title":"JCI Insight"},{"key":"2991_CR180","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13024-023-00644-1","volume":"18","author":"HS Jiao","year":"2023","unstructured":"Jiao, H.S., Yuan, P., and Yu, J.T. (2023). TMEM106B aggregation in neurodegenerative diseases: linking genetics to function. Mol Neurodegener 18, 54.","journal-title":"Mol Neurodegener"},{"key":"2991_CR181","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1742-2094-5-23","volume":"5","author":"JJ Jin","year":"2008","unstructured":"Jin, J.J., Kim, H.D., Maxwell, J.A., Li, L., and Fukuchi, K. (2008). Toll-like receptor 4-dependent upregulation of cytokines in a transgenic mouse model of Alzheimer\u2019s disease. J Neuroinflamm 5, 23.","journal-title":"J Neuroinflamm"},{"key":"2991_CR182","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1007\/s12035-017-0385-x","volume":"55","author":"M Jose Perez","year":"2018","unstructured":"Jose Perez, M., Vergara-Pulgar, K., Jara, C., Cabezas-Opazo, F., and Quintanilla, R.A. (2018). Caspase-cleaved tau impairs mitochondrial dynamics in Alzheimer\u2019s disease. Mol Neurobiol 55, 1004\u20131018.","journal-title":"Mol Neurobiol"},{"key":"2991_CR183","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1111\/j.1471-4159.1992.tb10039.x","volume":"58","author":"K Kanemaru","year":"1992","unstructured":"Kanemaru, K., Takio, K., Miura, R., Titani, K., and Ihara, Y. (1992). Fetal-type phosphorylation of the \u03c4 in paired helical filaments. J Neurochem 58, 1667\u20131675.","journal-title":"J Neurochem"},{"key":"2991_CR184","doi-asserted-by":"publisher","first-page":"17883","DOI":"10.1038\/s41598-022-22761-5","volume":"12","author":"G Karapetyan","year":"2022","unstructured":"Karapetyan, G., Fereshetyan, K., Harutyunyan, H., and Yenkoyan, K. (2022). The synergy of \u03b2 amyloid 1\u201342 and oxidative stress in the development of Alzheimer\u2019s disease-like neurodegeneration of hippocampal cells. Sci Rep 12, 17883.","journal-title":"Sci Rep"},{"key":"2991_CR185","doi-asserted-by":"publisher","first-page":"42751","DOI":"10.1074\/jbc.M112.380642","volume":"287","author":"CM Karch","year":"2012","unstructured":"Karch, C.M., Jeng, A.T., and Goate, A.M. (2012). Extracellular tau levels are influenced by variability in tau that is associated with tauopathies. J Biol Chem 287, 42751\u201342762.","journal-title":"J Biol Chem"},{"key":"2991_CR186","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.neuron.2006.07.019","volume":"51","author":"SL Karsten","year":"2006","unstructured":"Karsten, S.L., Sang, T.K., Gehman, L.T., Chatterjee, S., Liu, J., Lawless, G.M., Sengupta, S., Berry, R.W., Pomakian, J., Oh, H.S., et al. (2006). A genomic screen for modifiers of tauopathy identifies puromycin-sensitive aminopeptidase as an inhibitor of tau-induced neurodegeneration. Neuron 51, 549\u2013560.","journal-title":"Neuron"},{"key":"2991_CR187","doi-asserted-by":"publisher","first-page":"e2302939","DOI":"10.1002\/adhm.202302939","volume":"13","author":"J Ke","year":"2024","unstructured":"Ke, J., Yu, C., Li, S., Hong, Y., Xu, Y., Wang, K., Meng, T., Ping, Y., Fu, Q., Yuan, H., et al. (2024). Combining multifunctional delivery system with blood-brain barrier reversible opening strategy for the enhanced treatment of Alzheimer\u2019s disease. Adv Healthcare Mater 13, e2302939.","journal-title":"Adv Healthcare Mater"},{"key":"2991_CR188","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/S1474-4422(20)30231-3","volume":"19","author":"D Kellar","year":"2020","unstructured":"Kellar, D., and Craft, S. (2020). Brain insulin resistance in Alzheimer\u2019s disease and related disorders: mechanisms and therapeutic approaches. Lancet Neurol 19, 758\u2013766.","journal-title":"Lancet Neurol"},{"key":"2991_CR189","doi-asserted-by":"publisher","first-page":"102491","DOI":"10.1016\/j.jbc.2022.102491","volume":"298","author":"JM Kenyaga","year":"2022","unstructured":"Kenyaga, J.M., Cheng, Q., and Qiang, W. (2022). Early stage \u03b2-amyloid-membrane interactions modulate lipid dynamics and influence structural interfaces and fibrillation. J Biol Chem 298, 102491.","journal-title":"J Biol Chem"},{"key":"2991_CR190","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1111\/j.1471-4159.1992.tb09432.x","volume":"59","author":"S Khatoon","year":"1992","unstructured":"Khatoon, S., Grundke-Iqbal, I., and Iqbal, K. (1992). Brain levels of microtubule-associated protein \u03c4 are elevated in Alzheimer\u2019s disease: a radioimmuno-slot-blot assay for nanograms of the protein. J Neurochem 59, 750\u2013753.","journal-title":"J Neurochem"},{"key":"2991_CR191","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/0014-5793(94)00829-9","volume":"351","author":"S Khatoon","year":"1994","unstructured":"Khatoon, S., Grundke-Iqbal, I., and Iqbal, K. (1994). Levels of normal and abnormally phosphorylated tau in different cellular and regional compartments of Alzheimer disease and control brains. FEBS Lett 351, 80\u201384.","journal-title":"FEBS Lett"},{"key":"2991_CR192","doi-asserted-by":"publisher","first-page":"686","DOI":"10.14283\/jpad.2023.109","volume":"10","author":"M Kiraly","year":"2023","unstructured":"Kiraly, M., Foss, J.F., and Giordano, T. (2023). Neuroinflammation, its role in Alzheimer\u2019s disease and therapeutic strategies. J Prev Alzheimers Dis 10, 686\u2013698.","journal-title":"J Prev Alzheimers Dis"},{"key":"2991_CR193","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ebiom.2017.04.013","volume":"21","author":"JL Kirkland","year":"2017","unstructured":"Kirkland, J.L., and Tchkonia, T. (2017). Cellular senescence: a translational perspective. EBioMedicine 21, 21\u201328.","journal-title":"EBioMedicine"},{"key":"2991_CR194","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1038\/s41467-021-21443-6","volume":"12","author":"L Kiss","year":"2021","unstructured":"Kiss, L., Clift, D., Renner, N., Neuhaus, D., and James, L.C. (2021). RING domains act as both substrate and enzyme in a catalytic arrangement to drive self-anchored ubiquitination. Nat Commun 12, 1220.","journal-title":"Nat Commun"},{"key":"2991_CR195","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/s41582-018-0070-3","volume":"14","author":"M Kivipelto","year":"2018","unstructured":"Kivipelto, M., Mangialasche, F., and Ngandu, T. (2018). Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease. Nat Rev Neurol 14, 653\u2013666.","journal-title":"Nat Rev Neurol"},{"key":"2991_CR196","doi-asserted-by":"publisher","first-page":"1205207","DOI":"10.3389\/fphar.2023.1205207","volume":"14","author":"F Kong","year":"2023","unstructured":"Kong, F., Wu, T., Dai, J., Zhai, Z., Cai, J., Zhu, Z., Xu, Y., and Sun, T. (2023). Glucagon-like peptide 1 (GLP-1) receptor agonists in experimental Alzheimer\u2019s disease models: a systematic review and meta-analysis of preclinical studies. Front Pharmacol 14, 1205207.","journal-title":"Front Pharmacol"},{"key":"2991_CR197","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/alzrt278","volume":"6","author":"E Kontsekova","year":"2014","unstructured":"Kontsekova, E., Zilka, N., Kovacech, B., Novak, P., and Novak, M. (2014). First-in-man tau vaccine targeting structural determinants essential for pathological tautau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer\u2019s disease model. Alzheimers Res Ther 6, 44.","journal-title":"Alzheimers Res Ther"},{"key":"2991_CR198","doi-asserted-by":"publisher","first-page":"24374","DOI":"10.1016\/S0021-9258(20)80536-5","volume":"268","author":"E K\u00f6pke","year":"1993","unstructured":"K\u00f6pke, E., Tung, Y.C., Shaikh, S., Alonso, A.C., Iqbal, K., and Grundke-Iqbal, I. (1993). Microtubule-associated protein tau. Abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease. J Biol Chem 268, 24374\u201324384.","journal-title":"J Biol Chem"},{"key":"2991_CR199","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1093\/brain\/awz364","volume":"143","author":"M Koronyo-Hamaoui","year":"2020","unstructured":"Koronyo-Hamaoui, M., Sheyn, J., Hayden, E.Y., Li, S., Fuchs, D.T., Regis, G.C., Lopes, D.H.J., Black, K.L., Bernstein, K.E., Teplow, D.B., et al. (2020). Peripherally derived angiotensin converting enzyme-enhanced macrophages alleviate Alzheimer-related disease. Brain 143, 336\u2013358.","journal-title":"Brain"},{"key":"2991_CR200","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s43587-023-00368-3","volume":"3","author":"N Koutsodendris","year":"2023","unstructured":"Koutsodendris, N., Blumenfeld, J., Agrawal, A., Traglia, M., Grone, B., Zilberter, M., Yip, O., Rao, A., Nelson, M.R., Hao, Y., et al. (2023a). Neuronal APOE4 removal protects against tau-mediated gliosis, neurodegeneration and myelin deficits. Nat Aging 3, 275\u2013296.","journal-title":"Nat Aging"},{"key":"2991_CR201","doi-asserted-by":"publisher","first-page":"113252","DOI":"10.1016\/j.celrep.2023.113252","volume":"42","author":"N Koutsodendris","year":"2023","unstructured":"Koutsodendris, N., Blumenfeld, J., Agrawal, A., Traglia, M., Yip, O., Rao, A., Kim, M.J., Nelson, M.R., Wang, Y.H., Grone, B., et al. (2023b). APOE4-promoted gliosis and degeneration in tauopathy are ameliorated by pharmacological inhibition of HMGB1 release. Cell Rep 42, 113252.","journal-title":"Cell Rep"},{"key":"2991_CR202","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S0896-6273(04)00017-0","volume":"41","author":"II Kruman","year":"2004","unstructured":"Kruman, I.I., Wersto, R.P., Cardozo-Pelaez, F., Smilenov, L., Chan, S.L., Chrest, F.J., EmokpaeJr., R., Gorospe, M., and Mattson, M.P. (2004). Cell cycle activation linked to neuronal cell death initiated by DNA damage. Neuron 41, 549\u2013561.","journal-title":"Neuron"},{"key":"2991_CR203","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.3390\/cells8111424","volume":"8","author":"S Kuhn","year":"2019","unstructured":"Kuhn, S., Gritti, L., Crooks, D., and Dombrowski, Y. (2019). Oligodendrocytes in development, myelin generation and beyond. Cells 8, 1424.","journal-title":"Cells"},{"key":"2991_CR204","doi-asserted-by":"publisher","first-page":"e12001","DOI":"10.1002\/trc2.12001","volume":"6","author":"J Kutzsche","year":"2020","unstructured":"Kutzsche, J., J\u00fcrgens, D., Willuweit, A., Adermann, K., Fuchs, C., Simons, S., Windisch, M., H\u00fcmpel, M., Rossberg, W., Wolzt, M., et al. (2020). Safety and pharmacokinetics of the orally available antiprionic compound PRI-002: a single and multiple ascending dose phase I study. Alzheimers Dement (N Y) 6, e12001.","journal-title":"Alzheimers Dement (N Y)"},{"key":"2991_CR205","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","volume":"51","author":"BW Kunkle","year":"2019","unstructured":"Kunkle, B.W., Grenier-Boley, B., Sims, R., Bis, J.C., Damotte, V., Naj, A.C., Boland, A., Vronskaya, M., van der Lee, S.J., Amlie-Wolf, A., et al. (2019). Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing. Nat Genet 51, 414\u2013430.","journal-title":"Nat Genet"},{"key":"2991_CR206","doi-asserted-by":"publisher","first-page":"783","DOI":"10.14348\/molcells.2016.0233","volume":"39","author":"MJ Kwon","year":"2016","unstructured":"Kwon, M.J., Kim, S., Han, M.H., and Lee, S.B. (2016). Epigenetic Changes in neurodegenerative diseases. Mol Cells 39, 783\u2013789.","journal-title":"Mol Cells"},{"key":"2991_CR207","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.cell.2019.02.032","volume":"177","author":"T Lappalainen","year":"2019","unstructured":"Lappalainen, T., Scott, A.J., Brandt, M., and Hall, I.M. (2019). Genomic analysis in the age of human genome sequencing. Cell 177, 70\u201384.","journal-title":"Cell"},{"key":"2991_CR208","doi-asserted-by":"publisher","first-page":"107155","DOI":"10.1016\/j.bpc.2023.107155","volume":"305","author":"A Lasorsa","year":"2024","unstructured":"Lasorsa, A., Merzougui, H., Cantrelle, F.X., Sicoli, G., Dupr\u00e9, E., Hanoulle, X., Belle, V., Smet-Nocca, C., and Landrieu, I. (2024). Magnetic resonance investigation of conformational responses of tau protein to specific phosphorylation. Biophys Chem 305, 107155.","journal-title":"Biophys Chem"},{"key":"2991_CR209","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1146\/annurev-pathmechdis-012419-032551","volume":"16","author":"CS Latimer","year":"2021","unstructured":"Latimer, C.S., Lucot, K.L., Keene, C.D., Cholerton, B., and Montine, T.J. (2021). Genetic insights into Alzheimer\u2019s disease. Annu Rev Pathol Mech Dis 16, 351\u2013376.","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"2991_CR210","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.cmet.2019.09.001","volume":"30","author":"S Lautrup","year":"2019","unstructured":"Lautrup, S., Sinclair, D.A., Mattson, M.P., and Fang, E.F. (2019). NAD+ in brain aging and neurodegenerative disorders. Cell Metab 30, 630\u2013655.","journal-title":"Cell Metab"},{"key":"2991_CR211","first-page":"7856","volume":"16","author":"CY Lee","year":"2024","unstructured":"Lee, C.Y., Chan, L., Hu, C.J., Hong, C.T., and Chen, J.H. (2024a). Role of vitamin B12 and folic acid in treatment of Alzheimer\u2019s disease: a meta-analysis of randomized control trials. Aging 16, 7856.","journal-title":"Aging"},{"key":"2991_CR212","doi-asserted-by":"publisher","first-page":"1137197","DOI":"10.3389\/fnagi.2023.1137197","volume":"15","author":"HW Lee","year":"2023","unstructured":"Lee, H.W., Kim, S., Jo, Y., Kim, Y., Ye, B.S., and Yu, Y.M. (2023). Neuroprotective effect of angiotensin II receptor blockers on the risk of incident Alzheimer\u2019s disease: a nationwide population-based cohort study. Front Aging Neurosci 15, 1137197.","journal-title":"Front Aging Neurosci"},{"key":"2991_CR213","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1083\/jcb.200307017","volume":"164","author":"JT Lee","year":"2004","unstructured":"Lee, J.T., Xu, J., Lee, J.M., Ku, G., Han, X., Yang, D.I., Chen, S., and Hsu, C.Y. (2004). Amyloid-\u03b2 peptide induces oligodendrocyte death by activating the neutral sphingomyelinase\u2014ceramide pathway. J Cell Biol 164, 123\u2013131.","journal-title":"J Cell Biol"},{"key":"2991_CR214","doi-asserted-by":"publisher","first-page":"3397","DOI":"10.1002\/alz.13796","volume":"20","author":"S Lee","year":"2024","unstructured":"Lee, S., Hecker, J., Hahn, G., Mullin, K., Lutz, S.M., Tanzi, R.E., Lange, C., and Prokopenko, D. (2024b). On the effect heterogeneity of established disease susceptibility loci for Alzheimer\u2019s disease across different genetic ancestries. Alzheimers Dement 20, 3397\u20133405.","journal-title":"Alzheimers Dement"},{"key":"2991_CR215","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1038\/ncomms2278","volume":"3","author":"S Lee","year":"2012","unstructured":"Lee, S., Wang, J.W., Yu, W., and Lu, B. (2012). Phospho-dependent ubiquitination and degradation of PAR-1 regulates synaptic morphology and tau-mediated A\u03b2 toxicity in Drosophila. Nat Commun 3, 1312.","journal-title":"Nat Commun"},{"key":"2991_CR216","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40035-025-00473-w","volume":"14","author":"H Lei","year":"2025","unstructured":"Lei, H., Lv, J., Zhang, F., Wei, L., Shi, K., Liu, J., He, T., Xiong, R., Sun, F., Zhong, T., et al. (2025). Improving vulnerable Calbindin1\u2014neurons in the ventral hippocampus rescues tau-induced impairment of episodic memory. Transl Neurodegener 14, 12.","journal-title":"Transl Neurodegener"},{"key":"2991_CR217","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40779-024-00512-z","volume":"11","author":"HY Lei","year":"2024","unstructured":"Lei, H.Y., Pi, G.L., He, T., Xiong, R., Lv, J.R., Liu, J.L., Wu, D.Q., Li, M.Z., Shi, K., Li, S. H., et al. (2024). Targeting vulnerable microcircuits in the ventral hippocampus of male transgenic mice to rescue Alzheimer-like social memory loss. Military Med Res 11, 16.","journal-title":"Military Med Res"},{"key":"2991_CR218","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3233\/JAD-215145","volume":"84","author":"MJ Lennon","year":"2021","unstructured":"Lennon, M.J., Rigney, G., Raymont, V., and Sachdev, P. (2021). Genetic therapies for Alzheimer\u2019s disease: a scoping review. J Alzheimer Dis 84, 491\u2013504.","journal-title":"J Alzheimer Dis"},{"key":"2991_CR219","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1073\/pnas.0609303104","volume":"104","author":"HL Li","year":"2007","unstructured":"Li, H.L., Wang, H.H., Liu, S.J., Deng, Y.Q., Zhang, Y.J., Tian, Q., Wang, X.C., Chen, X. Q., Yang, Y., Zhang, J.Y., et al. (2007). Phosphorylation of tau antagonizes apoptosis by stabilizing \u03b2-catenin, a mechanism involved in Alzheimer\u2019s neurodegeneration. Proc Natl Acad Sci USA 104, 3591\u20133596.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2991_CR220","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s40779-022-00396-x","volume":"9","author":"MZ Li","year":"2022","unstructured":"Li, M.Z., Liu, E.J., Zhou, Q.Z., Li, S.H., Liu, S.J., Yu, H.T., Pan, Q.H., Sun, F., He, T., Wang, W.J., et al. (2022a). Intracellular accumulation of tau inhibits autophagosome formation by activating TIA1-amino acid-mTORC1 signaling. Military Med Res 9, 38.","journal-title":"Military Med Res"},{"key":"2991_CR221","doi-asserted-by":"publisher","first-page":"e13600","DOI":"10.1111\/acel.13600","volume":"21","author":"S Li","year":"2022","unstructured":"Li, S., Zhou, Q., Liu, E., Du, H., Yu, N., Yu, H., Wang, W., Li, M., Weng, Y., Gao, Y., et al. (2022b). Alzheimer-like tau accumulation in dentate gyrus mossy cells induces spatial cognitive deficits by disrupting multiple memory-related signaling and inhibiting local neural circuit. Aging Cell 21, e13600.","journal-title":"Aging Cell"},{"key":"2991_CR222","doi-asserted-by":"publisher","first-page":"4825","DOI":"10.1038\/emboj.2011.376","volume":"30","author":"X Li","year":"2011","unstructured":"Li, X., Kumar, Y., Zempel, H., Mandelkow, E.M., Biernat, J., and Mandelkow, E. (2011). Novel diffusion barrier for axonal retention of Tau in neurons and its failure in neurodegeneration. EMBO J 30, 4825\u20134837.","journal-title":"EMBO J"},{"key":"2991_CR223","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00702-005-0303-7","volume":"113","author":"X Li","year":"2006","unstructured":"Li, X., Lu, F., Tian, Q., Yang, Y., Wang, Q., and Wang, J.Z. (2006). Activation of glycogen synthase kinase-3 induces Alzheimer-like tau hyperphosphorylation in rat hippocampus slices in culture. J Neural Transm 113, 93\u2013102.","journal-title":"J Neural Transm"},{"key":"2991_CR224","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ymthe.2016.10.010","volume":"25","author":"X Li","year":"2017","unstructured":"Li, X., Wang, Z., Tan, L., Wang, Y., Lu, C., Chen, R., Zhang, S., Gao, Y., Liu, Y., Yin, Y., et al. (2017). Correcting miR92a-vGAT-mediated GABAergic dysfunctions rescues human tau-induced anxiety in mice. Mol Ther 25, 140\u2013152.","journal-title":"Mol Ther"},{"key":"2991_CR225","doi-asserted-by":"publisher","first-page":"e47202","DOI":"10.15252\/embr.201847202","volume":"20","author":"X Li","year":"2019","unstructured":"Li, X., Hong, X., Wang, Y., Zhang, S., Zhang, J., Li, X., Liu, Y., Sun, D., Feng, Q., Ye, J., et al. (2019). Tau accumulation triggers STAT1-dependent memory deficits by suppressing NMDA receptor expression. EMBO Rep 20, e47202.","journal-title":"EMBO Rep"},{"key":"2991_CR226","doi-asserted-by":"publisher","first-page":"7397","DOI":"10.1007\/s00018-021-03986-5","volume":"78","author":"Y Li","year":"2021","unstructured":"Li, Y., Laws, S.M., Miles, L.A., Wiley, J.S., Huang, X., Masters, C.L., and Gu, B.J. (2021). Genomics of Alzheimer\u2019s disease implicates the innate and adaptive immune systems. Cell Mol Life Sci 78, 7397\u20137426.","journal-title":"Cell Mol Life Sci"},{"key":"2991_CR227","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.1002\/alz.12927","volume":"19","author":"Y Li","year":"2023","unstructured":"Li, Y., Nuytemans, K., La, J., Jiang, R., Slifer, S.H., Sun, S., Naj, A., Gao, X.R., and Martin, E.R. (2023). Identification of novel genes for age-at-onset of Alzheimer\u2019s disease by combining quantitative and survival trait analyses. Alzheimers Dement 19, 3148\u20133157.","journal-title":"Alzheimers Dement"},{"key":"2991_CR228","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.neuron.2018.05.008","volume":"98","author":"YT Lin","year":"2018","unstructured":"Lin, Y.T., Seo, J., Gao, F., Feldman, H.M., Wen, H.L., Penney, J., Cam, H.P., Gjoneska, E., Raja, W.K., Cheng, J., et al. (2018). APOE4 causes widespread molecular and cellular alterations associated with Alzheimer\u2019s disease phenotypes in human iPSC-derived brain cell types. Neuron 98, 1141\u20131154.e7.","journal-title":"Neuron"},{"key":"2991_CR229","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3233\/JAD-130503","volume":"37","author":"C Liu","year":"2013","unstructured":"Liu, C., G\u00f6tz, J., Alonso, A., and Gong, C. (2013a). How it all started: tau and protein phosphatase 2A. J Alzheimer Dis 37, 483\u2013494.","journal-title":"J Alzheimer Dis"},{"key":"2991_CR230","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1038\/s41590-023-01640-9","volume":"24","author":"CC Liu","year":"2023","unstructured":"Liu, C.C., Wang, N., Chen, Y., Inoue, Y., Shue, F., Ren, Y., Wang, M., Qiao, W., Ikezu, T.C., Li, Z., et al. (2023a). Cell-autonomous effects of APOE4 in restricting microglial response in brain homeostasis and Alzheimer\u2019s disease. Nat Immunol 24, 1854\u20131866.","journal-title":"Nat Immunol"},{"key":"2991_CR231","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/j.neurobiolaging.2012.11.020","volume":"34","author":"D Liu","year":"2013","unstructured":"Liu, D., Pitta, M., Jiang, H., Lee, J.H., Zhang, G., Chen, X., Kawamoto, E.M., and Mattson, M.P. (2013b). Nicotinamide forestalls pathology and cognitive decline in Alzheimer mice: evidence for improved neuronal bioenergetics and autophagy procession. Neurobiol Aging 34, 1564\u20131580.","journal-title":"Neurobiol Aging"},{"key":"2991_CR232","doi-asserted-by":"publisher","first-page":"e48328","DOI":"10.15252\/embr.201948328","volume":"21","author":"E Liu","year":"2020","unstructured":"Liu, E., Zhou, Q., Xie, A., Li, X., Li, M., Ye, J., Li, S., Ke, D., Wang, Q., Xu, Z., et al. (2020). Tau acetylates and stabilizes \u03b2-catenin thereby promoting cell survival. EMBO Rep 21, e48328.","journal-title":"EMBO Rep"},{"key":"2991_CR233","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1111\/j.1460-9568.2005.04391.x","volume":"22","author":"F Liu","year":"2005","unstructured":"Liu, F., Grundke-Iqbal, I., Iqbal, K., and Gong, C. (2005). Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation. Eur J Neurosci 22, 1942\u20131950.","journal-title":"Eur J Neurosci"},{"key":"2991_CR234","doi-asserted-by":"publisher","first-page":"10804","DOI":"10.1073\/pnas.0400348101","volume":"101","author":"F Liu","year":"2004","unstructured":"Liu, F., Iqbal, K., Grundke-Iqbal, I., Hart, G.W., and Gong, C.X. (2004). O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer\u2019s disease. Proc Natl Acad Sci USA 101, 10804\u201310809.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2991_CR235","doi-asserted-by":"publisher","first-page":"102697","DOI":"10.1016\/j.redox.2023.102697","volume":"62","author":"Q Liu","year":"2023","unstructured":"Liu, Q., Wang, X., Hu, Y., Zhao, J.N., Huang, C.H., Li, T., Zhang, B.G., He, Y., Wu, Y. Q., Zhang, Z.J., et al. (2023b). Acetylated tau exacerbates learning and memory impairment by disturbing with mitochondrial homeostasis. Redox Biol 62, 102697.","journal-title":"Redox Biol"},{"key":"2991_CR236","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/s41392-022-01157-x","volume":"7","author":"X Liu","year":"2022","unstructured":"Liu, X., Che, R., Liang, W., Zhang, Y., Wu, L., Han, C., Lu, H., Song, W., Wu, Y., and Wang, Z. (2022). Clusterin transduces Alzheimer-risk signals to amyloidogenesis. Sig Transduct Target Ther 7, 325.","journal-title":"Sig Transduct Target Ther"},{"key":"2991_CR237","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40035-024-00397-x","volume":"13","author":"Y Liu","year":"2024","unstructured":"Liu, Y., Tan, Y., Zhang, Z., Yi, M., Zhu, L., and Peng, W. (2024). The interaction between ageing and Alzheimer\u2019s disease: insights from the hallmarks of ageing. Transl Neurodegener 13, 7.","journal-title":"Transl Neurodegener"},{"key":"2991_CR238","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/joim.12759","volume":"284","author":"R Loera-Valencia","year":"2018","unstructured":"Loera-Valencia, R., Piras, A., Ismail, M.A.M., Manchanda, S., Eyjolfsdottir, H., Saido, T.C., Johansson, J., Eriksdotter, M., Winblad, B., and Nilsson, P. (2018). Targeting Alzheimer\u2019s disease with gene and cell therapies. J Intern Med 284, 2\u201336.","journal-title":"J Intern Med"},{"key":"2991_CR239","doi-asserted-by":"publisher","first-page":"106429","DOI":"10.1016\/j.nbd.2024.106429","volume":"192","author":"DM Long","year":"2024","unstructured":"Long, D.M., Cravetchi, O., Chow, E.S., Allen, C., and Kretzschmar, D. (2024). The amyloid precursor protein intracellular domain induces sleep disruptions and its nuclear localization fluctuates in circadian pacemaker neurons in Drosophila and mice. Neurobiol Dis 192, 106429.","journal-title":"Neurobiol Dis"},{"key":"2991_CR240","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1038\/s41591-023-02318-3","volume":"29","author":"F Lopera","year":"2023","unstructured":"Lopera, F., Marino, C., Chandrahas, A.S., O\u2019Hare, M., Villalba-Moreno, N.D., Aguillon, D., Baena, A., Sanchez, J.S., Vila-Castelar, C., Ramirez Gomez, L., et al. (2023). Resilience to autosomal dominant Alzheimer\u2019s disease in a Reelin-COLBOS heterozygous man. Nat Med 29, 1243\u20131252.","journal-title":"Nat Med"},{"key":"2991_CR241","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1046\/j.1471-4159.1999.0720771.x","volume":"72","author":"MA Lovell","year":"1999","unstructured":"Lovell, M.A., Gabbita, S.P., and Markesbery, W.R. (1999). Increased DNA oxidation and decreased levels of repair products in Alzheimer\u2019s disease ventricular CSF. J Neurochem 72, 771\u2013776.","journal-title":"J Neurochem"},{"key":"2991_CR242","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/S0960-9822(00)00246-3","volume":"4","author":"S Lovestone","year":"1994","unstructured":"Lovestone, S., Reynolds, C.H., Latimer, D., Davis, D.R., Anderton, B.H., Gallo, J.M., Hanger, D., Mulot, S., Marquardt, B., Stabel, S., et al. (1994). Alzheimer\u2019s disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells. Curr Biol 4, 1077\u20131086.","journal-title":"Curr Biol"},{"key":"2991_CR243","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ejmech.2018.01.063","volume":"146","author":"M Lu","year":"2018","unstructured":"Lu, M., Liu, T., Jiao, Q., Ji, J., Tao, M., Liu, Y., You, Q., and Jiang, Z. (2018). Discovery of a Keap1-dependent peptide PROTAC to knockdown Tau by ubiquitination-proteasome degradation pathway. Eur J Med Chem 146, 251\u2013259.","journal-title":"Eur J Med Chem"},{"key":"2991_CR244","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/21650","volume":"399","author":"PJ Lu","year":"1999","unstructured":"Lu, P.J., Wulf, G., Zhou, X.Z., Davies, P., and Lu, K.P. (1999). The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein. Nature 399, 784\u2013788.","journal-title":"Nature"},{"key":"2991_CR245","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3233\/JAD-2007-12410","volume":"12","author":"J Luna-Mu\u00f1oz","year":"2007","unstructured":"Luna-Mu\u00f1oz, J., Ch\u00e1vez-Mac\u00edas, L., Garc\u00eda-Sierra, F., and Mena, R. (2007). Earliest stages of tau conformational changes are related to the appearance of a sequence of specific phospho-dependent tau epitopes in Alzheimer\u2019s disease. J Alzheimer Dis 12, 365\u2013375.","journal-title":"J Alzheimer Dis"},{"key":"2991_CR246","doi-asserted-by":"publisher","first-page":"16586","DOI":"10.1073\/pnas.1417548111","volume":"111","author":"HB Luo","year":"2014","unstructured":"Luo, H.B., Xia, Y.Y., Shu, X.J., Liu, Z.C., Feng, Y., Liu, X.H., Yu, G., Yin, G., Xiong, Y. S., Zeng, K., et al. (2014). SUMOylation at K340 inhibits tau degradation through deregulating its phosphorylation and ubiquitination. Proc Natl Acad Sci USA 111, 16586\u201316591.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2991_CR247","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1007\/s11427-023-2595-5","volume":"67","author":"J Luo","year":"2024","unstructured":"Luo, J., Liang, S., and Jin, F. (2024). Gut microbiota and healthy longevity. Sci China Life Sci 67, 2590\u20132602.","journal-title":"Sci China Life Sci"},{"key":"2991_CR248","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1172\/JCI64516","volume":"123","author":"PTT Ly","year":"2013","unstructured":"Ly, P.T.T., Wu, Y., Zou, H., Wang, R., Zhou, W., Kinoshita, A., Zhang, M., Yang, Y., Cai, F., Woodgett, J., et al. (2013). Inhibition of GSK3\u03b2-mediated BACE1 expression reduces Alzheimer-associated phenotypes. J Clin Invest 123, 224\u2013235.","journal-title":"J Clin Invest"},{"key":"2991_CR249","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1007\/s12035-014-8800-z","volume":"51","author":"J Ma","year":"2015","unstructured":"Ma, J., Yu, J.T., and Tan, L. (2015). MS4A cluster in Alzheimer\u2019s disease. Mol Neurobiol 51, 1240\u20131248.","journal-title":"Mol Neurobiol"},{"key":"2991_CR250","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.3390\/jcm12041459","volume":"12","author":"K Ma","year":"2023","unstructured":"Ma, K., Zheng, Z.R., and Meng, Y. (2023). Pathogenesis of chronic kidney disease is closely bound up with Alzheimer\u2019s disease, especially via the renin-angiotensin system. J Clin Med 12, 1459.","journal-title":"J Clin Med"},{"key":"2991_CR251","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40035-024-00404-1","volume":"13","author":"YY Ma","year":"2024","unstructured":"Ma, Y.Y., Li, X., Yu, J.T., and Wang, Y.J. (2024). Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside. Transl Neurodegener 13, 12.","journal-title":"Transl Neurodegener"},{"key":"2991_CR252","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.neuron.2014.06.034","volume":"83","author":"R Madabhushi","year":"2014","unstructured":"Madabhushi, R., Pan, L., and Tsai, L.H. (2014). DNA damage and its links to neurodegeneration. Neuron 83, 266\u2013282.","journal-title":"Neuron"},{"key":"2991_CR253","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1038\/d41586-025-01102-2","volume":"640","author":"S Makin","year":"2025","unstructured":"Makin, S. (2025). The future of Alzheimer\u2019s treatment. Nature 640, S4\u2013S6.","journal-title":"Nature"},{"key":"2991_CR254","doi-asserted-by":"publisher","first-page":"19985","DOI":"10.1073\/pnas.1014074107","volume":"107","author":"DL Mallery","year":"2010","unstructured":"Mallery, D.L., McEwan, W.A., Bidgood, S.R., Towers, G.J., Johnson, C.M., and James, L.C. (2010). Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21). Proc Natl Acad Sci USA 107, 19985\u201319990.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2991_CR255","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S1474-4422(16)00065-X","volume":"15","author":"B Maloney","year":"2016","unstructured":"Maloney, B., and Lahiri, D.K. (2016). Epigenetics of dementia: understanding the disease as a transformation rather than a state. Lancet Neurol 15, 760\u2013774.","journal-title":"Lancet Neurol"},{"key":"2991_CR256","doi-asserted-by":"publisher","first-page":"a006247","DOI":"10.1101\/cshperspect.a006247","volume":"2","author":"EM Mandelkow","year":"2012","unstructured":"Mandelkow, E.M., and Mandelkow, E. (2012). Biochemistry and cell biology of tau protein in neurofibrillary degeneration. Cold Spring Harb Perspect Med 2, a006247.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2991_CR257","doi-asserted-by":"publisher","first-page":"5922","DOI":"10.1038\/s41467-023-41545-7","volume":"14","author":"I Maniv","year":"2023","unstructured":"Maniv, I., Sarji, M., Bdarneh, A., Feldman, A., Ankawa, R., Koren, E., Magid-Gold, I., Reis, N., Soteriou, D., Salomon-Zimri, S., et al. (2023). Altered ubiquitin signaling induces Alzheimer\u2019s disease-like hallmarks in a three-dimensional human neural cell culture model. Nat Commun 14, 5922.","journal-title":"Nat Commun"},{"key":"2991_CR258","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.arr.2012.06.008","volume":"12","author":"L Martin","year":"2013","unstructured":"Martin, L., Latypova, X., Wilson, C.M., Magnaudeix, A., Perrin, M.L., and Terro, F. (2013). Tau protein phosphatases in Alzheimer\u2019s disease: the leading role of PP2A. Ageing Res Rev 12, 39\u201349.","journal-title":"Ageing Res Rev"},{"key":"2991_CR259","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.3390\/pharmaceutics14112447","volume":"14","author":"O Mart\u00ednez-Iglesias","year":"2022","unstructured":"Mart\u00ednez-Iglesias, O., Naidoo, V., Carrera, I., Corzo, L., and Cacabelos, R. (2022). Nosustrophine: an epinutraceutical bioproduct with Effects on DNA methylation, histone acetylation and sirtuin expression in Alzheimer\u2019s disease. Pharmaceutics 14, 2447.","journal-title":"Pharmaceutics"},{"key":"2991_CR260","doi-asserted-by":"publisher","first-page":"e00601","DOI":"10.1016\/j.heliyon.2018.e00601","volume":"4","author":"T Maruyama","year":"2018","unstructured":"Maruyama, T., Abe, Y., and Niikura, T. (2018). SENP1 and SENP2 regulate SUMOylation of amyloid precursor protein. Heliyon 4, e00601.","journal-title":"Heliyon"},{"key":"2991_CR261","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1038\/s41586-024-07606-7","volume":"632","author":"H Mathys","year":"2024","unstructured":"Mathys, H., Boix, C.A., Akay, L.A., Xia, Z., Davila-Velderrain, J., Ng, A.P., Jiang, X., Abdelhady, G., Galani, K., Mantero, J., et al. (2024). Single-cell multiregion dissection of Alzheimer\u2019s disease. Nature 632, 858\u2013868.","journal-title":"Nature"},{"key":"2991_CR262","doi-asserted-by":"publisher","first-page":"4365","DOI":"10.1016\/j.cell.2023.08.039","volume":"186","author":"H Mathys","year":"2023","unstructured":"Mathys, H., Peng, Z., Boix, C.A., Victor, M.B., Leary, N., Babu, S., Abdelhady, G., Jiang, X., Ng, A.P., Ghafari, K., et al. (2023). Single-cell atlas reveals correlates of high cognitive function, dementia, and resilience to Alzheimer\u2019s disease pathology. Cell 186, 4365\u20134385.e27.","journal-title":"Cell"},{"key":"2991_CR263","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1073\/pnas.1607215114","volume":"114","author":"WA McEwan","year":"2017","unstructured":"McEwan, W.A., Falcon, B., Vaysburd, M., Clift, D., Oblak, A.L., Ghetti, B., Goedert, M., and James, L.C. (2017). Cytosolic Fc receptor TRIM21 inhibits seeded tau aggregation. Proc Natl Acad Sci USA 114, 574\u2013579.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2991_CR264","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1523\/JNEUROSCI.2283-18.2018","volume":"39","author":"HM Melo","year":"2019","unstructured":"Melo, H.M. (2019). Potential effects of aspirin on lysosomal biogenesis and amyloid-\u03b2 clearance: an old drug and novel insights in Alzheimer\u2019s disease therapy. J Neurosci 39, 197\u2013198.","journal-title":"J Neurosci"},{"key":"2991_CR265","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jalz.2016.09.002","volume":"13","author":"J Mez","year":"2017","unstructured":"Mez, J., Chung, J., Jun, G., Kriegel, J., Bourlas, A.P., Sherva, R., Logue, M.W., Barnes, L.L., Bennett, D.A., Buxbaum, J.D., et al. (2017). Two novel loci, COBL and SLC10A2, for Alzheimer\u2019s disease in African Americans. Alzheimers & Dement 13, 119\u2013129.","journal-title":"Alzheimers & Dement"},{"key":"2991_CR266","doi-asserted-by":"publisher","first-page":"5967","DOI":"10.1016\/j.cell.2024.08.024","volume":"187","author":"LVC Miller","year":"2024","unstructured":"Miller, L.V.C., Papa, G., Vaysburd, M., Cheng, S., Sweeney, P.W., Smith, A., Franco, C., Katsinelos, T., Huang, M., Sanford, S.A.I., et al. (2024). Co-opting templated aggregation to degrade pathogenic tau assemblies and improve motor function. Cell 187, 5967\u20135980.e17.","journal-title":"Cell"},{"key":"2991_CR267","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/s41586-022-04640-1","volume":"604","author":"MB Miller","year":"2022","unstructured":"Miller, M.B., Huang, A.Y., Kim, J., Zhou, Z., Kirkham, S.L., Maury, E.A., Ziegenfuss, J. S., Reed, H.C., Neil, J.E., Rento, L., et al. (2022). Somatic genomic changes in single Alzheimer\u2019s disease neurons. Nature 604, 714\u2013722.","journal-title":"Nature"},{"key":"2991_CR268","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/nm.3951","volume":"21","author":"SW Min","year":"2015","unstructured":"Min, S.W., Chen, X., Tracy, T.E., Li, Y., Zhou, Y., Wang, C., Shirakawa, K., Minami, S. S., Defensor, E., Mok, S.A., et al. (2015). Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits. Nat Med 21, 1154\u20131162.","journal-title":"Nat Med"},{"key":"2991_CR269","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.neuron.2010.08.044","volume":"67","author":"SW Min","year":"2010","unstructured":"Min, S.W., Cho, S.H., Zhou, Y., Schroeder, S., Haroutunian, V., Seeley, W.W., Huang, E.J., Shen, Y., Masliah, E., Mukherjee, C., et al. (2010). Acetylation of tau inhibits its degradation and contributes to tauopathy. Neuron 67, 953\u2013966.","journal-title":"Neuron"},{"key":"2991_CR270","doi-asserted-by":"publisher","first-page":"3680","DOI":"10.1523\/JNEUROSCI.2369-17.2018","volume":"38","author":"SW Min","year":"2018","unstructured":"Min, S.W., Sohn, P.D., Li, Y., Devidze, N., Johnson, J.R., Krogan, N.J., Masliah, E., Mok, S.A., Gestwicki, J.E., and Gan, L. (2018). SIRT1 deacetylates tau and reduces pathogenic tau spread in a mouse model of tauopathy. J Neurosci 38, 3680\u20133688.","journal-title":"J Neurosci"},{"key":"2991_CR271","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","volume":"384","author":"MA Mintun","year":"2021","unstructured":"Mintun, M.A., Lo, A.C., Duggan Evans, C., Wessels, A.M., Ardayfio, P.A., Andersen, S. W., Shcherbinin, S., Sparks, J.D., Sims, J.R., Brys, M., et al. (2021). Donanemab in early Alzheimer\u2019s disease. N Engl J Med 384, 1691\u20131704.","journal-title":"N Engl J Med"},{"key":"2991_CR272","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s00401-010-0657-2","volume":"119","author":"S Mitew","year":"2010","unstructured":"Mitew, S., Kirkcaldie, M.T.K., Halliday, G.M., Shepherd, C.E., Vickers, J.C., and Dickson, T.C. (2010). Focal demyelination in Alzheimer\u2019s disease and transgenic mouse models. Acta Neuropathol 119, 567\u2013577.","journal-title":"Acta Neuropathol"},{"key":"2991_CR273","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/jnc.15748","volume":"165","author":"KK Mok","year":"2023","unstructured":"Mok, K.K., Yeung, S.H., Cheng, G.W., Ma, I.W., Lee, R.H., Herrup, K., and Tse, K. (2023). Apolipoprotein E \u03b54 disrupts oligodendrocyte differentiation by interfering with astrocyte-derived lipid transport. J Neurochem 165, 55\u201375.","journal-title":"J Neurochem"},{"key":"2991_CR274","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1002\/alz.12321","volume":"17","author":"CM Moloney","year":"2021","unstructured":"Moloney, C.M., Lowe, V.J., and Murray, M.E. (2021). Visualization of neurofibrillary tangle maturity in Alzheimer\u2019s disease: a clinicopathologic perspective for biomarker research. Alzheimers & Dement 17, 1554\u20131574.","journal-title":"Alzheimers & Dement"},{"key":"2991_CR275","doi-asserted-by":"publisher","first-page":"2304545","DOI":"10.1002\/advs.202304545","volume":"11","author":"P Mondal","year":"2024","unstructured":"Mondal, P., Bai, P., Gomm, A., Bakiasi, G., Lin, C.J., Wang, Y., Choi, S.H., Tanzi, R.E., Wang, C., and Zhang, C. (2024). Structure-based discovery of a small molecule inhibitor of histone deacetylase 6 (HDAC6) that significantly reduces Alzheimer\u2019s disease neuropathology. Adv Sci 11, 2304545.","journal-title":"Adv Sci"},{"key":"2991_CR276","doi-asserted-by":"publisher","first-page":"104547","DOI":"10.1016\/j.ebiom.2023.104547","volume":"90","author":"L Montoliu-Gaya","year":"2023","unstructured":"Montoliu-Gaya, L., Alcolea, D., Ashton, N.J., Pegueroles, J., Levin, J., Bosch, B., Lantero-Rodriguez, J., Carmona-Iragui, M., Wagemann, O., Balasa, M., et al. (2023). Plasma and cerebrospinal fluid glial fibrillary acidic protein levels in adults with Down syndrome: a longitudinal cohort study. EBioMedicine 90, 104547.","journal-title":"EBioMedicine"},{"key":"2991_CR277","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1089\/hum.2023.092","volume":"34","author":"B Moore","year":"2023","unstructured":"Moore, B., Sharma, A., Goulet, M., Suter, T., Pelletier, C., Hu, R., Schaeffer, E., and KelleherIII, R.J. (2023). Developing a gene therapy for the treatment of autosomal dominant Alzheimer\u2019s disease. Hum Gene Ther 34, 1049\u20131063.","journal-title":"Hum Gene Ther"},{"key":"2991_CR278","doi-asserted-by":"publisher","first-page":"3758","DOI":"10.1016\/j.cell.2023.08.003","volume":"186","author":"M Moqri","year":"2023","unstructured":"Moqri, M., Herzog, C., Poganik, J.R., Justice, J., Belsky, D.W., Higgins-Chen, A., Moskalev, A., Fuellen, G., Cohen, A.A., Bautmans, I., et al. (2023). Biomarkers of aging for the identification and evaluation of longevity interventions. Cell 186, 3758\u20133775.","journal-title":"Cell"},{"key":"2991_CR279","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s12035-012-8246-0","volume":"46","author":"T Morawe","year":"2012","unstructured":"Morawe, T., Hiebel, C., Kern, A., and Behl, C. (2012). Protein homeostasis, aging and Alzheimer\u2019s disease. Mol Neurobiol 46, 41\u201354.","journal-title":"Mol Neurobiol"},{"key":"2991_CR280","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1126\/science.3029875","volume":"235","author":"H Mori","year":"1987","unstructured":"Mori, H., Kondo, J., and Ihara, Y. (1987). Ubiquitin is a component of paired helical filaments in Alzheimer\u2019s disease. Science 235, 1641\u20131644.","journal-title":"Science"},{"key":"2991_CR281","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.dsx.2019.01.035","volume":"13","author":"SJ Morrill","year":"2019","unstructured":"Morrill, S.J., and Gibas, K.J. (2019). Ketogenic diet rescues cognition in ApoE4+ patient with mild Alzheimer\u2019s disease: a case study. Diabetes Metab Syndr Clin Res Rev 13, 1187\u20131191.","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"2991_CR282","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/nn.4067","volume":"18","author":"M Morris","year":"2015","unstructured":"Morris, M., Knudsen, G.M., Maeda, S., Trinidad, J.C., Ioanoviciu, A., Burlingame, A.L., and Mucke, L. (2015a). Tau post-translational modifications in wild-type and human amyloid precursor protein transgenic mice. Nat Neurosci 18, 1183\u20131189.","journal-title":"Nat Neurosci"},{"key":"2991_CR283","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.jalz.2015.04.011","volume":"11","author":"MC Morris","year":"2015","unstructured":"Morris, M.C., Tangney, C.C., Wang, Y., Sacks, F.M., Barnes, L.L., Bennett, D.A., and Aggarwal, N.T. (2015b). MIND diet slows cognitive decline with aging. Alzheimers Dement 11, 1015\u20131022.","journal-title":"Alzheimers Dement"},{"key":"2991_CR284","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.exger.2011.12.005","volume":"47","author":"S Mov\u00e9rare-Skrtic","year":"2012","unstructured":"Mov\u00e9rare-Skrtic, S., Johansson, P., Mattsson, N., Hansson, O., Wallin, A., Johansson, J.O., Zetterberg, H., Blennow, K., and Svensson, J. (2012). Leukocyte telomere length (LTL) is reduced in stable mild cognitive impairment but low LTL is not associated with conversion to Alzheimer\u2019s disease: a pilot study. Exp Gerontol 47, 179\u2013182.","journal-title":"Exp Gerontol"},{"key":"2991_CR285","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1038\/s41591-023-02326-3","volume":"29","author":"CJ Mummery","year":"2023","unstructured":"Mummery, C.J., B\u00f6rjesson-Hanson, A., Blackburn, D.J., Vijverberg, E.G.B., De Deyn, P. P., Ducharme, S., Jonsson, M., Schneider, A., Rinne, J.O., Ludolph, A.C., et al. (2023). Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer\u2019s disease: a phase 1b, randomized, placebo-controlled trial. Nat Med 29, 1437\u20131447.","journal-title":"Nat Med"},{"key":"2991_CR286","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41593-022-01222-2","volume":"26","author":"MH Murdock","year":"2023","unstructured":"Murdock, M.H., and Tsai, L.H. (2023). Insights into Alzheimer\u2019s disease from single-cell genomic approaches. Nat Neurosci 26, 181\u2013195.","journal-title":"Nat Neurosci"},{"key":"2991_CR287","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1001\/jamaneurol.2017.4719","volume":"75","author":"ES Musiek","year":"2018","unstructured":"Musiek, E.S., Bhimasani, M., Zangrilli, M.A., Morris, J.C., Holtzman, D.M., and Ju, Y.E.S. (2018). Circadian rest-activity pattern changes in aging and preclinical Alzheimer disease. JAMA Neurol 75, 582\u2013590.","journal-title":"JAMA Neurol"},{"key":"2991_CR288","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13195-025-01702-0","volume":"17","author":"H Nan","year":"2025","unstructured":"Nan, H., Chu, M., Jiang, D., Liang, W., Li, Y., Wu, Y., Wang, Z., and Wu, L. (2025). Identification and characterization of variants in PSEN1, PSEN2, and APP genes in Chinese patients with early-onset Alzheimer\u2019s disease. Alzheimers Res Ther 17, 54.","journal-title":"Alzheimers Res Ther"},{"key":"2991_CR289","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/nu14010020","volume":"14","author":"R Naomi","year":"2021","unstructured":"Naomi, R., Embong, H., Othman, F., Ghazi, H.F., Maruthey, N., and Bahari, H. (2021). Probiotics for Alzheimer\u2019s disease: a systematic review. Nutrients 14, 20.","journal-title":"Nutrients"},{"key":"2991_CR290","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/s41588-020-0696-0","volume":"52","author":"R Nativio","year":"2020","unstructured":"Nativio, R., Lan, Y., Donahue, G., Sidoli, S., Berson, A., Srinivasan, A.R., Shcherbakova, O., Amlie-Wolf, A., Nie, J., Cui, X., et al. (2020). An integrated multi-omics approach identifies epigenetic alterations associated with Alzheimer\u2019s disease. Nat Genet 52, 1024\u20131035.","journal-title":"Nat Genet"},{"key":"2991_CR291","doi-asserted-by":"publisher","first-page":"8681","DOI":"10.1073\/pnas.1711357114","volume":"114","author":"AR Nelson","year":"2017","unstructured":"Nelson, A.R., Sagare, A.P., and Zlokovic, B.V. (2017). Role of clusterin in the brain vascular clearance of amyloid-\u03b2. Proc Natl Acad Sci USA 114, 8681\u20138682.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2991_CR292","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s12974-018-1313-3","volume":"15","author":"EA Newcombe","year":"2018","unstructured":"Newcombe, E.A., Camats-Perna, J., Silva, M.L., Valmas, N., Huat, T.J., and Medeiros, R. (2018). Inflammation: the link between comorbidities, genetics, and Alzheimer\u2019s disease. J Neuroinflamm 15, 276.","journal-title":"J Neuroinflamm"},{"key":"2991_CR293","doi-asserted-by":"publisher","first-page":"e197978","DOI":"10.1001\/jamanetworkopen.2019.7978","volume":"2","author":"K Nho","year":"2019","unstructured":"Nho, K., Kueider-Paisley, A., Ahmad, S., MahmoudianDehkordi, S., Arnold, M., Risacher, S.L., Louie, G., Blach, C., Baillie, R., Han, X., et al. (2019). Association of altered liver enzymes with Alzheimer disease diagnosis, cognition, neuroimaging measures, and cerebrospinal fluid biomarkers. JAMA Netw Open 2, e197978.","journal-title":"JAMA Netw Open"},{"key":"2991_CR294","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00401-018-1939-3","volume":"137","author":"G Nicolas","year":"2019","unstructured":"Nicolas, G., and Veltman, J.A. (2019). The role of de novo mutations in adult-onset neurodegenerative disorders. Acta Neuropathol 137, 183\u2013207.","journal-title":"Acta Neuropathol"},{"key":"2991_CR295","doi-asserted-by":"publisher","first-page":"101082","DOI":"10.1016\/j.gim.2024.101082","volume":"26","author":"G Nicolas","year":"2024","unstructured":"Nicolas, G., Zar\u00e9a, A., Lacour, M., Quenez, O., Rousseau, S., Richard, A.C., Bonnevalle, A., Schramm, C., Olaso, R., Sandron, F., et al. (2024). Assessment of Mendelian and risk-factor genes in Alzheimer disease: a prospective nationwide clinical utility study and recommendations for genetic screening. Genet Med 26, 101082.","journal-title":"Genet Med"},{"key":"2991_CR296","doi-asserted-by":"publisher","first-page":"e20202207","DOI":"10.1084\/jem.20202207","volume":"218","author":"AM Nikolakopoulou","year":"2021","unstructured":"Nikolakopoulou, A.M., Wang, Y., Ma, Q., Sagare, A.P., Montagne, A., Huuskonen, M. T., Rege, S.V., Kisler, K., Dai, Z., K\u00f6rbelin, J., et al. (2021). Endothelial LRP1 protects against neurodegeneration by blocking cyclophilin A. J Exp Med 218, e20202207.","journal-title":"J Exp Med"},{"key":"2991_CR297","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1111\/bph.14618","volume":"176","author":"S Nizami","year":"2019","unstructured":"Nizami, S., Hall-Roberts, H., Warrier, S., Cowley, S.A., and Di Daniel, E. (2019). Microglial inflammation and phagocytosis in Alzheimer\u2019s disease: potential therapeutic targets. Br J Pharmacol 176, 3515\u20133532.","journal-title":"Br J Pharmacol"},{"key":"2991_CR298","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/j.1460-2075.1993.tb05665.x","volume":"12","author":"M Novak","year":"1993","unstructured":"Novak, M., Kabat, J., and Wischik, C.M. (1993). Molecular characterization of the minimal protease resistant tau unit of the Alzheimer\u2019s disease paired helical filament. EMBO J 12, 365\u2013370.","journal-title":"EMBO J"},{"key":"2991_CR299","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s43587-021-00070-2","volume":"1","author":"P Novak","year":"2021","unstructured":"Novak, P., Kovacech, B., Katina, S., Schmidt, R., Scheltens, P., Kontsekova, E., Ropele, S., Fialova, L., Kramberger, M., Paulenka-Ivanovova, N., et al. (2021). ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer\u2019s disease. Nat Aging 1, 521\u2013534.","journal-title":"Nat Aging"},{"key":"2991_CR300","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S1474-4422(16)30331-3","volume":"16","author":"P Novak","year":"2017","unstructured":"Novak, P., Schmidt, R., Kontsekova, E., Zilka, N., Kovacech, B., Skrabana, R., Vince-Kazmerova, Z., Katina, S., Fialova, L., Prcina, M., et al. (2017). Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer\u2019s disease: a randomised, double-blind, placebo-controlled, phase 1 trial. Lancet Neurol 16, 123\u2013134.","journal-title":"Lancet Neurol"},{"key":"2991_CR301","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13195-022-01028-1","volume":"14","author":"SD Noveir","year":"2022","unstructured":"Noveir, S.D., Kerman, B.E., Xian, H., Meuret, C., Smadi, S., Martinez, A.E., Johansson, J., Zetterberg, H., Parks, B.A., Kuklenyik, Z., et al. (2022). Effect of the ABCA1 agonist CS-6253 on amyloid-\u03b2 and lipoprotein metabolism in cynomolgus monkeys. Alzheimers Res Ther 14, 87.","journal-title":"Alzheimers Res Ther"},{"key":"2991_CR302","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13024-021-00449-0","volume":"16","author":"G Novikova","year":"2021","unstructured":"Novikova, G., Andrews, S.J., Renton, A.E., and Marcora, E. (2021a). Beyond association: successes and challenges in linking non-coding genetic variation to functional consequences that modulate Alzheimer\u2019s disease risk. Mol Neurodegener 16, 27.","journal-title":"Mol Neurodegener"},{"key":"2991_CR303","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1038\/s41467-021-21823-y","volume":"12","author":"G Novikova","year":"2021","unstructured":"Novikova, G., Kapoor, M., Tcw, J., Abud, E.M., Efthymiou, A.G., Chen, S.X., Cheng, H., Fullard, J.F., Bendl, J., Liu, Y., et al. (2021b). Integration of Alzheimer\u2019s disease genetics and myeloid genomics identifies disease risk regulatory elements and genes. Nat Commun 12, 1610.","journal-title":"Nat Commun"},{"key":"2991_CR304","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.expneurol.2012.07.018","volume":"237","author":"G N\u00fcbling","year":"2012","unstructured":"N\u00fcbling, G., Levin, J., Bader, B., Israel, L., B\u00f6tzel, K., Lorenzl, S., and Giese, A. (2012). Limited cleavage of tau with matrix-metalloproteinase MMP-9, but not MMP-3, enhances tau oligomer formation. Exp Neurol 237, 470\u2013476.","journal-title":"Exp Neurol"},{"key":"2991_CR305","doi-asserted-by":"publisher","first-page":"6065","DOI":"10.1038\/s41380-021-01251-6","volume":"26","author":"YN Ou","year":"2021","unstructured":"Ou, Y.N., Yang, Y.X., Deng, Y.T., Zhang, C., Hu, H., Wu, B.S., Liu, Y., Wang, Y.J., Zhu, Y., Suckling, J., et al. (2021). Identification of novel drug targets for Alzheimer\u2019s disease by integrating genetics and proteomes from brain and blood. Mol Psychiatry 26, 6065\u20136073.","journal-title":"Mol Psychiatry"},{"key":"2991_CR306","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.neurobiolaging.2014.10.006","volume":"36","author":"MH Ou-Yang","year":"2015","unstructured":"Ou-Yang, M.H., Xu, F., Liao, M.C., Davis, J., Robinson, J.K., and Van Nostrand, W.E. (2015). The N-terminal region of myelin basic protein reduces fibrillar amyloid-\u03b2 deposition in Tg-5xFAD mice. Neurobiol Aging 36, 801\u2013811.","journal-title":"Neurobiol Aging"},{"key":"2991_CR307","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/wps.20870","volume":"20","author":"MJ Owen","year":"2021","unstructured":"Owen, M.J., and Williams, N.M. (2021). Explaining the missing heritability of psychiatric disorders. World Psychiatry 20, 294\u2013295.","journal-title":"World Psychiatry"},{"key":"2991_CR308","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1002\/alz.13603","volume":"20","author":"HA Owens","year":"2024","unstructured":"Owens, H.A., Thorburn, L.E., Walsby, E., Moon, O.R., Rizkallah, P., Sherwani, S., Tinsley, C.L., Rogers, L., Cerutti, C., Ridley, A.J., et al. (2024). Alzheimer\u2019s disease-associated P460L variant of EphA1 dysregulates receptor activity and blood-brain barrier function. Alzheimers Dement 20, 2016\u20132033.","journal-title":"Alzheimers Dement"},{"key":"2991_CR309","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1038\/s41591-025-03622-w","volume":"31","author":"S Palmqvist","year":"2025","unstructured":"Palmqvist, S., Warmenhoven, N., Anastasi, F., Pilotto, A., Janelidze, S., Tideman, P., Stomrud, E., Mattsson-Carlgren, N., Smith, R., Ossenkoppele, R., et al. (2025). Plasma phospho-tau217 for Alzheimer\u2019s disease diagnosis in primary and secondary care using a fully automated platform. Nat Med 31, 2036\u20132043.","journal-title":"Nat Med"},{"key":"2991_CR310","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/S0896-6273(00)80187-7","volume":"17","author":"DM Paresce","year":"1996","unstructured":"Paresce, D.M., Ghosh, R.N., and Maxfield, F.R. (1996). Microglial cells internalize aggregates of the Alzheimer\u2019s disease amyloid \u03b2-protein via a scavenger receptor. Neuron 17, 553\u2013565.","journal-title":"Neuron"},{"key":"2991_CR311","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.neurobiolaging.2013.12.015","volume":"35","author":"HH Park","year":"2014","unstructured":"Park, H.H., Lee, K.Y., Kim, S., Lee, J.W., Choi, N.Y., Lee, E.H., Lee, Y.J., Lee, S.H., and Koh, S.H. (2014). The novel vaccine peptide GV1001 effectively blocks \u03b2-amyloid toxicity by mimicking the extra-telomeric functions of human telomerase reverse transcriptase. Neurobiol Aging 35, 1255\u20131274.","journal-title":"Neurobiol Aging"},{"key":"2991_CR312","doi-asserted-by":"publisher","first-page":"9728","DOI":"10.1021\/bi9906827","volume":"38","author":"S Parvathy","year":"1999","unstructured":"Parvathy, S., Hussain, I., Karran, E.H., Turner, A.J., and Hooper, N.M. (1999). Cleavage of Alzheimer\u2019s amyloid precursor protein by a-secretase occurs at the surface of neuronal cells. Biochemistry 38, 9728\u20139734.","journal-title":"Biochemistry"},{"key":"2991_CR313","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.neurobiolaging.2004.09.014","volume":"26","author":"NV Patel","year":"2005","unstructured":"Patel, N.V., Gordon, M.N., Connor, K.E., Good, R.A., Engelman, R.W., Mason, J., Morgan, D.G., Morgan, T.E., and Finch, C.E. (2005). Caloric restriction attenuates A\u03b2-deposition in Alzheimer transgenic models. Neurobiol Aging 26, 995\u20131000.","journal-title":"Neurobiol Aging"},{"key":"2991_CR314","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.3109\/10715762.2015.1040788","volume":"49","author":"R Pei","year":"2015","unstructured":"Pei, R., Mah, E., Leonard, S.W., Traber, M.G., and Bruno, R.S. (2015). \u03b1-Tocopherol supplementation reduces 5-nitro-\u03b3-tocopherol accumulation by decreasing \u03b3-tocopherol in young adult smokers. Free Radical Res 49, 1114\u20131121.","journal-title":"Free Radical Res"},{"key":"2991_CR315","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/jnr.20879","volume":"84","author":"M Perluigi","year":"2006","unstructured":"Perluigi, M., Joshi, G., Sultana, R., Calabrese, V., De Marco, C., Coccia, R., Cini, C., and Butterfield, D.A. (2006). In vivo protective effects of ferulic acid ethyl ester against amyloid-beta peptide 1\u201342-induced oxidative stress. J Neurosci Res 84, 418\u2013426.","journal-title":"J Neurosci Res"},{"key":"2991_CR316","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1056\/NEJMoa050151","volume":"352","author":"RC Petersen","year":"2005","unstructured":"Petersen, R.C., Thomas, R.G., Grundman, M., Bennett, D., Doody, R., Ferris, S., Galasko, D., Jin, S., Kaye, J., Levey, A., et al. (2005). Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 352, 2379\u20132388.","journal-title":"N Engl J Med"},{"key":"2991_CR317","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1093\/hmg\/ddh083","volume":"13","author":"L Petrucelli","year":"2004","unstructured":"Petrucelli, L. (2004). CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation. Hum Mol Genet 13, 703\u2013714.","journal-title":"Hum Mol Genet"},{"key":"2991_CR318","doi-asserted-by":"publisher","first-page":"102250","DOI":"10.1016\/j.arr.2024.102250","volume":"96","author":"FI Pinheiro","year":"2024","unstructured":"Pinheiro, F.I., Ara\u00fajo-Filho, I., do Rego, A.C.M., de Azevedo, E.P., Cobucci, R.N., and Guzen, F.P. (2024). Hepatopancreatic metabolic disorders and their implications in the development of Alzheimer\u2019s disease and vascular dementia. Ageing Res Rev 96, 102250.","journal-title":"Ageing Res Rev"},{"key":"2991_CR319","doi-asserted-by":"publisher","first-page":"e36873","DOI":"10.1371\/journal.pone.0036873","volume":"7","author":"V Plouffe","year":"2012","unstructured":"Plouffe, V., Mohamed, N.V., Rivest-McGraw, J., Bertrand, J., Lauzon, M., Leclerc, N., and Cookson, M.R. (2012). Hyperphosphorylation and cleavage at D421 enhance tau secretion. PLoS One 7, e36873.","journal-title":"PLoS One"},{"key":"2991_CR320","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.2174\/13816128113196660706","volume":"20","author":"M Polidori","year":"2014","unstructured":"Polidori, M., and Nelles, G. (2014). Antioxidant clinical trials in mild cognitive impairment and Alzheimer\u2019s disease\u2014challenges and perspectives. Curr Pharm Des 20, 3083\u20133092.","journal-title":"Curr Pharm Des"},{"key":"2991_CR321","doi-asserted-by":"publisher","first-page":"6995","DOI":"10.1021\/jacs.4c17873","volume":"147","author":"WC Powell","year":"2025","unstructured":"Powell, W.C., Jing, R., Herlory, M., Holland, P., Poliyenko, D., Ebmeier, C.C., Stowell, M.H.B., and Walczak, M.A. (2025). Chemical synthesis reveals pathogenic role of N-glycosylation in microtubule-associated protein tau. J Am Chem Soc 147, 6995\u20137007.","journal-title":"J Am Chem Soc"},{"key":"2991_CR322","doi-asserted-by":"publisher","first-page":"102476","DOI":"10.1016\/j.arr.2024.102476","volume":"101","author":"S Prabha","year":"2024","unstructured":"Prabha, S., Sajad, M., Hasan, G.M., Islam, A., Imtaiyaz Hassan, M., and Thakur, S.C. (2024). Recent advancement in understanding of Alzheimer\u2019s disease: risk factors, subtypes, and drug targets and potential therapeutics. Ageing Res Rev 101, 102476.","journal-title":"Ageing Res Rev"},{"key":"2991_CR323","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s12974-020-01915-0","volume":"17","author":"BR Price","year":"2020","unstructured":"Price, B.R., Sudduth, T.L., Weekman, E.M., Johnson, S., Hawthorne, D., Woolums, A., and Wilcock, D.M. (2020). Therapeutic Trem2 activation ameliorates amyloid-beta deposition and improves cognition in the 5XFAD model of amyloid deposition. J Neuroinflamm 17, 238.","journal-title":"J Neuroinflamm"},{"key":"2991_CR324","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1038\/s41380-022-01475-0","volume":"27","author":"D Prokopenko","year":"2022","unstructured":"Prokopenko, D., Lee, S., Hecker, J., Mullin, K., Morgan, S., Katsumata, Y., Weiner, M. W., Fardo, D.W., Laird, N., Bertram, L., et al. (2022). Region-based analysis of rare genomic variants in whole-genome sequencing datasets reveal two novel Alzheimer\u2019s disease-associated genes: DTNB and DLG2. Mol Psychiatry 27, 1963\u20131969.","journal-title":"Mol Psychiatry"},{"key":"2991_CR325","doi-asserted-by":"publisher","first-page":"5548","DOI":"10.1007\/s12035-023-03414-8","volume":"60","author":"X Qian","year":"2023","unstructured":"Qian, X., Chen, S., Liu, X., and Tang, H. (2023). ABCA7-associated clinical features and molecular mechanisms in Alzheimer\u2019s disease. Mol Neurobiol 60, 5548\u20135556.","journal-title":"Mol Neurobiol"},{"key":"2991_CR326","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.nbd.2014.08.016","volume":"71","author":"RA Quintanilla","year":"2014","unstructured":"Quintanilla, R.A., von Bernhardi, R., Godoy, J.A., Inestrosa, N.C., and Johnson, G.V.W. (2014). Phosphorylated tau potentiates A\u03b2-induced mitochondrial damage in mature neurons. Neurobiol Dis 71, 260\u2013269.","journal-title":"Neurobiol Dis"},{"key":"2991_CR327","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/s41419-019-1636-8","volume":"10","author":"T Quintela-L\u00f3pez","year":"2019","unstructured":"Quintela-L\u00f3pez, T., Ortiz-Sanz, C., Serrano-Regal, M.P., Gaminde-Blasco, A., Valero, J., Baleriola, J., S\u00e1nchez-G\u00f3mez, M.V., Matute, C., and Alberdi, E. (2019). A\u03b2 oligomers promote oligodendrocyte differentiation and maturation via integrin \u03b21 and Fyn kinase signaling. Cell Death Dis 10, 445.","journal-title":"Cell Death Dis"},{"key":"2991_CR328","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/s41576-021-00387-z","volume":"22","author":"WR Reay","year":"2021","unstructured":"Reay, W.R., and Cairns, M.J. (2021). Advancing the use of genome-wide association studies for drug repurposing. Nat Rev Genet 22, 658\u2013671.","journal-title":"Nat Rev Genet"},{"key":"2991_CR329","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/0896-6273(93)90070-8","volume":"11","author":"GW Rebeck","year":"1993","unstructured":"Rebeck, G.W., Reiter, J.S., Strickland, D.K., and Hyman, B.T. (1993). Apolipoprotein E in sporadic Alzheimer\u2019s disease: allelic variation and receptor interactions. Neuron 11, 575\u2013580.","journal-title":"Neuron"},{"key":"2991_CR330","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41467-019-14279-8","volume":"11","author":"EM Reiman","year":"2020","unstructured":"Reiman, E.M., Arboleda-Velasquez, J.F., Quiroz, Y.T., Huentelman, M.J., Beach, T.G., Caselli, R.J., Chen, Y., Su, Y., Myers, A.J., Hardy, J., et al. (2020). Exceptionally low likelihood of Alzheimer\u2019s dementia in APOE2 homozygotes from a 5,000-person neuropathological study. Nat Commun 11, 667.","journal-title":"Nat Commun"},{"key":"2991_CR331","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s11883-012-0307-3","volume":"15","author":"C Reitz","year":"2013","unstructured":"Reitz, C. (2013). Dyslipidemia and the risk of Alzheimer\u2019s disease. Curr Atheroscler Rep 15, 307.","journal-title":"Curr Atheroscler Rep"},{"key":"2991_CR332","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s00401-011-0898-8","volume":"123","author":"JF Reyes","year":"2012","unstructured":"Reyes, J.F., Geula, C., Vana, L., and Binder, L. I. (2012). Selective tau tyrosine nitration in non-AD tauopathies. Acta Neuropathol 123, 119\u2013132.","journal-title":"Acta Neuropathol"},{"key":"2991_CR333","doi-asserted-by":"publisher","first-page":"10636","DOI":"10.1523\/JNEUROSCI.2143-06.2006","volume":"26","author":"MR Reynolds","year":"2006","unstructured":"Reynolds, M.R., Reyes, J.F., Fu, Y., Bigio, E.H., Guillozet-Bongaarts, A.L., Berry, R.W., and Binder, L.I. (2006). Tau nitration occurs at tyrosine 29 in the fibrillar lesions of Alzheimer\u2019s disease and other tauopathies. J Neurosci 26, 10636\u201310645.","journal-title":"J Neurosci"},{"key":"2991_CR334","doi-asserted-by":"publisher","first-page":"20057","DOI":"10.1073\/pnas.0905529106","volume":"106","author":"V Rhein","year":"2009","unstructured":"Rhein, V., Song, X., Wiesner, A., Ittner, L.M., Baysang, G., Meier, F., Ozmen, L., Bluethmann, H., Dr\u00f6se, S., Brandt, U., et al. (2009). Amyloid-\u03b2 and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer\u2019s disease mice. Proc Natl Acad Sci USA 106, 20057\u201320062.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2991_CR335","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.mad.2014.10.002","volume":"141\u2013142","author":"RO Roberts","year":"2014","unstructured":"Roberts, R.O., Boardman, L.A., Cha, R.H., Pankratz, V.S., Johnson, R.A., Druliner, B. R., Christianson, T.J.H., Roberts, L.R., and Petersen, R.C. (2014). Short and long telomeres increase risk of amnestic mild cognitive impairment. Mech Ageing Dev 141\u2013142, 64\u201369.","journal-title":"Mech Ageing Dev"},{"key":"2991_CR336","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1523\/JNEUROSCI.2964-15.2016","volume":"36","author":"EM Rodrigues","year":"2016","unstructured":"Rodrigues, E.M., Scudder, S.L., Goo, M.S., and Patrick, G.N. (2016). A\u03b2-induced synaptic alterations require the E3 ubiquitin ligase Nedd4-1. J Neurosci 36, 1590\u20131595.","journal-title":"J Neurosci"},{"key":"2991_CR337","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0169-328X(97)00045-4","volume":"47","author":"HA Rohan de Silva","year":"1997","unstructured":"Rohan de Silva, H.A., Jen, A., Wickenden, C., Jen, L.S., Wilkinson, S.L., and Patel, A.J. (1997). Cell-specific expression of \u03b2-amyloid precursor protein isoform mRNAs and proteins in neurons and astrocytes. Mol Brain Res 47, 147\u2013156.","journal-title":"Mol Brain Res"},{"key":"2991_CR338","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.neurobiolaging.2009.02.011","volume":"32","author":"RF Rosen","year":"2011","unstructured":"Rosen, R.F., Walker, L.C., and LeVineIII, H. (2011). PIB binding in aged primate brain: enrichment of high-affinity sites in humans with Alzheimer\u2019s disease. Neurobiol Aging 32, 223\u2013234.","journal-title":"Neurobiol Aging"},{"key":"2991_CR339","first-page":"521","volume":"4","author":"N Rosenqvist","year":"2018","unstructured":"Rosenqvist, N., Asuni, A.A., Andersson, C.R., Christensen, S., Daechsel, J.A., Egebjerg, J., Falsig, J., Helboe, L., Jul, P., Kartberg, F., et al. (2018). Highly specific and selective anti-pS396-tau antibody C10.2 targets seeding-competent tau. Alzheimers Dement 4, 521\u2013534.","journal-title":"Alzheimers Dement"},{"key":"2991_CR340","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/tpj.2009.69","volume":"10","author":"AD Roses","year":"2010","unstructured":"Roses, A.D., Lutz, M.W., Amrine-Madsen, H., Saunders, A.M., Crenshaw, D.G., Sundseth, S.S., Huentelman, M.J., Welsh-Bohmer, K.A., and Reiman, E.M. (2010). A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer\u2019s disease. Pharmacogenomics J 10, 375\u2013384.","journal-title":"Pharmacogenomics J"},{"key":"2991_CR341","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1161\/STROKEAHA.118.022596","volume":"49","author":"E Ruiz Vargas","year":"2018","unstructured":"Ruiz Vargas, E., Sposato, L.A., Lee, S.A.W., Hachinski, V., and Cipriano, L.E. (2018). Anticoagulation therapy for atrial fibrillation in patients with Alzheimer\u2019s disease. Stroke 49, 2844\u20132850.","journal-title":"Stroke"},{"key":"2991_CR342","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1038\/mt.2010.111","volume":"18","author":"DA Ryan","year":"2010","unstructured":"Ryan, D.A., Mastrangelo, M.A., Narrow, W.C., Sullivan, M.A., Federoff, H.J., and Bowers, W.J. (2010). A\u03b2-directed single-chain antibody delivery via a serotype-1 AAV vector improves learning behavior and pathology in Alzheimer\u2019s disease mice. Mol Ther 18, 1471\u20131481.","journal-title":"Mol Ther"},{"key":"2991_CR343","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/nm.4132","volume":"22","author":"D Ryu","year":"2016","unstructured":"Ryu, D., Mouchiroud, L., Andreux, P.A., Katsyuba, E., Moullan, N., Nicolet-dit-F\u00e9lix, A.A., Williams, E.G., Jha, P., Lo Sasso, G., Huzard, D., et al. (2016). Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents. Nat Med 22, 879\u2013888.","journal-title":"Nat Med"},{"key":"2991_CR344","doi-asserted-by":"publisher","first-page":"100341","DOI":"10.1016\/j.xgen.2023.100341","volume":"3","author":"MC Sadler","year":"2023","unstructured":"Sadler, M.C., Auwerx, C., Deelen, P., and Kutalik, Z. (2023). Multi-layered genetic approaches to identify approved drug targets. Cell Genomics 3, 100341.","journal-title":"Cell Genomics"},{"key":"2991_CR345","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s41583-020-0325-z","volume":"21","author":"S Saez-Atienzar","year":"2020","unstructured":"Saez-Atienzar, S., and Masliah, E. (2020). Cellular senescence and Alzheimer disease: the egg and the chicken scenario. Nat Rev Neurosci 21, 433\u2013444.","journal-title":"Nat Rev Neurosci"},{"key":"2991_CR346","doi-asserted-by":"publisher","first-page":"3842","DOI":"10.1074\/jbc.M111.277061","volume":"287","author":"S Saman","year":"2012","unstructured":"Saman, S., Kim, W.H., Raya, M., Visnick, Y., Miro, S., Saman, S., Jackson, B., McKee, A.C., Alvarez, V.E., Lee, N.C.Y., et al. (2012). Exosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease. J Biol Chem 287, 3842\u20133849.","journal-title":"J Biol Chem"},{"key":"2991_CR347","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.bmcl.2016.11.087","volume":"27","author":"P Sandhu","year":"2017","unstructured":"Sandhu, P., Naeem, M.M., Lu, C., Kumarathasan, P., Gomes, J., and Basak, A. (2017). Ser422 phosphorylation blocks human Tau cleavage by caspase-3: biochemical implications to Alzheimer\u2019s Disease. Bioorg Med Chem Lett 27, 642\u2013652.","journal-title":"Bioorg Med Chem Lett"},{"key":"2991_CR348","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1056\/NEJM199704243361704","volume":"336","author":"M Sano","year":"1997","unstructured":"Sano, M., Ernesto, C., Thomas, R.G., Klauber, M.R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C.W., Pfeiffer, E., et al. (1997). A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer\u2019s disease. N Engl J Med 336, 1216\u20131222.","journal-title":"N Engl J Med"},{"key":"2991_CR349","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.neuron.2018.02.015","volume":"97","author":"C Sato","year":"2018","unstructured":"Sato, C., Barth\u00e9lemy, N.R., Mawuenyega, K.G., Patterson, B.W., Gordon, B.A., Jockel-Balsarotti, J., Sullivan, M., Crisp, M.J., Kasten, T., Kirmess, K.M., et al. (2018). Tau kinetics in neurons and the human central nervous system. Neuron 97, 1284\u20131298.e7.","journal-title":"Neuron"},{"key":"2991_CR350","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1212\/WNL.43.8.1467","volume":"43","author":"AM Saunders","year":"1993","unstructured":"Saunders, A.M., Strittmatter, W.J., Schmechel, D., St. George-Hyslop, P.H., Pericak-Vance, M.A., Joo, S.H., Rosi, B.L., Gusella, J.F., Crapper-MacLachlan, D.R., Alberts, M.J., et al. (1993). Association of apolipoprotein E allele \u03b54 with late-onset familial and sporadic Alzheimer\u2019s disease. Neurology 43, 1467.","journal-title":"Neurology"},{"key":"2991_CR351","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.neurobiolaging.2014.10.043","volume":"36","author":"MJ Schafer","year":"2015","unstructured":"Schafer, M.J., Alldred, M.J., Lee, S.H., Calhoun, M.E., Petkova, E., Mathews, P.M., and Ginsberg, S.D. (2015). Reduction of \u03b2-amyloid and \u03b3-secretase by calorie restriction in female Tg2576 mice. Neurobiol Aging 36, 1293\u20131302.","journal-title":"Neurobiol Aging"},{"key":"2991_CR352","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s12263-011-0255-5","volume":"7","author":"S Schaffer","year":"2012","unstructured":"Schaffer, S., and Halliwell, B. (2012). Do polyphenols enter the brain and does it matter? Some theoretical and practical considerations. Genes Nutr 7, 99\u2013109.","journal-title":"Genes Nutr"},{"key":"2991_CR353","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens, P., De Strooper, B., Kivipelto, M., Holstege, H., Ch\u00e9telat, G., Teunissen, C.E., Cummings, J., and van der Flier, W.M. (2021). Alzheimer\u2019s disease. Lancet 397, 1577\u20131590.","journal-title":"Lancet"},{"key":"2991_CR354","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.tics.2021.11.001","volume":"26","author":"V Segen","year":"2022","unstructured":"Segen, V., Ying, J., Morgan, E., Brandon, M., and Wolbers, T. (2022). Path integration in normal aging and Alzheimer\u2019s disease. Trends Cogn Sci 26, 142\u2013158.","journal-title":"Trends Cogn Sci"},{"key":"2991_CR355","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe, D.J., and Hardy, J. (2016). The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol Med 8, 595\u2013608.","journal-title":"EMBO Mol Med"},{"key":"2991_CR356","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S1474-4422(20)30412-9","volume":"20","author":"A Serrano-Pozo","year":"2021","unstructured":"Serrano-Pozo, A., Das, S., and Hyman, B.T. (2021). APOE and Alzheimer\u2019s disease: advances in genetics, pathophysiology, and therapeutic approaches. Lancet Neurol 20, 68\u201380.","journal-title":"Lancet Neurol"},{"key":"2991_CR357","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature19323","volume":"537","author":"J Sevigny","year":"2016","unstructured":"Sevigny, J., Chiao, P., Bussi\u00e8re, T., Weinreb, P.H., Williams, L., Maier, M., Dunstan, R., Salloway, S., Chen, T., Ling, Y., et al. (2016). The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease. Nature 537, 50\u201356.","journal-title":"Nature"},{"key":"2991_CR358","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/nm1782","volume":"14","author":"GM Shankar","year":"2008","unstructured":"Shankar, G.M., Li, S., Mehta, T.H., Garcia-Munoz, A., Shepardson, N.E., Smith, I., Brett, F.M., Farrell, M.A., Rowan, M.J., Lemere, C.A., et al. (2008). Amyloid-\u03b2 protein dimers isolated directly from Alzheimer\u2019s brains impair synaptic plasticity and memory. Nat Med 14, 837\u2013842.","journal-title":"Nat Med"},{"key":"2991_CR359","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/mp.2014.3","volume":"20","author":"P Shaw","year":"2015","unstructured":"Shaw, P., Sharp, W., Sudre, G., Wharton, A., Greenstein, D., Raznahan, A., Evans, A., Chakravarty, M.M., Lerch, J.P., and Rapoport, J. (2015). Subcortical and cortical morphological anomalies as an endophenotype in obsessive-compulsive disorder. Mol Psychiatry 20, 224\u2013231.","journal-title":"Mol Psychiatry"},{"key":"2991_CR360","doi-asserted-by":"publisher","first-page":"9707","DOI":"10.1073\/pnas.1707039114","volume":"114","author":"LB Shelton","year":"2017","unstructured":"Shelton, L.B., Baker, J.D., Zheng, D., Sullivan, L.E., Solanki, P.K., Webster, J.M., Sun, Z., Sabbagh, J.J., Nordhues, B.A., Koren III, J., et al. (2017). Hsp90 activator Aha1 drives production of pathological tau aggregates. Proc Natl Acad Sci USA 114, 9707\u20139712.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2991_CR361","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.celrep.2018.06.009","volume":"24","author":"YP Shentu","year":"2018","unstructured":"Shentu, Y.P., Huo, Y., Feng, X.L., Gilbert, J., Zhang, Q., Liuyang, Z.Y., Wang, X.L., Wang, G., Zhou, H., Wang, X.C., et al. (2018). CIP2A causes Tau\/APP phosphorylation, synaptopathy, and memory deficits in Alzheimer\u2019s disease. Cell Rep 24, 713\u2013723.","journal-title":"Cell Rep"},{"key":"2991_CR362","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1084\/jem.20190980","volume":"216","author":"Y Shi","year":"2019","unstructured":"Shi, Y., Manis, M., Long, J., Wang, K., Sullivan, P.M., Remolina Serrano, J., Hoyle, R., and Holtzman, D.M. (2019). Microglia drive APOE-dependent neurodegeneration in a tauopathy mouse model. J Exp Med 216, 2546\u20132561.","journal-title":"J Exp Med"},{"key":"2991_CR363","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41398-021-01272-3","volume":"11","author":"D Shigemizu","year":"2021","unstructured":"Shigemizu, D., Mitsumori, R., Akiyama, S., Miyashita, A., Morizono, T., Higaki, S., Asanomi, Y., Hara, N., Tamiya, G., Kinoshita, K., et al. (2021). Ethnic and transethnic genome-wide association studies identify new loci influencing Japanese Alzheimer\u2019s disease risk. Transl Psychiatry 11, 151.","journal-title":"Transl Psychiatry"},{"key":"2991_CR364","doi-asserted-by":"publisher","first-page":"8144","DOI":"10.3390\/ijms23158144","volume":"23","author":"KH Shim","year":"2022","unstructured":"Shim, K.H., Ha, S., Choung, J.S., Choi, J.I., Kim, D.Y., Kim, J.M., and Kim, M.Y. (2022). Therapeutic effect of erythropoietin on Alzheimer\u2019s disease by activating the serotonin pathway. Int J Mol Sci 23, 8144.","journal-title":"Int J Mol Sci"},{"key":"2991_CR365","doi-asserted-by":"publisher","first-page":"4869","DOI":"10.1074\/jbc.M305838200","volume":"279","author":"H Shimura","year":"2004","unstructured":"Shimura, H., Schwartz, D., Gygi, S.P., and Kosik, K.S. (2004). CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival. J Biol Chem 279, 4869\u20134876.","journal-title":"J Biol Chem"},{"key":"2991_CR366","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1016\/j.cell.2021.03.032","volume":"184","author":"MK Shin","year":"2021","unstructured":"Shin, M.K., V\u00e1zquez-Rosa, E., Koh, Y., Dhar, M., Chaubey, K., Cintr\u00f3n-P\u00e9rez, C.J., Barker, S., Miller, E., Franke, K., Noterman, M.F., et al. (2021). Reducing acetylated tau is neuroprotective in brain injury. Cell 184, 2715\u20132732.e23.","journal-title":"Cell"},{"key":"2991_CR367","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1093\/hmg\/ddt478","volume":"23","author":"JM Shulman","year":"2014","unstructured":"Shulman, J.M., Imboywa, S., Giagtzoglou, N., Powers, M.P., Hu, Y., Devenport, D., Chipendo, P., Chibnik, L.B., Diamond, A., Perrimon, N., et al. (2014). Functional screening in Drosophila identifies Alzheimer\u2019s disease susceptibility genes and implicates Tau-mediated mechanisms. Hum Mol Genet 23, 870\u2013877.","journal-title":"Hum Mol Genet"},{"key":"2991_CR368","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1126\/science.abb8575","volume":"370","author":"A Sierksma","year":"2020","unstructured":"Sierksma, A., Escott-Price, V., and De Strooper, B. (2020). Translating genetic risk of Alzheimer\u2019s disease into mechanistic insight and drug targets. Science 370, 61\u201366.","journal-title":"Science"},{"key":"2991_CR369","doi-asserted-by":"publisher","first-page":"e45457","DOI":"10.7554\/eLife.45457","volume":"8","author":"MC Silva","year":"2019","unstructured":"Silva, M.C., Ferguson, F.M., Cai, Q., Donovan, K.A., Nandi, G., Patnaik, D., Zhang, T., Huang, H.T., Lucente, D.E., Dickerson, B.C., et al. (2019). Targeted degradation of aberrant tau in frontotemporal dementia patient-derived neuronal cell models. eLife 8, e45457.","journal-title":"eLife"},{"key":"2991_CR370","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jama.2023.13239","volume":"330","author":"JR Sims","year":"2023","unstructured":"Sims, J.R., Zimmer, J.A., Evans, C.D., Lu, M., Ardayfio, P., Sparks, J.D., Wessels, A.M., Shcherbinin, S., Wang, H., Monkul Nery, E.S., et al. (2023). Donanemab in early symptomatic Alzheimer disease. JAMA 330, 512.","journal-title":"JAMA"},{"key":"2991_CR371","doi-asserted-by":"publisher","first-page":"5710","DOI":"10.1073\/pnas.91.12.5710","volume":"91","author":"MA Smith","year":"1994","unstructured":"Smith, M.A., Taneda, S., Richey, P.L., Miyata, S., Yan, S.D., Stern, D., Sayre, L.M., Monnier, V.M., and Perry, G. (1994). Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc Natl Acad Sci USA 91, 5710\u20135714.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2991_CR372","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13024-016-0109-0","volume":"11","author":"PD Sohn","year":"2016","unstructured":"Sohn, P.D., Tracy, T.E., Son, H.I., Zhou, Y., Leite, R.E.P., Miller, B.L., Seeley, W.W., Grinberg, L.T., and Gan, L. (2016). Acetylated tau destabilizes the cytoskeleton in the axon initial segment and is mislocalized to the somatodendritic compartment. Mol Neurodegener 11, 47.","journal-title":"Mol Neurodegener"},{"key":"2991_CR373","doi-asserted-by":"publisher","first-page":"11610","DOI":"10.3390\/ijms231911610","volume":"23","author":"L Song","year":"2022","unstructured":"Song, L., Oseid, D.E., Wells, E.A., and Robinson, A.S. (2022). The interplay between GSK3\u03b2 and tau Ser262 phosphorylation during the progression of tau pathology. Int J Mol Sci 23, 11610.","journal-title":"Int J Mol Sci"},{"key":"2991_CR374","doi-asserted-by":"publisher","first-page":"e14476","DOI":"10.1002\/alz.14476","volume":"21","author":"M Soudy","year":"2025","unstructured":"Soudy, M., Bars, S.L., and Glaab, E. (2025). Sex-dependent molecular landscape of Alzheimer\u2019s disease revealed by large-scale single-cell transcriptomics. Alzheimers Dement 21, e14476.","journal-title":"Alzheimers Dement"},{"key":"2991_CR375","doi-asserted-by":"publisher","first-page":"13880","DOI":"10.3390\/ijms241813880","volume":"24","author":"S Stanca","year":"2023","unstructured":"Stanca, S., Rossetti, M., and Bongioanni, P. (2023). Astrocytes as neuroimmunocytes in Alzheimer\u2019s disease: a biochemical tool in the neuron-glia crosstalk along the pathogenetic pathways. Int J Mol Sci 24, 13880.","journal-title":"Int J Mol Sci"},{"key":"2991_CR376","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/S1474-4422(12)70191-6","volume":"11","author":"Y Stern","year":"2012","unstructured":"Stern, Y. (2012). Cognitive reserve in ageing and Alzheimer\u2019s disease. Lancet Neurol 11, 1006\u20131012.","journal-title":"Lancet Neurol"},{"key":"2991_CR377","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1126\/science.1105681","volume":"307","author":"GB Stokin","year":"2005","unstructured":"Stokin, G.B., Lillo, C., Falzone, T.L., Brusch, R.G., Rockenstein, E., Mount, S.L., Raman, R., Davies, P., Masliah, E., Williams, D.S., et al. (2005). Axonopathy and transport deficits early in the pathogenesis of Alzheimer\u2019s disease. Science 307, 1282\u20131288.","journal-title":"Science"},{"key":"2991_CR378","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.scib.2024.01.019","volume":"69","author":"J Su","year":"2024","unstructured":"Su, J., Xiao, Y., Wei, L., Lei, H., Sun, F., Wang, W., Yin, J., Xiong, R., Li, S., Zhang, P., et al. (2024a). Generation of tau dephosphorylation-targeting chimeras for the treatment of Alzheimer\u2019s disease and related tauopathies. Sci Bull 69, 1137\u20131152.","journal-title":"Sci Bull"},{"key":"2991_CR379","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1038\/s41401-024-01326-4","volume":"45","author":"JF Su","year":"2024","unstructured":"Su, J.F., Xiao, Y., Wei, L. Y., Lei, H.Y., Sun, F., Wang, W.X., Li, S.H., Wang, X.C., Zheng, J., and Wang, J.Z. (2024b). A new tau dephosphorylation-targeting chimera for the treatment of tauopathies. Acta Pharmacol Sin 45, 2267\u20132276.","journal-title":"Acta Pharmacol Sin"},{"key":"2991_CR380","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1136\/jnnp-2023-331142","volume":"94","author":"WM Su","year":"2023","unstructured":"Su, W.M., Gu, X.J., Dou, M., Duan, Q.Q., Jiang, Z., Yin, K.F., Cai, W.C., Cao, B., Wang, Y., and Chen, Y.P. (2023). Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 94, 954\u2013961.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2991_CR381","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/s41593-020-00778-1","volume":"24","author":"J Sun","year":"2021","unstructured":"Sun, J., and Roy, S. (2021). Gene-based therapies for neurodegenerative diseases. Nat Neurosci 24, 297\u2013311.","journal-title":"Nat Neurosci"},{"key":"2991_CR382","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/s41398-019-0525-3","volume":"9","author":"J Sun","year":"2019","unstructured":"Sun, J., Xu, J., Ling, Y., Wang, F., Gong, T., Yang, C., Ye, S., Ye, K., Wei, D., Song, Z., et al. (2019). Fecal microbiota transplantation alleviated Alzheimer\u2019s disease-like pathogenesis in APP\/PS1 transgenic mice. Transl Psychiatry 9, 189.","journal-title":"Transl Psychiatry"},{"key":"2991_CR383","doi-asserted-by":"publisher","first-page":"18727","DOI":"10.1073\/pnas.0606298103","volume":"103","author":"X Sun","year":"2006","unstructured":"Sun, X., He, G., Qing, H., Zhou, W., Dobie, F., Cai, F., Staufenbiel, M., Huang, L.E., and Song, W. (2006a). Hypoxia facilitates Alzheimer\u2019s disease pathogenesis by upregulating BACE1 gene expression. Proc Natl Acad Sci USA 103, 18727\u201318732.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2991_CR384","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1096\/fj.05-5632com","volume":"20","author":"X Sun","year":"2006","unstructured":"Sun, X., He, G., and Song, W. (2006b). BACE2, as a novel APP \u03b8-secretase, is not responsible for the pathogenesis of Alzheimer\u2019s disease in Down syndrome. FASEB J 20, 1369\u20131376.","journal-title":"FASEB J"},{"key":"2991_CR385","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","volume":"14","author":"MD Sweeney","year":"2018","unstructured":"Sweeney, M.D., Sagare, A.P., and Zlokovic, B.V. (2018). Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol 14, 133\u2013150.","journal-title":"Nat Rev Neurol"},{"key":"2991_CR386","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40035-017-0077-5","volume":"6","author":"P Sweeney","year":"2017","unstructured":"Sweeney, P., Park, H., Baumann, M., Dunlop, J., Frydman, J., Kopito, R., McCampbell, A., Leblanc, G., Venkateswaran, A., Nurmi, A., et al. (2017). Protein misfolding in neurodegenerative diseases: implications and strategies. Transl Neurodegener 6, 6.","journal-title":"Transl Neurodegener"},{"key":"2991_CR387","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1093\/nar\/gku1356","volume":"43","author":"P Sykora","year":"2015","unstructured":"Sykora, P., Misiak, M., Wang, Y., Ghosh, S., Leandro, G.S., Liu, D., Tian, J., Baptiste, B. A., Cong, W.N., Brenerman, B.M., et al. (2015). DNA polymerase \u03b2 deficiency leads to neurodegeneration and exacerbates Alzheimer disease phenotypes. Nucleic Acids Res 43, 943\u2013959.","journal-title":"Nucleic Acids Res"},{"key":"2991_CR388","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1038\/s41588-023-01572-y","volume":"55","author":"A Sziraki","year":"2023","unstructured":"Sziraki, A., Lu, Z., Lee, J., Banyai, G., Anderson, S., Abdulraouf, A., Metzner, E., Liao, A., Banfelder, J., Epstein, A., et al. (2023). A global view of aging and Alzheimer\u2019s pathogenesis-associated cell population dynamics and molecular signatures in human and mouse brains. Nat Genet 55, 2104\u20132116.","journal-title":"Nat Genet"},{"key":"2991_CR389","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1172\/JCI59903","volume":"122","author":"K Talbot","year":"2012","unstructured":"Talbot, K., Wang, H.Y., Kazi, H., Han, L.Y., Bakshi, K.P., Stucky, A., Fuino, R.L., Kawaguchi, K.R., Samoyedny, A.J., Wilson, R.S., et al. (2012). Demonstrated brain insulin resistance in Alzheimer\u2019s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest 122, 1316\u20131338.","journal-title":"J Clin Invest"},{"key":"2991_CR390","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1074\/jbc.RA118.005222","volume":"294","author":"JZA Tan","year":"2019","unstructured":"Tan, J.Z.A., and Gleeson, P.A. (2019). The trans-Golgi network is a major site for \u03b1-secretase processing of amyloid precursor protein in primary neurons. J Biol Chem 294, 1618\u20131631.","journal-title":"J Biol Chem"},{"key":"2991_CR391","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13195-020-00755-7","volume":"13","author":"MS Tan","year":"2021","unstructured":"Tan, M.S., Yang, Y.X., Xu, W., Wang, H.F., Tan, L., Zuo, C.T., Dong, Q., Tan, L., Suckling, J., and Yu, J.T. (2021). Associations of Alzheimer\u2019s disease risk variants with gene expression, amyloidosis, tauopathy, and neurodegeneration. Alzheimers Res Ther 13, 15.","journal-title":"Alzheimers Res Ther"},{"key":"2991_CR392","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.bbamcr.2013.03.012","volume":"1843","author":"K Tanaka","year":"2014","unstructured":"Tanaka, K., and Matsuda, N. (2014). Proteostasis and neurodegeneration: The roles of proteasomal degradation and autophagy. Biochim Biophys Acta 1843, 197\u2013204.","journal-title":"Biochim Biophys Acta"},{"key":"2991_CR393","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s40478-016-0386-4","volume":"4","author":"M Tardivel","year":"2016","unstructured":"Tardivel, M., B\u00e9gard, S., Bousset, L., Dujardin, S., Coens, A., Melki, R., Bu\u00e9e, L., and Colin, M. (2016). Tunneling nanotube (TNT)-mediated neuron-to neuron transfer of pathological Tau protein assemblies. Acta Neuropathol Commun 4, 117.","journal-title":"Acta Neuropathol Commun"},{"key":"2991_CR394","doi-asserted-by":"publisher","first-page":"306","DOI":"10.4049\/jimmunol.1901068","volume":"204","author":"AJ Tenner","year":"2020","unstructured":"Tenner, A.J. (2020). Complement-mediated events in Alzheimer\u2019s disease: mechanisms and potential therapeutic targets. J Immunol 204, 306\u2013315.","journal-title":"J Immunol"},{"key":"2991_CR395","doi-asserted-by":"publisher","first-page":"20931","DOI":"10.1074\/jbc.M111.316232","volume":"287","author":"A Tennstaedt","year":"2012","unstructured":"Tennstaedt, A., P\u00f6psel, S., Truebestein, L., Hauske, P., Brockmann, A., Schmidt, N., Irle, I., Sacca, B., Niemeyer, C.M., Brandt, R., et al. (2012). Human high temperature requirement serine protease A1 (HTRA1) Degrades tau protein aggregates. J Biol Chem 287, 20931\u201320941.","journal-title":"J Biol Chem"},{"key":"2991_CR396","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s12035-020-02109-8","volume":"58","author":"N Thadathil","year":"2021","unstructured":"Thadathil, N., Delotterie, D.F., Xiao, J., Hori, R., McDonald, M.P., and Khan, M.M. (2021). DNA double-strand break accumulation in Alzheimer\u2019s disease: evidence from experimental models and postmortem human brains. Mol Neurobiol 58, 118\u2013131.","journal-title":"Mol Neurobiol"},{"key":"2991_CR397","doi-asserted-by":"publisher","first-page":"18320","DOI":"10.1002\/jcb.29142","volume":"120","author":"S Thomas","year":"2019","unstructured":"Thomas, S., Hoxha, K., Tran, A., and Prendergast, G.C. (2019). Bin1 antibody lowers the expression of phosphorylated Tau in Alzheimer\u2019s disease. J Cell Biochem 120, 18320\u201318331.","journal-title":"J Cell Biochem"},{"key":"2991_CR398","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s00401-011-0893-0","volume":"123","author":"SN Thomas","year":"2012","unstructured":"Thomas, S.N., Funk, K.E., Wan, Y., Liao, Z., Davies, P., Kuret, J., and Yang, A.J. (2012). Dual modification of Alzheimer\u2019s disease PHF-tau protein by lysine methylation and ubiquitylation: a mass spectrometry approach. Acta Neuropathol 123, 105\u2013117.","journal-title":"Acta Neuropathol"},{"key":"2991_CR399","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/d41586-023-03931-5","volume":"625","author":"T Thompson","year":"2024","unstructured":"Thompson, T. (2024). How CRISPR gene editing could help treat Alzheimer\u2019s. Nature 625, 13\u201314.","journal-title":"Nature"},{"key":"2991_CR400","doi-asserted-by":"publisher","first-page":"6074","DOI":"10.1038\/s41380-021-01073-6","volume":"26","author":"DY Tian","year":"2021","unstructured":"Tian, D.Y., Cheng, Y., Zhuang, Z.Q., He, C.Y., Pan, Q.G., Tang, M.Z., Hu, X.L., Shen, Y. Y., Wang, Y.R., Chen, S.H., et al. (2021). Physiological clearance of amyloid-beta by the kidney and its therapeutic potential for Alzheimer\u2019s disease. Mol Psychiatry 26, 6074\u20136082.","journal-title":"Mol Psychiatry"},{"key":"2991_CR401","doi-asserted-by":"publisher","first-page":"5090","DOI":"10.1093\/emboj\/cdg447","volume":"22","author":"T Timm","year":"2003","unstructured":"Timm, T. (2003). MARKK, a Ste20-like kinase, activates the polarity-inducing kinase MARK\/PAR-1. EMBO J 22, 5090\u20135101.","journal-title":"EMBO J"},{"key":"2991_CR402","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/acn3.223","volume":"2","author":"G Tosto","year":"2015","unstructured":"Tosto, G., Fu, H., Vardarajan, B.N., Lee, J.H., Cheng, R., Reyes-Dumeyer, D., Lantigua, R., Medrano, M., Jimenez-Velazquez, I.Z., Elkind, M.S.V., et al. (2015). F-box\/LRR-repeat protein 7 is genetically associated with Alzheimer\u2019s disease. Ann Clin Transl Neurol 2, 810\u2013820.","journal-title":"Ann Clin Transl Neurol"},{"key":"2991_CR403","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.neuron.2016.03.005","volume":"90","author":"TE Tracy","year":"2016","unstructured":"Tracy, T.E., Sohn, P.D., Minami, S.S., Wang, C., Min, S.W., Li, Y., Zhou, Y., Le, D., Lo, I., Ponnusamy, R., et al. (2016). Acetylated tau obstructs KIBRA-mediated signaling in synaptic plasticity and promotes tauopathy-related memory loss. Neuron 90, 245\u2013260.","journal-title":"Neuron"},{"key":"2991_CR404","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41392-023-01601-6","volume":"8","author":"Z Tu","year":"2023","unstructured":"Tu, Z., Yan, S., Han, B., Li, C., Liang, W., Lin, Y., Ding, Y., Wei, H., Wang, L., Xu, H., et al. (2023). Tauopathy promotes spinal cord-dependent production of toxic amyloid-beta in transgenic monkeys. Sig Transduct Target Ther 8, 358.","journal-title":"Sig Transduct Target Ther"},{"key":"2991_CR405","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/NEN.0b013e31820e1152","volume":"70","author":"DA Turner","year":"2011","unstructured":"Turner, D.A., and Adamson, D.C. (2011). Neuronal-astrocyte metabolic interactions: understanding the transition into abnormal astrocytoma metabolism. J Neuropathol Exp Neurol 70, 167\u2013176.","journal-title":"J Neuropathol Exp Neurol"},{"key":"2991_CR406","doi-asserted-by":"publisher","first-page":"102","DOI":"10.15252\/embr.201642738","volume":"18","author":"F Ubelmann","year":"2017","unstructured":"Ubelmann, F., Burrinha, T., Salavessa, L., Gomes, R., Ferreira, C., Moreno, N., and Guimas Almeida, C. (2017). Bin1 and CD2AP polarise the endocytic generation of beta-amyloid. EMBO Rep 18, 102\u2013122.","journal-title":"EMBO Rep"},{"key":"2991_CR407","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1750-1326-9-20","volume":"9","author":"JD Ulrich","year":"2014","unstructured":"Ulrich, J.D., Finn, M.B., Wang, Y., Shen, A., Mahan, T.E., Jiang, H., Stewart, F.R., Piccio, L., Colonna, M., and Holtzman, D.M. (2014). Altered microglial response to A\u03b2 plaques in APPPS1-21 mice heterozygous for TREM2. Mol Neurodegener 9, 20.","journal-title":"Mol Neurodegener"},{"key":"2991_CR408","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/acn3.171","volume":"2","author":"T Umeda","year":"2015","unstructured":"Umeda, T., Eguchi, H., Kunori, Y., Matsumoto, Y., Taniguchi, T., Mori, H., and Tomiyama, T. (2015). Passive immunotherapy of tauopathy targeting pSer413-tau: a pilot study in mice. Ann Clin Transl Neurol 2, 241\u2013255.","journal-title":"Ann Clin Transl Neurol"},{"key":"2991_CR409","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41581-021-00430-6","volume":"17","author":"Z Ungvari","year":"2021","unstructured":"Ungvari, Z., Toth, P., Tarantini, S., Prodan, C.I., Sorond, F., Merkely, B., and Csiszar, A. (2021). Hypertension-induced cognitive impairment: from pathophysiology to public health. Nat Rev Nephrol 17, 639\u2013654.","journal-title":"Nat Rev Nephrol"},{"key":"2991_CR410","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00401-020-02234-7","volume":"141","author":"L Vaillant-Beuchot","year":"2021","unstructured":"Vaillant-Beuchot, L., Mary, A., Pardossi-Piquard, R., Bourgeois, A., Lauritzen, I., Eysert, F., Kinoshita, P.F., Cazareth, J., Badot, C., Fragaki, K., et al. (2021). Accumulation of amyloid precursor protein C-terminal fragments triggers mitochondrial structure, function, and mitophagy defects in Alzheimer\u2019s disease models and human brains. Acta Neuropathol 141, 39\u201365.","journal-title":"Acta Neuropathol"},{"key":"2991_CR411","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck, C.H., Swanson, C.J., Aisen, P., Bateman, R.J., Chen, C., Gee, M., Kanekiyo, M., Li, D., Reyderman, L., Cohen, S., et al. (2023). Lecanemab in early Alzheimer\u2019s disease. N Engl J Med 388, 9\u201321.","journal-title":"N Engl J Med"},{"key":"2991_CR412","doi-asserted-by":"publisher","first-page":"13888","DOI":"10.1073\/pnas.1009038107","volume":"107","author":"J van Eersel","year":"2010","unstructured":"van Eersel, J., Ke, Y.D., Liu, X., Delerue, F., Kril, J.J., G\u00f6tz, J., and Ittner, L.M. (2010). Sodium selenate mitigates tau pathology, neurodegeneration, and functional deficits in Alzheimer\u2019s disease models. Proc Natl Acad Sci USA 107: 13888\u201313893.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2991_CR413","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1038\/s41591-025-03574-1","volume":"31","author":"L van Olst","year":"2025","unstructured":"van Olst, L., Simonton, B., Edwards, A.J., Forsyth, A.V., Boles, J., Jamshidi, P., Watson, T., Shepard, N., Krainc, T., Argue, B.M., et al. (2025). Microglial mechanisms drive amyloid-\u03b2 clearance in immunized patients with Alzheimer\u2019s disease. Nat Med 31, 1604\u20131616.","journal-title":"Nat Med"},{"key":"2991_CR414","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.conb.2015.10.004","volume":"36","author":"C Villegas-Llerena","year":"2016","unstructured":"Villegas-Llerena, C., Phillips, A., Garcia-Reitboeck, P., Hardy, J., and Pocock, J.M. (2016). Microglial genes regulating neuroinflammation in the progression of Alzheimer\u2019s disease. Curr Opin Neurobiol 36, 74\u201381.","journal-title":"Curr Opin Neurobiol"},{"key":"2991_CR415","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s00228-022-03315-0","volume":"78","author":"A Vitiello","year":"2022","unstructured":"Vitiello, A., Troiano, V., and La Porta, R. (2022). Statins in Alzheimer\u2019s disease (AD). Eur J Clin Pharmacol 78, 1201\u20131202.","journal-title":"Eur J Clin Pharmacol"},{"key":"2991_CR416","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.2174\/1568026615666150610141524","volume":"15","author":"C Vivar","year":"2015","unstructured":"Vivar, C. (2015). Adult hippocampal neurogenesis, aging and neurodegenerative diseases: possible strategies to prevent cognitive impairment. CTMC 15, 2175\u20132192.","journal-title":"CTMC"},{"key":"2991_CR417","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/s41591-021-01309-6","volume":"27","author":"JW Vogel","year":"2021","unstructured":"Vogel, J.W., Young, A.L., Oxtoby, N.P., Smith, R., Ossenkoppele, R., Strandberg, O.T., La Joie, R., Aksman, L.M., Grothe, M.J., Iturria-Medina, Y., et al. (2021). Four distinct trajectories of tau deposition identified in Alzheimer\u2019s disease. Nat Med 27, 871\u2013881.","journal-title":"Nat Med"},{"key":"2991_CR418","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13024-023-00627-2","volume":"18","author":"KA Walker","year":"2023","unstructured":"Walker, K.A., Le Page, L.M., Terrando, N., Duggan, M.R., Heneka, M.T., and Bettcher, B.M. (2023). The role of peripheral inflammatory insults in Alzheimer\u2019s disease: a review and research roadmap. Mol Neurodegener 18, 37.","journal-title":"Mol Neurodegener"},{"key":"2991_CR419","doi-asserted-by":"publisher","first-page":"5511","DOI":"10.7150\/thno.56541","volume":"11","author":"HL Wan","year":"2021","unstructured":"Wan, H.L., Hong, X.Y., Zhao, Z.H., Li, T., Zhang, B.G., Liu, Q., Zhao, S., Wang, J.Z., Shen, X.F., and Liu, G.P. (2021). STAT3 ameliorates cognitive deficits via regulation of NMDAR expression in an Alzheimer\u2019s disease animal model. Theranostics 11, 5511\u20135524.","journal-title":"Theranostics"},{"key":"2991_CR420","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41593-023-01494-2","volume":"27","author":"B Wang","year":"2024","unstructured":"Wang, B., Martini-Stoica, H., Qi, C., Lu, T.C., Wang, S., Xiong, W., Qi, Y., Xu, Y., Sardiello, M., Li, H., et al. (2024a). TFEB\u2014vacuolar ATPase signaling regulates lysosomal function and microglial activation in tauopathy. Nat Neurosci 27, 48\u201362.","journal-title":"Nat Neurosci"},{"key":"2991_CR421","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/j.bbapap.2009.11.015","volume":"1804","author":"J Wang","year":"2010","unstructured":"Wang, J., Fivecoat, H., Ho, L., Pan, Y., Ling, E., and Pasinetti, G.M. (2010). The role of Sirt1: at the crossroad between promotion of longevity and protection against Alzheimer\u2019s disease neuropathology. Biochim Biophys Acta 1804, 1690\u20131694.","journal-title":"Biochim Biophys Acta"},{"key":"2991_CR422","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/nrneurol.2017.111","volume":"13","author":"J Wang","year":"2017","unstructured":"Wang, J., Gu, B.J., Masters, C.L., and Wang, Y.J. (2017a). A systemic view of Alzheimer disease\u2014insights from amyloid-\u03b2 metabolism beyond the brain. Nat Rev Neurol 13, 612\u2013623.","journal-title":"Nat Rev Neurol"},{"key":"2991_CR423","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.ijbiomac.2020.07.046","volume":"163","author":"J Wang","year":"2020","unstructured":"Wang, J., Liu, Y., Xia, Q., Xia, Q., Wang, B., Yang, C., Liang, J., and Liu, X. (2020). Potential roles of telomeres and telomerase in neurodegenerative diseases. Int J Biol Macromol 163, 1060\u20131078.","journal-title":"Int J Biol Macromol"},{"key":"2991_CR424","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/nm0896-871","volume":"2","author":"JZ Wang","year":"1996","unstructured":"Wang, J.Z., Grundke-Iqbal, I., and Iqbal, K. (1996). Glycosylation of microtubule-associated protein tau: an abnormal posttranslational modification in Alzheimer\u2019s disease. Nat Med 2, 871\u2013875.","journal-title":"Nat Med"},{"key":"2991_CR425","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1460-9568.2006.05226.x","volume":"25","author":"J Wang","year":"2007","unstructured":"Wang, J., Grundke-Iqbal, I., and Iqbal, K. (2007). Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration. Eur J Neurosci 25, 59\u201368.","journal-title":"Eur J Neurosci"},{"key":"2991_CR426","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.pneurobio.2008.03.002","volume":"85","author":"JZ Wang","year":"2008","unstructured":"Wang, J.Z., and Liu, F. (2008). Microtubule-associated protein tau in development, degeneration and protection of neurons. Prog Neurobiol 85, 148\u2013175.","journal-title":"Prog Neurobiol"},{"key":"2991_CR427","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1002\/alz.13655","volume":"20","author":"P Wang","year":"2024","unstructured":"Wang, P., Lynn, A., Miskimen, K., Song, Y.E., Wisniewski, T., Cohen, M., Appleby, B. S., Safar, J.G., and Haines, J.L. (2024b). Genome-wide association studies identify novel loci in rapidly progressive Alzheimer\u2019s disease. Alzheimers Dement 20, 2034\u20132046.","journal-title":"Alzheimers Dement"},{"key":"2991_CR428","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41586-021-03855-y","volume":"597","author":"Q Wang","year":"2021","unstructured":"Wang, Q., Dhindsa, R.S., Carss, K., Harper, A.R., Nag, A., Tachmazidou, I., Vitsios, D., Deevi, S.V.V., Mackay, A., Muthas, D., et al. (2021a). Rare variant contribution to human disease in 281,104 UK Biobank exomes. Nature 597, 527\u2013532.","journal-title":"Nature"},{"key":"2991_CR429","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1186\/s12967-022-03786-w","volume":"20","author":"Q Wang","year":"2022","unstructured":"Wang, Q., Zang, F., He, C., Zhang, Z., and Xie, C. (2022). Dyslipidemia induced large-scale network connectivity abnormality facilitates cognitive decline in the Alzheimer\u2019s disease. J Transl Med 20, 567.","journal-title":"J Transl Med"},{"key":"2991_CR430","doi-asserted-by":"publisher","first-page":"5279","DOI":"10.7150\/thno.55680","volume":"11","author":"W Wang","year":"2021","unstructured":"Wang, W., Zhou, Q., Jiang, T., Li, S., Ye, J., Zheng, J., Wang, X., Liu, Y., Deng, M., Ke, D., et al. (2021b). A novel small-molecule PROTAC selectively promotes tau clearance to improve cognitive functions in Alzheimer-like models. Theranostics 11, 5279\u20135295.","journal-title":"Theranostics"},{"key":"2991_CR431","doi-asserted-by":"publisher","first-page":"e1233","DOI":"10.1038\/cddis.2014.196","volume":"5","author":"X Wang","year":"2014","unstructured":"Wang, X., Wang, Z., Chen, Y., Huang, X., Hu, Y., Zhang, R., Ho, M.S., and Xue, L. (2014). FoxO mediates APP-induced AICD-dependent cell death. Cell Death Dis 5, e1233.","journal-title":"Cell Death Dis"},{"key":"2991_CR432","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13024-016-0143-y","volume":"12","author":"Y Wang","year":"2017","unstructured":"Wang, Y., Balaji, V., Kaniyappan, S., Kr\u00fcger, L., Irsen, S., Tepper, K., Chandupatla, R. R., Maetzler, W., Schneider, A., Mandelkow, E., et al. (2017b). The release and trans-synaptic transmission of Tau via exosomes. Mol Neurodegener 12, 5.","journal-title":"Mol Neurodegener"},{"key":"2991_CR433","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1126\/science.1257132","volume":"347","author":"S Wang","year":"2015","unstructured":"Wang, S., Tsun, Z.Y., Wolfson, R.L., Shen, K., Wyant, G.A., Plovanich, M.E., Yuan, E. D., Jones, T.D., Chantranupong, L., Comb, W., et al. (2015). Lysosomal amino acid transporter SLC38A9 signals arginine sufficiency to mTORC1. Science 347, 188\u2013194.","journal-title":"Science"},{"key":"2991_CR434","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1038\/s41467-018-04120-z","volume":"9","author":"ZH Wang","year":"2018","unstructured":"Wang, Z.H., Gong, K., Liu, X., Zhang, Z., Sun, X., Wei, Z.Z., Yu, S.P., Manfredsson, F. P., Sandoval, I.M., Johnson, P.F., et al. (2018a). C\/EBP\u03b2 regulates delta-secretase expression and mediates pathogenesis in mouse models of Alzheimer\u2019s disease. Nat Commun 9, 1784.","journal-title":"Nat Commun"},{"key":"2991_CR435","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1084\/jem.20180539","volume":"215","author":"ZH Wang","year":"2018","unstructured":"Wang, Z.H., Liu, P., Liu, X., Yu, S.P., Wang, J.Z., and Ye, K. (2018b). Delta-secretase (AEP) mediates tau-splicing imbalance and accelerates cognitive decline in tauopathies. J Exp Med 215, 3038\u20133056.","journal-title":"J Exp Med"},{"key":"2991_CR436","doi-asserted-by":"publisher","first-page":"99007","DOI":"10.1172\/jci.insight.99007","volume":"3","author":"ZH Wang","year":"2018","unstructured":"Wang, Z.H., Wu, W., Kang, S.S., Liu, X., Wu, Z., Peng, J., Yu, S.P., Manfredsson, F.P., Sandoval, I.M., Liu, X., et al. (2018c). BDNF inhibits neurodegenerative disease-associated asparaginyl endopeptidase activity via phosphorylation by AKT. JCI Insight 3, 99007.","journal-title":"JCI Insight"},{"key":"2991_CR437","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.celrep.2019.06.054","volume":"28","author":"ZH Wang","year":"2019","unstructured":"Wang, Z.H., Xiang, J., Liu, X., Yu, S.P., Manfredsson, F.P., Sandoval, I.M., Wu, S., Wang, J.Z., and Ye, K. (2019). Deficiency in BDNF\/TrkB neurotrophic activity stimulates \u03b4-secretase by upregulating C\/EBP\u03b2 in Alzheimer\u2019s disease. Cell Rep 28, 655\u2013669.e5.","journal-title":"Cell Rep"},{"key":"2991_CR438","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0197-4580(00)00181-0","volume":"22","author":"J Wegiel","year":"2001","unstructured":"Wegiel, J. (2001). The role of microglial cells and astrocytes in fibrillar plaque evolution in transgenic APPSW mice. Neurobiol Aging 22, 49\u201361.","journal-title":"Neurobiol Aging"},{"key":"2991_CR439","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s13311-020-00841-6","volume":"17","author":"H Wei","year":"2020","unstructured":"Wei, H., Zhang, H., Wang, X., Xie, J., An, D., Wan, L., Wang, J., Zeng, Y., Shu, X., Westermarck, J., et al. (2020). Direct activation of protein phosphatase 2A (PP2A) by tricyclic sulfonamides ameliorates Alzheimer\u2019s disease pathogenesis in cell and animal models. Neurotherapeutics 17, 1087\u20131103.","journal-title":"Neurotherapeutics"},{"key":"2991_CR440","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0092-8674(89)90177-3","volume":"57","author":"A Weidemann","year":"1989","unstructured":"Weidemann, A., K\u00f6nig, G., Bunke, D., Fischer, P., Salbaum, J.M., Masters, C.L., and Beyreuther, K. (1989). Identification, biogenesis, and localization of precursors of Alzheimer\u2019s disease A4 amyloid protein. Cell 57, 115\u2013126.","journal-title":"Cell"},{"key":"2991_CR441","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1038\/s41588-021-00921-z","volume":"53","author":"DP Wightman","year":"2021","unstructured":"Wightman, D.P., Jansen, I.E., Savage, J.E., Shadrin, A.A., Bahrami, S., Holland, D., Rongve, A., B\u00f8rte, S., Winsvold, B.S., Drange, O.K., et al. (2021). A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer\u2019s disease. Nat Genet 53, 1276\u20131282.","journal-title":"Nat Genet"},{"key":"2991_CR442","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","volume":"186","author":"DM Wilson III","year":"2023","unstructured":"Wilson III, D.M., Cookson, M.R., Van Den Bosch, L., Zetterberg, H., Holtzman, D.M., and Dewachter, I. (2023). Hallmarks of neurodegenerative diseases. Cell 186, 693\u2013714.","journal-title":"Cell"},{"key":"2991_CR443","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S1474-4422(16)00062-4","volume":"15","author":"B Winblad","year":"2016","unstructured":"Winblad, B., Amouyel, P., Andrieu, S., Ballard, C., Brayne, C., Brodaty, H., Cedazo-Minguez, A., Dubois, B., Edvardsson, D., Feldman, H., et al. (2016). Defeating Alzheimer\u2019s disease and other dementias: a priority for European science and society. Lancet Neurol 15, 455\u2013532.","journal-title":"Lancet Neurol"},{"key":"2991_CR444","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41588-020-00773-z","volume":"53","author":"AP Wingo","year":"2021","unstructured":"Wingo, A.P., Liu, Y., Gerasimov, E.S., Gockley, J., Logsdon, B.A., Duong, D.M., Dammer, E.B., Robins, C., Beach, T.G., Reiman, E.M., et al. (2021). Integrating human brain proteomes with genome-wide association data implicates new proteins in Alzheimer\u2019s disease pathogenesis. Nat Genet 53, 143\u2013146.","journal-title":"Nat Genet"},{"key":"2991_CR445","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1001\/archneurol.2011.221","volume":"69","author":"TS Wingo","year":"2012","unstructured":"Wingo, T.S. (2012). Autosomal recessive causes likely in early-onset Alzheimer disease. Arch Neurol 69, 59\u201364.","journal-title":"Arch Neurol"},{"key":"2991_CR446","doi-asserted-by":"publisher","first-page":"4506","DOI":"10.1073\/pnas.85.12.4506","volume":"85","author":"CM Wischik","year":"1988","unstructured":"Wischik, C.M., Novak, M., Th\u00f8gersen, H.C., Edwards, P.C., Runswick, M.J., Jakes, R., Walker, J.E., Milstein, C., Roth, M., and Klug, A. (1988). Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. Proc Natl Acad Sci USA 85, 4506\u20134510.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2991_CR447","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1097\/00005072-197310000-00007","volume":"32","author":"HM Wisniewski","year":"1973","unstructured":"Wisniewski, H.M., Ghetti, B., and Terry, R.D. (1973). Neuritic (Senile) plaques and filamentous changes in aged rhesus monkeys. J Neuropathol Exp Neurol 32, 566\u2013584.","journal-title":"J Neuropathol Exp Neurol"},{"key":"2991_CR448","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/d41586-023-03590-6","volume":"623","author":"C Wong","year":"2023","unstructured":"Wong, C. (2023). UK first to approve CRISPR treatment for diseases: what you need to know. Nature 623, 676\u2013677.","journal-title":"Nature"},{"key":"2991_CR449","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S1474-4422(15)00382-8","volume":"15","author":"S Wray","year":"2016","unstructured":"Wray, S., and Fox, N.C. (2016). Stem cell therapy for Alzheimer\u2019s disease: hope or hype? Lancet Neurol 15, 133\u2013135.","journal-title":"Lancet Neurol"},{"key":"2991_CR450","doi-asserted-by":"publisher","first-page":"e428","DOI":"10.1002\/ctm2.428","volume":"11","author":"D Wu","year":"2021","unstructured":"Wu, D., Gao, D., Yu, H., Pi, G., Xiong, R., Lei, H., Wang, X., Liu, E., Ye, J., Yu, H., et al. (2021a). Medial septum tau accumulation induces spatial memory deficit via disrupting medial septum-hippocampus cholinergic pathway. Clin Transl Med 11, e428.","journal-title":"Clin Transl Med"},{"key":"2991_CR451","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13024-023-00614-7","volume":"18","author":"D Wu","year":"2023","unstructured":"Wu, D., Yu, N., Gao, Y., Xiong, R., Liu, L., Lei, H., Jin, S., Liu, J., Liu, Y., Xie, J., et al. (2023). Targeting a vulnerable septum-hippocampus cholinergic circuit in a critical time window ameliorates tau-impaired memory consolidation. Mol Neurodegener 18, 23.","journal-title":"Mol Neurodegener"},{"key":"2991_CR452","doi-asserted-by":"publisher","first-page":"101409","DOI":"10.1016\/j.arr.2021.101409","volume":"70","author":"KM Wu","year":"2021","unstructured":"Wu, K.M., Zhang, Y.R., Huang, Y.Y., Dong, Q., Tan, L., and Yu, J.T. (2021b). The role of the immune system in Alzheimer\u2019s disease. Ageing Res Rev 70, 101409.","journal-title":"Ageing Res Rev"},{"key":"2991_CR453","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1016\/j.chembiol.2024.09.003","volume":"31","author":"Y Xiao","year":"2024","unstructured":"Xiao, Y., Wei, L., Su, J., Lei, H., Sun, F., Li, M., Li, S., Wang, X., Zheng, J., and Wang, J. Z. (2024). A tau dephosphorylation-targeting chimera selectively recruits protein phosphatase-1 to ameliorate Alzheimer\u2019s disease and tauopathies. Cell Chem Biol 31, 1787\u20131799.e6.","journal-title":"Cell Chem Biol"},{"key":"2991_CR454","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/s41586-022-04463-0","volume":"603","author":"J Xiong","year":"2022","unstructured":"Xiong, J., Kang, S.S., Wang, Z., Liu, X., Kuo, T.C., Korkmaz, F., Padilla, A., Miyashita, S., Chan, P., Zhang, Z., et al. (2022). FSH blockade improves cognition in mice with Alzheimer\u2019s disease. Nature 603, 470\u2013476.","journal-title":"Nature"},{"key":"2991_CR455","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1007\/s12264-023-01025-w","volume":"39","author":"J Xiong","year":"2023","unstructured":"Xiong, J., Zhang, Z., and Ye, K. (2023). C\/EBP\u03b2\/AEP signaling drives Alzheimer\u2019s disease pathogenesis. Neurosci Bull 39, 1173\u20131185.","journal-title":"Neurosci Bull"},{"key":"2991_CR456","doi-asserted-by":"publisher","first-page":"RC118","DOI":"10.1523\/JNEUROSCI.21-01-j0001.2001","volume":"21","author":"J Xu","year":"2001","unstructured":"Xu, J., Chen, S., Ahmed, S.H., Chen, H., Ku, G., Goldberg, M.P., and Hsu, C.Y. (2001). Amyloid-\u03b2 peptides are cytotoxic to oligodendrocytes. J Neurosci 21, RC118.","journal-title":"J Neurosci"},{"key":"2991_CR457","doi-asserted-by":"publisher","first-page":"L23","DOI":"10.1016\/j.bpj.2013.10.006","volume":"105","author":"J Xu","year":"2013","unstructured":"Xu, J., King, S.J., Lapierre-Landry, M., and Nemec, B. (2013). Interplay between velocity and travel distance of kinesin-based transport in the presence of tau. Biophys J 105, L23\u2013L25.","journal-title":"Biophys J"},{"key":"2991_CR458","doi-asserted-by":"publisher","first-page":"111717","DOI":"10.1016\/j.celrep.2022.111717","volume":"41","author":"J Xu","year":"2022","unstructured":"Xu, J., Mao, C., Hou, Y., Luo, Y., Binder, J.L., Zhou, Y., Bekris, L.M., Shin, J., Hu, M., Wang, F., et al. (2022). Interpretable deep learning translation of GWAS and multi-omics findings to identify pathobiology and drug repurposing in Alzheimer\u2019s disease. Cell Rep 41, 111717.","journal-title":"Cell Rep"},{"key":"2991_CR459","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1242\/jcs.109.5.999","volume":"109","author":"T Yamazaki","year":"1996","unstructured":"Yamazaki, T., Koo, E.H., and Selkoe, D.J. (1996). Trafficking of cell-surface amyloid \u03b2-protein precursor: II. Endocytosis, recycling, and lysosomal targeting detected by immunolocalization. J Cell Sci 109, 999\u20131008.","journal-title":"J Cell Sci"},{"key":"2991_CR460","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","volume":"15","author":"Y Yamazaki","year":"2019","unstructured":"Yamazaki, Y., Zhao, N., Caulfield, T.R., Liu, C.C., and Bu, G. (2019). Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. Nat Rev Neurol 15, 501\u2013518.","journal-title":"Nat Rev Neurol"},{"key":"2991_CR461","doi-asserted-by":"publisher","first-page":"682","DOI":"10.3389\/fphar.2018.00682","volume":"9","author":"C Yang","year":"2018","unstructured":"Yang, C., Li, X., Gao, W., Wang, Q., Zhang, L., Li, Y., Li, L., and Zhang, L. (2018). Cornel iridoid glycoside inhibits tau hyperphosphorylation via regulating cross-talk between GSK-3\u03b2 and PP2A signaling. Front Pharmacol 9, 682.","journal-title":"Front Pharmacol"},{"key":"2991_CR462","doi-asserted-by":"publisher","first-page":"5938","DOI":"10.3390\/molecules28165938","volume":"28","author":"MH Yang","year":"2023","unstructured":"Yang, M.H., Ho, T.C., Chang, C.C., Su, Y.S., Yuan, C.H., Chuang, K.P., and Tyan, Y.C. (2023a). Utilizing proteomic approaches to uncover the neuroprotective effects of ACE inhibitors: implications for Alzheimer\u2019s disease treatment. Molecules 28, 5938.","journal-title":"Molecules"},{"key":"2991_CR463","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1038\/s41588-023-01506-8","volume":"55","author":"X Yang","year":"2023","unstructured":"Yang, X., Wen, J., Yang, H., Jones, I.R., Zhu, X., Liu, W., Li, B., Clelland, C.D., Luo, W., Wong, M.Y., et al. (2023b). Functional characterization of Alzheimer\u2019s disease genetic variants in microglia. Nat Genet 55, 1735\u20131744.","journal-title":"Nat Genet"},{"key":"2991_CR464","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/j.1471-4159.2007.04603.x","volume":"102","author":"Y Yang","year":"2007","unstructured":"Yang, Y., Yang, X., Wang, Y., Tian, Q., Wang, X., Li, H., Wang, Q., and Wang, J. (2007). Inhibition of protein phosphatases induces transport deficits and axonopathy. J Neurochem 102, 878\u2013886.","journal-title":"J Neurochem"},{"key":"2991_CR465","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1002\/alz.12845","volume":"19","author":"HN Yassine","year":"2023","unstructured":"Yassine, H.N., Self, W., Kerman, B.E., Santoni, G., Navalpur Shanmugam, N.K., Abdullah, L., Golden, L.R., Fonteh, A.N., Harrington, M.G., Gr\u00e4ff, J., et al. (2023). Nutritional metabolism and cerebral bioenergetics in Alzheimer\u2019s disease and related dementias. Alzheimers Dement 19, 1041\u20131066.","journal-title":"Alzheimers Dement"},{"key":"2991_CR466","doi-asserted-by":"publisher","first-page":"9220","DOI":"10.1096\/fj.201900604R","volume":"33","author":"T Yasumoto","year":"2019","unstructured":"Yasumoto, T., Takamura, Y., Tsuji, M., Watanabe-Nakayama, T., Imamura, K., Inoue, H., Nakamura, S., Inoue, T., Kimura, A., Yano, S., et al. (2019). High molecular weight amyloid \u03b21-42 oligomers induce neurotoxicity via plasma membrane damage. FASEB J 33, 9220\u20139234.","journal-title":"FASEB J"},{"key":"2991_CR467","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.4103\/1673-5374.385847","volume":"19","author":"J Ye","year":"2024","unstructured":"Ye, J., Wan, H., Chen, S., and Liu, G.P. (2024). Targeting tau in Alzheimer\u2019s disease: from mechanisms to clinical therapy. Neural Regener Res 19, 1489\u20131498.","journal-title":"Neural Regener Res"},{"key":"2991_CR468","doi-asserted-by":"publisher","first-page":"e13209","DOI":"10.1111\/acel.13209","volume":"19","author":"J Ye","year":"2020","unstructured":"Ye, J., Yin, Y., Yin, Y., Zhang, H., Wan, H., Wang, L., Zuo, Y., Gao, D., Li, M., Li, J., et al. (2020). Tau-induced upregulation of C\/EBP\u03b2-TRPC1-SOCE signaling aggravates tauopathies: a vicious cycle in Alzheimer neurodegeneration. Aging Cell 19, e13209.","journal-title":"Aging Cell"},{"key":"2991_CR469","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1471-4159.2006.04052.x","volume":"99","author":"H Yoshida","year":"2006","unstructured":"Yoshida, H., and Goedert, M. (2006). Sequential phosphorylation of tau protein by cAMP-dependent protein kinase and SAPK4\/p38\u03b4 or JNK2 in the presence of heparin generates the AT100 epitope. J Neurochem 99, 154\u2013164.","journal-title":"J Neurochem"},{"key":"2991_CR470","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.stem.2015.02.004","volume":"16","author":"JE Young","year":"2015","unstructured":"Young, J.E., Boulanger-Weill, J., Williams, D.A., Woodruff, G., Buen, F., Revilla, A.C., Herrera, C., Israel, M.A., Yuan, S.H., Edland, S.D., et al. (2015). Elucidating molecular phenotypes caused by the SORL1 Alzheimer\u2019s disease genetic risk factor using human induced pluripotent stem cells. Cell Stem Cell 16, 373\u2013385.","journal-title":"Cell Stem Cell"},{"key":"2991_CR471","doi-asserted-by":"publisher","first-page":"937.e1","DOI":"10.1016\/j.neurobiolaging.2013.10.075","volume":"35","author":"JT Yu","year":"2014","unstructured":"Yu, J.T., Jiang, T., Wang, Y.L., Wang, H.F., Zhang, W., Hu, N., Tan, L., Sun, L., Tan, M.S., Zhu, X.C., et al. (2014). Triggering receptor expressed on myeloid cells 2 variant is rare in late-onset Alzheimer\u2019s disease in Han Chinese individuals. Neurobiol Aging 35, 937.e1\u2013937.e3.","journal-title":"Neurobiol Aging"},{"key":"2991_CR472","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1001\/jamaneurol.2014.3049","volume":"72","author":"L Yu","year":"2015","unstructured":"Yu, L., Chibnik, L.B., Srivastava, G.P., Pochet, N., Yang, J., Xu, J., Kozubek, J., Obholzer, N., Leurgans, S.E., Schneider, J.A., et al. (2015). Association of brain DNA methylation in SORL1, ABCA7, HLA-DRB5, SLC24A4, and BIN1 with pathological diagnosis of Alzheimer disease. JAMA Neurol 72, 15\u201324.","journal-title":"JAMA Neurol"},{"key":"2991_CR473","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3233\/JAD-170061","volume":"58","author":"XZ Yuan","year":"2017","unstructured":"Yuan, X.Z., Sun, S., Tan, C.C., Yu, J.T., and Tan, L. (2017). The role of ADAM10 in Alzheimer\u2019s disease. J Alzheimer\u2019s Dis 58, 303\u2013322.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"2991_CR474","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/s41594-021-00560-2","volume":"28","author":"J Zeng","year":"2021","unstructured":"Zeng, J., Santos, A.F., Mukadam, A.S., Osswald, M., Jacques, D.A., Dickson, C.F., McLaughlin, S.H., Johnson, C.M., Kiss, L., Luptak, J., et al. (2021). Target-induced clustering activates Trim-Away of pathogens and proteins. Nat Struct Mol Biol 28, 278\u2013289.","journal-title":"Nat Struct Mol Biol"},{"key":"2991_CR475","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1038\/s41598-018-19641-2","volume":"8","author":"C Zhang","year":"2018","unstructured":"Zhang, C., Griciuc, A., Hudry, E., Wan, Y., Quinti, L., Ward, J., Forte, A.M., Shen, X., Ran, C., Elmaleh, D.R., et al. (2018). Cromolyn reduces levels of the Alzheimer\u2019s disease-associated amyloid \u03b2-protein by promoting microglial phagocytosis. Sci Rep 8, 1144.","journal-title":"Sci Rep"},{"key":"2991_CR476","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41593-019-0372-9","volume":"22","author":"P Zhang","year":"2019","unstructured":"Zhang, P., Kishimoto, Y., Grammatikakis, I., Gottimukkala, K., Cutler, R.G., Zhang, S., Abdelmohsen, K., Bohr, V.A., Misra Sen, J., Gorospe, M., et al. (2019). Senolytic therapy alleviates A\u03b2-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer\u2019s disease model. Nat Neurosci 22, 719\u2013728.","journal-title":"Nat Neurosci"},{"key":"2991_CR477","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41380-018-0101-x","volume":"25","author":"S Zhang","year":"2020","unstructured":"Zhang, S., Cai, F., Wu, Y., Bozorgmehr, T., Wang, Z., Zhang, S., Huang, D., Guo, J., Shen, L., Rankin, C., et al. (2020). A presenilin-1 mutation causes Alzheimer disease without affecting Notch signaling. Mol Psychiatry 25, 603\u2013613.","journal-title":"Mol Psychiatry"},{"key":"2991_CR478","doi-asserted-by":"publisher","first-page":"6915","DOI":"10.1523\/JNEUROSCI.0340-17.2017","volume":"37","author":"S Zhang","year":"2017","unstructured":"Zhang, S., Wang, Z., Cai, F., Zhang, M., Wu, Y., Zhang, J., and Song, W. (2017a). BACE1 cleavage site selection critical for amyloidogenesis and Alzheimer\u2019s pathogenesis. J Neurosci 37, 6915\u20136925.","journal-title":"J Neurosci"},{"key":"2991_CR479","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/alzrt211","volume":"5","author":"X Zhang","year":"2013","unstructured":"Zhang, X., and Song, W. (2013). The role of APP and BACE1 trafficking in APP processing and amyloid-\u03b2 generation. Alzheimers Res Ther 5, 46.","journal-title":"Alzheimers Res Ther"},{"key":"2991_CR480","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3233\/JAD-150041","volume":"48","author":"XF Zhang","year":"2015","unstructured":"Zhang, X.F., Zhao, Y.F., Zhu, S.W., Huang, W.J., Luo, Y., Chen, Q.Y., Ge, L.J., Li, R.S., Wang, J.F., Sun, M., et al. (2015). CXCL1 triggers caspase-3 dependent tau cleavage in long-term neuronal cultures and in the hippocampus of aged mice: implications in Alzheimer\u2019s disease. J Alzheimer\u2019s Dis 48, 89\u2013104.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"2991_CR481","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.pneurobio.2017.03.001","volume":"153","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y., and Song, W. (2017). Islet amyloid polypeptide: another key molecule in Alzheimer\u2019s pathogenesis? Prog Neurobiol 153, 100\u2013120.","journal-title":"Prog Neurobiol"},{"key":"2991_CR482","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13024-022-00533-z","volume":"17","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y., Wu, K.M., Yang, L., Dong, Q., and Yu, J.T. (2022). Tauopathies: new perspectives and challenges. Mol Neurodegeneration 17, 28.","journal-title":"Mol Neurodegeneration"},{"key":"2991_CR483","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/nsmb.3433","volume":"24","author":"Z Zhang","year":"2017","unstructured":"Zhang, Z., Kang, S.S., Liu, X., Ahn, E.H., Zhang, Z., He, L., Iuvone, P.M., Duong, D.M., Seyfried, N.T., Benskey, M.J., et al. (2017b). Asparagine endopeptidase cleaves \u03b1-synuclein and mediates pathologic activities in Parkinson\u2019s disease. Nat Struct Mol Biol 24, 632\u2013642.","journal-title":"Nat Struct Mol Biol"},{"key":"2991_CR484","doi-asserted-by":"publisher","first-page":"14740","DOI":"10.1038\/ncomms14740","volume":"8","author":"Z Zhang","year":"2017","unstructured":"Zhang, Z., Obianyo, O., Dall, E., Du, Y., Fu, H., Liu, X., Kang, S.S., Song, M., Yu, S.P., Cabrele, C., et al. (2017c). Inhibition of delta-secretase improves cognitive functions in mouse models of Alzheimer\u2019s disease. Nat Commun 8, 14740.","journal-title":"Nat Commun"},{"key":"2991_CR485","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1038\/nm.3700","volume":"20","author":"Z Zhang","year":"2014","unstructured":"Zhang, Z., Song, M., Liu, X., Kang, S.S., Kwon, I.S., Duong, D.M., Seyfried, N.T., Hu, W.T., Liu, Z., Wang, J.Z., et al. (2014). Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer\u2019s disease. Nat Med 20, 1254\u20131262.","journal-title":"Nat Med"},{"key":"2991_CR486","doi-asserted-by":"publisher","first-page":"5540","DOI":"10.1038\/s41467-020-19264-0","volume":"11","author":"J Zhao","year":"2020","unstructured":"Zhao, J., Fu, Y., Yamazaki, Y., Ren, Y., Davis, M.D., Liu, C.C., Lu, W., Wang, X., Chen, K., Cherukuri, Y., et al. (2020). APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer\u2019s disease patient iPSC-derived cerebral organoids. Nat Commun 11, 5540.","journal-title":"Nat Commun"},{"key":"2991_CR487","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.7150\/ijbs.81900","volume":"19","author":"X Zhao","year":"2023","unstructured":"Zhao, X., Sun, J., Xiong, L., She, L., Li, L., Tang, H., Zeng, Y., Chen, F., Han, X., Ye, S., et al. (2023). \u03b2-amyloid binds to microglia Dectin-1 to induce inflammatory response in the pathogenesis of Alzheimer\u2019s disease. Int J Biol Sci 19, 3249\u20133265.","journal-title":"Int J Biol Sci"},{"key":"2991_CR488","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/nn.4025","volume":"18","author":"Z Zhao","year":"2015","unstructured":"Zhao, Z., Sagare, A.P., Ma, Q., Halliday, M.R., Kong, P., Kisler, K., Winkler, E.A., Ramanathan, A., Kanekiyo, T., Bu, G., et al. (2015). Central role for PICALM in amyloid-\u03b2 blood-brain barrier transcytosis and clearance. Nat Neurosci 18, 978\u2013987.","journal-title":"Nat Neurosci"},{"key":"2991_CR489","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.stem.2019.12.015","volume":"26","author":"J Zheng","year":"2020","unstructured":"Zheng, J., Li, H.L., Tian, N., Liu, F., Wang, L., Yin, Y., Yue, L., Ma, L., Wan, Y., and Wang, J.Z. (2020). Interneuron accumulation of phosphorylated tau impairs adult hippocampal neurogenesis by suppressing GABAergic transmission. Cell Stem Cell 26, 331\u2013345.e6.","journal-title":"Cell Stem Cell"},{"key":"2991_CR490","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41392-021-00669-2","volume":"6","author":"J Zheng","year":"2021","unstructured":"Zheng, J., Tian, N., Liu, F., Zhang, Y., Su, J., Gao, Y., Deng, M., Wei, L., Ye, J., Li, H., et al. (2021). A novel dephosphorylation targeting chimera selectively promoting tau removal in tauopathies. Sig Transduct Target Ther 6, 269.","journal-title":"Sig Transduct Target Ther"},{"key":"2991_CR491","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12974-023-02722-z","volume":"20","author":"M Zy\u015bk","year":"2023","unstructured":"Zy\u015bk, M., Beretta, C., Naia, L., Dakhel, A., P\u00e5v\u00e9nius, L., Brismar, H., Lindskog, M., Ankarcrona, M., and Erlandsson, A. (2023). Amyloid-\u03b2 accumulation in human astrocytes induces mitochondrial disruption and changed energy metabolism. J Neuroinflamm 20, 43.","journal-title":"J Neuroinflamm"}],"container-title":["Science China Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-025-2991-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11427-025-2991-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-025-2991-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T16:02:20Z","timestamp":1784908940000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11427-025-2991-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":491,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["2991"],"URL":"https:\/\/doi.org\/10.1007\/s11427-025-2991-7","relation":{},"ISSN":["1674-7305","1869-1889"],"issn-type":[{"value":"1674-7305","type":"print"},{"value":"1869-1889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"25 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance and ethics"}}]}}